Genes that influence the PHENOTYPE only in the homozygous state.
The magnitude of INBREEDING in humans.
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
An individual in which both alleles at a given locus are identical.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
A genetic disorder with autosomal recessive inheritance, characterized by multiple CYSTS in both KIDNEYS and associated LIVER lesions. Serious manifestations are usually present at BIRTH with high PERINATAL MORTALITY.
The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME.
Any method used for determining the location of and relative distances between genes on a chromosome.
Genes that influence the PHENOTYPE both in the homozygous and the heterozygous state.
Biochemical identification of mutational changes in a nucleotide sequence.
A characteristic symptom complex.
An individual having different alleles at one or more loci regarding a specific character.
Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.
Hereditary, progressive degeneration of the neuroepithelium of the retina characterized by night blindness and progressive contraction of the visual field.
A mutation in which a codon is mutated to one directing the incorporation of a different amino acid. This substitution may result in an inactive or unstable product. (From A Dictionary of Genetics, King & Stansfield, 5th ed)
The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for "logarithmic odds."
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Genes whose loss of function or gain of function MUTATION leads to the death of the carrier prior to maturity. They may be essential genes (GENES, ESSENTIAL) required for viability, or genes which cause a block of function of an essential gene at a time when the essential gene function is required for viability.
Any of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
Deliberate breeding of two different individuals that results in offspring that carry part of the genetic material of each parent. The parent organisms must be genetically compatible and may be from different varieties or closely related species.
An amino acid-specifying codon that has been converted to a stop codon (CODON, TERMINATOR) by mutation. Its occurance is abnormal causing premature termination of protein translation and results in production of truncated and non-functional proteins. A nonsense mutation is one that converts an amino acid-specific codon to a stop codon.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
A congenital abnormality in which the CEREBRUM is underdeveloped, the fontanels close prematurely, and, as a result, the head is small. (Desk Reference for Neuroscience, 2nd ed.)
Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. All forms of dystrophic epidermolysis bullosa result from mutations in COLLAGEN TYPE VII, a major component fibrils of BASEMENT MEMBRANE and EPIDERMIS.
The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX.
The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.
A general term for the complete loss of the ability to hear from both ears.
Presence of less than the normal amount of hair. (Dorland, 27th ed)
A type of mutation in which a number of NUCLEOTIDES deleted from or inserted into a protein coding sequence is not divisible by three, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the mutation. These mutations may be induced by certain types of MUTAGENS or may occur spontaneously.
A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
Identification of genetic carriers for a given trait.
The presence of apparently similar characters for which the genetic evidence indicates that different genes or different genetic mechanisms are involved in different pedigrees. In clinical settings genetic heterogeneity refers to the presence of a variety of genetic defects which cause the same disease, often due to mutations at different loci on the same gene, a finding common to many human diseases including ALZHEIMER DISEASE; CYSTIC FIBROSIS; LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL; and POLYCYSTIC KIDNEY DISEASES. (Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed; Segen, Dictionary of Modern Medicine, 1992)
Designation for several severe forms of ichthyosis, present at birth, that are characterized by hyperkeratotic scaling. Infants may be born encased in a collodion membrane which begins shedding within 24 hours. This is followed in about two weeks by persistent generalized scaling. The forms include bullous (HYPERKERATOSIS, EPIDERMOLYTIC), non-bullous (ICHTHYOSIS, LAMELLAR), wet type, and dry type.
That part of the genome that corresponds to the complete complement of EXONS of an organism or cell.
A phenomenon that is observed when a small subgroup of a larger POPULATION establishes itself as a separate and isolated entity. The subgroup's GENE POOL carries only a fraction of the genetic diversity of the parental population resulting in an increased frequency of certain diseases in the subgroup, especially those diseases known to be autosomal recessive.
The health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members.
A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.
A test used to determine whether or not complementation (compensation in the form of dominance) will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell.
Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species.
A variety of simple repeat sequences that are distributed throughout the GENOME. They are characterized by a short repeat unit of 2-8 basepairs that is repeated up to 100 times. They are also known as short tandem repeats (STRs).
Abnormal development of cartilage and bone.
Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90)
A chronic, congenital ichthyosis inherited as an autosomal recessive trait. Infants are usually born encased in a collodion membrane which sheds within a few weeks. Scaling is generalized and marked with grayish-brown quadrilateral scales, adherent at their centers and free at the edges. In some cases, scales are so thick that they resemble armored plate.
A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.
Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment.
A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.
Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent's genome or they may be acquired in utero.
A non-fibrillar collagen involved in anchoring the epidermal BASEMENT MEMBRANE to underlying tissue. It is a homotrimer comprised of C-terminal and N-terminal globular domains connected by a central triple-helical region.
A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.
A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.
Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing.
The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION.
A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.
Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.
Variation in a population's DNA sequence that is detected by determining alterations in the conformation of denatured DNA fragments. Denatured DNA fragments are allowed to renature under conditions that prevent the formation of double-stranded DNA and allow secondary structure to form in single stranded fragments. These fragments are then run through polyacrylamide gels to detect variations in the secondary structure that is manifested as an alteration in migration through the gels.
The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.
Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder.
The different ways GENES and their ALLELES interact during the transmission of genetic traits that effect the outcome of GENE EXPRESSION.
Excessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis (HEMATOPOIESIS, EXTRAMEDULLARY).
Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.
A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.
Mice bearing mutant genes which are phenotypically expressed in the animals.
Members of a Semitic people inhabiting the Arabian peninsula or other countries of the Middle East and North Africa. The term may be used with reference to ancient, medieval, or modern ethnic or cultural groups. (From Random House Unabridged Dictionary, 2d ed)
Mutation process that restores the wild-type PHENOTYPE in an organism possessing a mutationally altered GENOTYPE. The second "suppressor" mutation may be on a different gene, on the same gene but located at a distance from the site of the primary mutation, or in extrachromosomal genes (EXTRACHROMOSOMAL INHERITANCE).
A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.
Inherited myotonic disorders with early childhood onset MYOTONIA. Muscular hypertrophy is common and myotonia may impair ambulation and other movements. It is classified as Thomsen (autosomal dominant) or Becker (autosomal recessive) generalized myotonia mainly based on the inheritance pattern. Becker type is also clinically more severe. An autosomal dominant variant with milder symptoms and later onset is known as myotonia levior. Mutations in the voltage-dependent skeletal muscle chloride channel are associated with the disorders.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual.
A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)
Deletion of sequences of nucleic acids from the genetic material of an individual.
A general term for the complete or partial loss of the ability to hear from one or both ears.
A group of hereditary disorders involving tissues and structures derived from the embryonic ectoderm. They are characterized by the presence of abnormalities at birth and involvement of both the epidermis and skin appendages. They are generally nonprogressive and diffuse. Various forms exist, including anhidrotic and hidrotic dysplasias, FOCAL DERMAL HYPOPLASIA, and aplasia cutis congenita.
An autosomal recessive disease, usually of childhood onset, characterized pathologically by degeneration of the spinocerebellar tracts, posterior columns, and to a lesser extent the corticospinal tracts. Clinical manifestations include GAIT ATAXIA, pes cavus, speech impairment, lateral curvature of spine, rhythmic head tremor, kyphoscoliosis, congestive heart failure (secondary to a cardiomyopathy), and lower extremity weakness. Most forms of this condition are associated with a mutation in a gene on chromosome 9, at band q13, which codes for the mitochondrial protein frataxin. (From Adams et al., Principles of Neurology, 6th ed, p1081; N Engl J Med 1996 Oct 17;335(16):1169-75) The severity of Friedreich ataxia associated with expansion of GAA repeats in the first intron of the frataxin gene correlates with the number of trinucleotide repeats. (From Durr et al, N Engl J Med 1996 Oct 17;335(16):1169-75)
Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.
Recording of electric potentials in the retina after stimulation by light.
Defective bone formation involving individual bones, singly or in combination.
An antineoplastic agent with alkylating properties. It also acts as a mutagen by damaging DNA and is used experimentally for that effect.
An infant during the first month after birth.
Clinical conditions caused by an abnormal chromosome constitution in which there is extra or missing chromosome material (either a whole chromosome or a chromosome segment). (from Thompson et al., Genetics in Medicine, 5th ed, p429)
Deformities in nail structure or appearance, including hypertrophy, splitting, clubbing, furrowing, etc. Genetic diseases such as PACHYONYCHIA CONGENITA can result in malformed nails.
A social group consisting of parents or parent substitutes and children.
A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
Coloration or discoloration of a part by a pigment.
Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types.
An ethnic group with historical ties to the land of ISRAEL and the religion of JUDAISM.
Congenital or developmental anomaly in which the eyeballs are abnormally small.
Persistent flexure or contracture of a joint.
A congenital anomaly of the hand or foot, marked by the webbing between adjacent fingers or toes. Syndactylies are classified as complete or incomplete by the degree of joining. Syndactylies can also be simple or complex. Simple syndactyly indicates joining of only skin or soft tissue; complex syndactyly marks joining of bony elements.
A group of connective tissue diseases in which skin hangs in loose pendulous folds. It is believed to be associated with decreased elastic tissue formation as well as an abnormality in elastin formation. Cutis laxa is usually a genetic disease, but acquired cases have been reported. (From Dorland, 27th ed)
A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.
A heterogeneous group of hereditary and acquired disorders in which the KIDNEY contains one or more CYSTS unilaterally or bilaterally (KIDNEY, CYSTIC).
The analysis of a sequence such as a region of a chromosome, a haplotype, a gene, or an allele for its involvement in controlling the phenotype of a specific trait, metabolic pathway, or disease.
A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)
Congenital absence of or defects in structures of the eye; may also be hereditary.
A group of genetic disorders of the KIDNEY TUBULES characterized by the accumulation of metabolically produced acids with elevated plasma chloride, hyperchloremic metabolic ACIDOSIS. Defective renal acidification of URINE (proximal tubules) or low renal acid excretion (distal tubules) can lead to complications such as HYPOKALEMIA, hypercalcinuria with NEPHROLITHIASIS and NEPHROCALCINOSIS, and RICKETS.
Alterations or deviations from normal shape or size which result in a disfigurement of the foot occurring at or before birth.
Diseases affecting the orderly growth and persistence of hair.
A group of inherited disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and clinically by loss of sensation and autonomic dysfunction. There are five subtypes. Type I features autosomal dominant inheritance and distal sensory involvement. Type II is characterized by autosomal inheritance and distal and proximal sensory loss. Type III is DYSAUTONOMIA, FAMILIAL. Type IV features insensitivity to pain, heat intolerance, and mental deficiency. Type V is characterized by a selective loss of pain with intact light touch and vibratory sensation. (From Joynt, Clinical Neurology, 1995, Ch51, pp142-4)
Disorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances (e.g., ACIDOSIS) and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life.
A group of inherited diseases that share similar phenotypes but are genetically diverse. Different genetic loci for autosomal recessive, autosomal dominant, and x-linked forms of hereditary spastic paraplegia have been identified. Clinically, patients present with slowly progressive distal limb weakness and lower extremity spasticity. Peripheral sensory neurons may be affected in the later stages of the disease. (J Neurol Neurosurg Psychiatry 1998 Jan;64(1):61-6; Curr Opin Neurol 1997 Aug;10(4):313-8)
Genetic diseases that are linked to gene mutations on the X CHROMOSOME in humans (X CHROMOSOME, HUMAN) or the X CHROMOSOME in other species. Included here are animal models of human X-linked diseases.
A family of transmembrane dystrophin-associated proteins that play a role in the membrane association of the DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX.
Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.
A SMN complex protein that is essential for the function of the SMN protein complex. In humans the protein is encoded by a single gene found near the inversion telomere of a large inverted region of CHROMOSOME 5. Mutations in the gene coding for survival of motor neuron 1 protein may result in SPINAL MUSCULAR ATROPHIES OF CHILDHOOD.
The functional hereditary units of PLANTS.
Short sequences (generally about 10 base pairs) of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques.
A metabolic disease characterized by the defective transport of CYSTINE across the lysosomal membrane due to mutation of a membrane protein cystinosin. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. In the KIDNEY, nephropathic cystinosis is a common cause of RENAL FANCONI SYNDROME.
The percent frequency with which a dominant or homozygous recessive gene or gene combination manifests itself in the phenotype of the carriers. (From Glossary of Genetics, 5th ed)
Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.
The appearance of the face that is often characteristic of a disease or pathological condition, as the elfin facies of WILLIAMS SYNDROME or the mongoloid facies of DOWN SYNDROME. (Random House Unabridged Dictionary, 2d ed)
A country in northern Africa between ALGERIA and LIBYA. Its capital is Tunis.
A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching.
Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004)
A species of fruit fly much used in genetics because of the large size of its chromosomes.
Group of mostly hereditary disorders characterized by thickening of the palms and soles as a result of excessive keratin formation leading to hypertrophy of the stratum corneum (hyperkeratosis).
Color of hair or fur.
Abnormal number or structure of the SEX CHROMOSOMES. Some sex chromosome aberrations are associated with SEX CHROMOSOME DISORDERS and SEX CHROMOSOME DISORDERS OF SEX DEVELOPMENT.
A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.
Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.
Process of generating a genetic MUTATION. It may occur spontaneously or be induced by MUTAGENS.
Failure or imperfection of vision at night or in dim light, with good vision only on bright days. (Dorland, 27th ed)
The relative amount by which the average fitness of a POPULATION is lowered, due to the presence of GENES that decrease survival, compared to the GENOTYPE with maximum or optimal fitness. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
Individuals whose ancestral origins are in the southeastern and eastern areas of the Asian continent.
Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.
The mating of plants or non-human animals which are closely related genetically.
Congenital structural deformities of the upper and lower extremities collectively or unspecified.
Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
Alterations or deviations from normal shape or size which result in a disfigurement of the hand occurring at or before birth.
A specific pair of GROUP F CHROMOSOMES of the human chromosome classification.
The degree of similarity between sequences of amino acids. This information is useful for the analyzing genetic relatedness of proteins and species.
The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
A group of recessively inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I (Werdnig-Hoffman disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. (J Med Genet 1996 Apr:33(4):281-3)
Nucleotide sequences located at the ends of EXONS and recognized in pre-messenger RNA by SPLICEOSOMES. They are joined during the RNA SPLICING reaction, forming the junctions between exons.
An autosomal recessive disorder characterized by RETINITIS PIGMENTOSA; POLYDACTYLY; OBESITY; MENTAL RETARDATION; hypogenitalism; renal dysplasia; and short stature. This syndrome has been distinguished as a separate entity from LAURENCE-MOON SYNDROME. (From J Med Genet 1997 Feb;34(2):92-8)
Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.
COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I.
A specific pair GROUP C CHROMSOMES of the human chromosome classification.
The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
A diverse class of enzymes that interact with UBIQUITIN-CONJUGATING ENZYMES and ubiquitination-specific protein substrates. Each member of this enzyme group has its own distinct specificity for a substrate and ubiquitin-conjugating enzyme. Ubiquitin-protein ligases exist as both monomeric proteins multiprotein complexes.
A complex of proteins that assemble the SNRNP CORE PROTEINS into a core structure that surrounds a highly conserved RNA sequence found in SMALL NUCLEAR RNA. They are found localized in the GEMINI OF COILED BODIES and in the CYTOPLASM. The SMN complex is named after the Survival of Motor Neuron Complex Protein 1, which is a critical component of the complex.
Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
Congenital absence of or defects in structures of the teeth.
An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 (11q22-q23).
Mapping of the linear order of genes on a chromosome with units indicating their distances by using methods other than genetic recombination. These methods include nucleotide sequencing, overlapping deletions in polytene chromosomes, and electron micrography of heteroduplex DNA. (From King & Stansfield, A Dictionary of Genetics, 5th ed)
The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms.
Genes that have a suppressor allele or suppressor mutation (SUPPRESSION, GENETIC) which cancels the effect of a previous mutation, enabling the wild-type phenotype to be maintained or partially restored. For example, amber suppressors cancel the effect of an AMBER NONSENSE MUTATION.
Autosomal recessive hereditary disorders characterized by congenital SENSORINEURAL HEARING LOSS and RETINITIS PIGMENTOSA. Genetically and symptomatically heterogeneous, clinical classes include type I, type II, and type III. Their severity, age of onset of retinitis pigmentosa and the degree of vestibular dysfunction are variable.
A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.
Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.
Genotypic differences observed among individuals in a population.
A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.
A family composed of spouses and their children.
A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Gross hypo- or aplasia of one or more long bones of one or more limbs. The concept includes amelia, hemimelia, phocomelia, and sirenomelia.
Persons or animals having at least one parent in common. (American College Dictionary, 3d ed)
The chromosomal constitution of cells, in which each type of CHROMOSOME is represented twice. Symbol: 2N or 2X.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
A clinically and genetically heterogeneous group of hereditary conditions characterized by malformed DENTAL ENAMEL, usually involving DENTAL ENAMEL HYPOPLASIA and/or TOOTH HYPOMINERALIZATION.
Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment.
The human female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in humans.
One of the two pairs of human chromosomes in the group B class (CHROMOSOMES, HUMAN, 4-5).
A heterogenous group of inherited muscular dystrophy that can be autosomal dominant or autosomal recessive. There are many forms (called LGMDs) involving genes encoding muscle membrane proteins such as the sarcoglycan (SARCOGLYCANS) complex that interacts with DYSTROPHIN. The disease is characterized by progressing wasting and weakness of the proximal muscles of arms and legs around the HIPS and SHOULDERS (the pelvic and shoulder girdles).
A group of dominantly inherited, predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. (From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57(6):531-43)
Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth.
Birth defect that results in a partial or complete absence of the CORPUS CALLOSUM. It may be isolated or a part of a syndrome (e.g., AICARDI'S SYNDROME; ACROCALLOSAL SYNDROME; ANDERMANN SYNDROME; and HOLOPROSENCEPHALY). Clinical manifestations include neuromotor skill impairment and INTELLECTUAL DISABILITY of variable severity.
A group of disorders involving predominantly the posterior portion of the ocular fundus, due to degeneration in the sensory layer of the RETINA; RETINAL PIGMENT EPITHELIUM; BRUCH MEMBRANE; CHOROID; or a combination of these tissues.
An inherited disorder of connective tissue with extensive degeneration and calcification of ELASTIC TISSUE primarily in the skin, eye, and vasculature. At least two forms exist, autosomal recessive and autosomal dominant. This disorder is caused by mutations of one of the ATP-BINDING CASSETTE TRANSPORTERS. Patients are predisposed to MYOCARDIAL INFARCTION and GASTROINTESTINAL HEMORRHAGE.
A congenital anomaly of the hand or foot, marked by the presence of supernumerary digits.
The concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. (Cline et al., Dictionary of Visual Science, 4th ed)
A group of homologous proteins which form the intermembrane channels of GAP JUNCTIONS. The connexins are the products of an identified gene family which has both highly conserved and highly divergent regions. The variety contributes to the wide range of functional properties of gap junctions.
Specific regions that are mapped within a GENOME. Genetic loci are usually identified with a shorthand notation that indicates the chromosome number and the position of a specific band along the P or Q arm of the chromosome where they are found. For example the locus 6p21 is found within band 21 of the P-arm of CHROMOSOME 6. Many well known genetic loci are also known by common names that are associated with a genetic function or HEREDITARY DISEASE.
A group of HEREDITARY AUTOINFLAMMATION DISEASES, characterized by recurrent fever, abdominal pain, headache, rash, PLEURISY; and ARTHRITIS. ORCHITIS; benign MENINGITIS; and AMYLOIDOSIS may also occur. Homozygous or compound heterozygous mutations in marenostrin gene result in autosomal recessive transmission; simple heterozygous, autosomal dominant form of the disease.
A cyclic nucleotide phosphodiesterase subfamily that is highly specific for CYCLIC GMP. It is found predominantly in the outer segment PHOTORECEPTOR CELLS of the RETINA. It is comprised of two catalytic subunits, referred to as alpha and beta, that form a dimer. In addition two regulatory subunits, referred to as gamma and delta, modulate the activity and localization of the enzyme.
The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses.
A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.
Any codon that signals the termination of genetic translation (TRANSLATION, GENETIC). PEPTIDE TERMINATION FACTORS bind to the stop codon and trigger the hydrolysis of the aminoacyl bond connecting the completed polypeptide to the tRNA. Terminator codons do not specify amino acids.
A rare degenerative inherited eye disease that appears at birth or in the first few months of life that results in a loss of vision. Not to be confused with LEBER HEREDITARY OPTIC NEUROPATHY, the disease is thought to be caused by abnormal development of PHOTORECEPTOR CELLS in the RETINA, or by the extremely premature degeneration of retinal cells.
The functional hereditary units of FUNGI.
An autosomal recessive disorder characterized by glassy degenerative thickening (hyalinosis) of SKIN; MUCOSA; and certain VISCERA. This disorder is caused by mutation in the extracellular matrix protein 1 gene (ECM1). Clinical features include hoarseness and skin eruption due to widespread deposition of HYALIN.
A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Assaying potential carcinogens with Drosophila. (1/2914)

Drosophila offers many advantages for the detection of mutagenic activity of carcinogenic agents. It provides the quickest assay system for detecting mutations in animals today. Its generation time is short, and Drosophila is cheap and easy to breed in large numbers. The simple genetic testing methods give unequivocal answers about the whole spectrum of relevant genetic damage. A comparison of the detection capacity of assays sampling different kinds of genetic damage revealed that various substances are highly effective in inducing mutations but do not produce chromosome breakage effects at all, or only at much higher concentrations than those required for mutation induction. Of the different assay systems available, the classical sex-linked recessive lethal test deserves priority, in view of its superior capacity to detect mutagens. Of practical importance is also its high sensitivity, because a large number of loci in one fifth of the genome is tested for newly induced forward mutations, including small deletions. The recent findings that Drosophila is capable of carrying out the same metabolic activation reactions as the mammalian liver makes the organism eminently suitable for verifying results obtained in prescreening with fast microbial assay systems. An additional advantage in this respect is the capacity of Drosophila for detecting short-lived activation products, because intracellular metabolic activation appears to occur within the spermatids and spermatocytes.  (+info)

Nonbehavioral selection for pawns, mutants of Paramecium aurelia with decreased excitability. (2/2914)

The reversal response in Paramecium aurelia is mediated by calcium which carries the inward current during excitation. Electrophysiological studies indicate that strontium and barium can also carry the inward current. Exposure to high concentrations of barium rapidly paralyzes and later kills wild-type paramecia. Following mutagenesis with nitrosoguanidine, seven mutants which continued to swim in the ;high-barium' solution were selected. All of the mutants show decreased reversal behavior, with phenotypes ranging from extremely non-reversing (;extreme' pawns) to nearly wild-type reversal behavior (;partial' pawns). The mutations fall into three complementation groups, identical to the pwA, pwB, and pwC genes of Kunget al. (1975). All of the pwA and pwB mutants withstand longer exposure to barium, the pwB mutants surviving longer than the pwA mutants. Among mutants of each gene, survival is correlated with loss of reversal behavior. Double mutants (A-B, A-C, B-C), identified in the exautogamous progeny of crosses between ;partial' mutants, exhibited a more extreme non-reversing phenotype than either of their single-mutant (;partial' pawn) parents.---Inability to reverse could be expected from an alteration in the calcium-activated reversal mechanism or in excitation. A normal calcium-activated structure was demonstrated in all pawns by chlorpromazine treatment. In a separate report (Schein, Bennett and Katz 1976) the results of electrophysiological investigations directly demonstrate decreased excitability in all of the mutants, a decrease due to an altered calcium activation. The studies of the genetics, the survival in barium and the electro-physiology of the pawns demonstrate that the pwA and pwB genes have different effects on calcium activation.  (+info)

The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia. (3/2914)

Single-channel recordings of the currents mediated by the muscle Cl- channel, ClC-1, expressed in Xenopus oocytes, provide the first direct evidence that this channel has two equidistant open conductance levels like the Torpedo ClC-0 prototype. As for the case of ClC-0, the probabilities and dwell times of the closed and conducting states are consistent with the presence of two independently gated pathways with approximately 1.2 pS conductance enabled in parallel via a common gate. However, the voltage dependence of the common gate is different and the kinetics are much faster than for ClC-0. Estimates of single-channel parameters from the analysis of macroscopic current fluctuations agree with those from single-channel recordings. Fluctuation analysis was used to characterize changes in the apparent double-gate behavior of the ClC-1 mutations I290M and I556N causing, respectively, a dominant and a recessive form of myotonia. We find that both mutations reduce about equally the open probability of single protopores and that mutation I290M yields a stronger reduction of the common gate open probability than mutation I556N. Our results suggest that the mammalian ClC-homologues have the same structure and mechanism proposed for the Torpedo channel ClC-0. Differential effects on the two gates that appear to modulate the activation of ClC-1 channels may be important determinants for the different patterns of inheritance of dominant and recessive ClC-1 mutations.  (+info)

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. (4/2914)

Autosomal recessive juvenile parkinsonism (AR-JP, PARK2; OMIM 602544), one of the monogenic forms of Parkinson's disease (PD), was initially described in Japan. It is characterized by early onset (before age 40), marked response to levodopa treatment and levodopa-induced dyskinesias. The gene responsible for AR-JP was recently identified and designated parkin. We have analysed the 12 coding exons of the parkin gene in 35 mostly European families with early onset autosomal recessive parkinsonism. In one family, a homozygous deletion of exon 4 could be demonstrated. By direct sequencing of the exons in the index patients of the remaining 34 families, eight previously undescribed point mutations (homozygous or heterozygous) were detected in eight families that included 20 patients. The mutations segregated with the disease in the families and were not detected on 110-166 control chromosomes. Four mutations caused truncation of the parkin protein. Three were frameshifts (202-203delAG, 255delA and 321-322insGT) and one a nonsense mutation (Trp453Stop). The other four were missense mutations (Lys161Asn, Arg256Cys, Arg275Trp and Thr415Asn) that probably affect amino acids that are important for the function of the parkin protein, since they result in the same phenotype as truncating mutations or homozygous exon deletions. Mean age at onset was 38 +/- 12 years, but onset up to age 58 was observed. Mutations in the parkin gene are therefore not invariably associated with early onset parkinsonism. In many patients, the phenotype is indistinguishable from that of idiopathic PD. This study has shown that a wide variety of different mutations in the parkin gene are a common cause of autosomal recessive parkinsonism in Europe and that different types of point mutations seem to be more frequently responsible for the disease phenotype than are deletions.  (+info)

Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia. (5/2914)

We previously described a Sardinian family in which the probands had a severe form of hypercholesterolemia, suggestive of familial hypercholesterolemia (FH). However, low density lipoprotein (LDL) receptor activity in fibroblasts from these subjects and LDL binding ability were normal. The characteristics of the pedigree were consistent with an autosomal recessive trait. Sitosterolemia and pseudohomozygous hyperlipidemia were ruled out. A second Sardinian kindred with similar characteristics was identified. Probands showed severe hypercholesterolemia, whereas their parents and grandparents were normolipidemic. FH, familial defective apoprotein (apo) B, sitosterolemia, and cholesteryl ester storage disease were excluded by in vitro studies. We addressed the metabolic basis of this inherited disorder by studying the in vivo metabolism of LDL in 3 probands from these 2 families. 125I-LDL turnover studies disclosed a marked reduction in the fractional catabolic rate (0.19+/-0.01 versus 0.36+/-0.03 pools per day, respectively; P<0.001) and a significant increase in the production rate [20.7+/-4.4 versus 14. 0+/-2.4 mg. kg-1. d-1, respectively; P<0.01] of LDL apoB in the probands compared with normolipidemic controls. We then studied the in vivo biodistribution and tissue uptake of 99mtechnetium-labeled LDL in the probands and compared them with those in normal controls and 1 FH homozygote. The probands showed a significant reduction in hepatic LDL uptake, similar to that observed in the FH homozygote. A reduced uptake of LDL by the kidney and spleen was also observed in all patients. Our findings suggest that this recessive form of hypercholesterolemia is due to a marked reduction of in vivo LDL catabolism. This appears to be caused by a selective reduction in hepatic LDL uptake. We propose that in this new lipid disorder, a recessive defect causes a selective impairment of LDL receptor function in the liver.  (+info)

Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. (6/2914)

BACKGROUND: Long-QT (LQT) syndrome is a cardiac disorder that causes syncope, seizures, and sudden death from ventricular arrhythmias, specifically torsade de pointes. Both autosomal dominant LQT (Romano-Ward syndrome) and autosomal recessive LQT (Jervell and Lange-Nielsen syndrome, JLNS) have been reported. Heterozygous mutations in 3 potassium channel genes, KVLQT1, KCNE1 (minK), and HERG, and the cardiac sodium channel gene SCN5A cause autosomal dominant LQT. Autosomal recessive LQT, which is associated with deafness, has been found to occur with homozygous mutations in KVLQT1 and KCNE1 in JLNS families in which QTc prolongation was inherited as a dominant trait. METHODS AND RESULTS: An Amish family with clinical evidence of JLNS was analyzed for mutations by use of single-strand conformation polymorphism and DNA sequencing analyses for mutations in all known LQT genes. A novel homozygous 2-bp deletion in the S2 transmembrane segment of KVLQT1 was identified in affected members of this Amish family in which both QTc prolongation and deafness were inherited as recessive traits. This deletion represents a new JLNS-associated mutation in KVLQT1 and has deleterious effects on the KVLQT1 potassium channel, causing a frameshift and the truncation of the KVLQT1 protein. In contrast to previous reports in which LQT was inherited as a clear dominant trait, 2 parents in the JLNS family described here have normal QTc intervals (0.43 and 0.44 seconds, respectively). CONCLUSIONS: A novel homozygous KVLQT1 mutation causes JLNS in an Amish family with deafness that is inherited as an autosomal recessive trait.  (+info)

High-resolution physical and genetic mapping of the critical region for Meckel syndrome and Mulibrey Nanism on chromosome 17q22-q23. (7/2914)

Previously, we assigned the genes for two autosomal recessive disorders, Meckel syndrome (MKS; MIM 249000) and Mulibrey Nanism [MUL (muscle-liver-brain-eye Nanism); MIM 253250] that are enriched in the Finnish population, to overlapping genomic regions on chromosome 17q. Now, we report the construction of a bacterial clone contig over the critical region for both disorders. Several novel CA-repeat markers were isolated from these clones, which allowed refined mapping of the MKS and MUL loci using haplotype and linkage disequilibrium analysis. The localization of the MKS locus was narrowed to <1 cM between markers D17S1290 and 132-CA, within an approximately 800-kb region. The MUL locus was refined into an approximately 1400-kb interval between markers D17S1290 and 52-CA. The whole MKS region falls within the MUL region. In the common critical region, the conserved haplotypes were different in MKS and MUL patients. A trancript map was constructed by assigning expressed sequence tags (ESTs) and genes, derived from the human gene map, to the bacterial clone contig. Altogether, four genes and a total of 20 ESTs were precisely localized. These data provide the molecular tools for the final identification of the MKS and the MUL genes.  (+info)

An arrested late endosome-lysosome intermediate aggregate observed in a Chinese hamster ovary cell mutant isolated by novel three-step screening. (8/2914)

Chinese hamster ovary cell mutants defective in the post-uptake degradation of low-density lipoprotein (LDL) in lysosomes were selected from mutagenized cells by novel three-step screening. First, in the presence of LDL, clones sensitive to an inhibitor of the rate-limiting enzyme of the cholesterol biosynthetic pathway, 3-hydroxy-3-methylglutaryl-CoA reductase, were isolated. Second, from the selected clones, those lacking in the degradation of a constituent of a fluorescent LDL were qualitatively screened by microscopy. Third, the clones were further screened by previously established quantitative analytical flow cytometry that detects the early-phase disintegration of LDL by lysosomal acid hydrolases. One of the isolated mutant clones, LEX1 (Lysosome-Endosome X 1), was a recessive mutant, and exhibited a specific disorder in the late endocytic pathway. LEX1 cells showed an unusual perinuclear aggregate of vesicles, heterogeneously positive for lysosomal glycoprotein-B/cathepsin D and rab7, yet negative for the cation-independent mannose 6-phosphate receptor. The aggregate was formed around the microtubule organizing center, and was disrupted by nocodazole treatment. Internalized octadecyl rhodamine B-labeled LDL (R18-LDL) was accumulated in the perinuclear rab7-positive vesicles. In a Percoll density gradient, neither internalized R18-LDL nor internalized horseradish peroxidase was efficiently chased into heavy lysosomal fractions positive for beta-hexosaminidase. LEX1 cells showed differences in the activity and subcellular distribution of lysosomal enzymes. These characteristics of LEX1 cells are consistent with the ideas that the perinuclear vesicle aggregate is an arrested intermediate of direct fusion or divergence between lysosomes and rab7-positive, cation-independent mannose 6-phosphate receptor-negative late endosomes, and that equilibrium between the lysosomes and the late endosomes is shifted towards the late endosomes in LEX1 cells. Such fusion or divergence between the late endosomes and the lysosomes would determine an appropriate equilibrium between them, and might thereby play an important role for proper lysosomal digestive functions. LEX1 mutant cells would be helpful for the dissection of the as yet unrevealed details of the late endocytic membrane dynamics and for the identification of factors involved in the process arrested by the mutation.  (+info)

Note: Autosomal recessive inheritance means that a person must inherit two copies of the mutated gene, one from each parent, to develop the condition. If a person inherits only one copy of the mutated gene, they will be a carrier but are unlikely to develop symptoms themselves.

Examples of syndromes include:

1. Down syndrome: A genetic disorder caused by an extra copy of chromosome 21 that affects intellectual and physical development.
2. Turner syndrome: A genetic disorder caused by a missing or partially deleted X chromosome that affects physical growth and development in females.
3. Marfan syndrome: A genetic disorder affecting the body's connective tissue, causing tall stature, long limbs, and cardiovascular problems.
4. Alzheimer's disease: A neurodegenerative disorder characterized by memory loss, confusion, and changes in personality and behavior.
5. Parkinson's disease: A neurological disorder characterized by tremors, rigidity, and difficulty with movement.
6. Klinefelter syndrome: A genetic disorder caused by an extra X chromosome in males, leading to infertility and other physical characteristics.
7. Williams syndrome: A rare genetic disorder caused by a deletion of genetic material on chromosome 7, characterized by cardiovascular problems, developmental delays, and a distinctive facial appearance.
8. Fragile X syndrome: The most common form of inherited intellectual disability, caused by an expansion of a specific gene on the X chromosome.
9. Prader-Willi syndrome: A genetic disorder caused by a defect in the hypothalamus, leading to problems with appetite regulation and obesity.
10. Sjogren's syndrome: An autoimmune disorder that affects the glands that produce tears and saliva, causing dry eyes and mouth.

Syndromes can be diagnosed through a combination of physical examination, medical history, laboratory tests, and imaging studies. Treatment for a syndrome depends on the underlying cause and the specific symptoms and signs presented by the patient.

The symptoms of RP can vary depending on the severity of the condition and the specific genetic mutations causing it. Common symptoms include:

* Night blindness
* Difficulty seeing in low light environments
* Blind spots or missing areas in central vision
* Difficulty reading or recognizing faces
* Sensitivity to light
* Reduced peripheral vision
* Blurred vision

There is currently no cure for RP, and treatment options are limited. However, researchers are actively working to develop new therapies and technologies to slow the progression of the disease and improve the quality of life for individuals with RP. These include:

* Gene therapy: Using viral vectors to deliver healthy copies of the missing gene to the retina in an effort to restore normal vision.

* Stem cell therapy: Transplanting healthy stem cells into the retina to replace damaged or missing cells.

* Pharmacological interventions: Developing drugs that can slow down or reverse the progression of RP by targeting specific molecular pathways.

* Retinal implants: Implanting a retinal implant, such as a retinal prosthetic, to bypass damaged or non-functional photoreceptors and directly stimulate the visual pathway.

It's important to note that these therapies are still in the experimental stage and have not yet been proven effective in humans. Therefore, individuals with RP should consult with their healthcare provider about the best treatment options available.

In summary, Retinitis Pigmentosa is a genetic disorder that causes progressive vision loss, particularly during childhood or adolescence. While there is currently no cure for RP, researchers are actively working to develop new therapies to slow down or restore vision in those affected by the disease. These include gene therapy, stem cell therapy, pharmacological interventions, and retinal implants. It's important to consult with a healthcare provider for the best treatment options available.

FAQs:

1. What is Retinitis Pigmentosa?

Retinitis Pigmentosa (RP) is a genetic disorder that causes progressive vision loss, typically during childhood or adolescence.

2. What are the symptoms of Retinitis Pigmentosa?

Symptoms of RP can vary depending on the specific mutation causing the disease, but common symptoms include difficulty seeing at night, loss of peripheral vision, and difficulty adjusting to bright light.

3. Is there a cure for Retinitis Pigmentosa?

Currently, there is no cure for RP, but researchers are actively working on developing new therapies to slow down or restore vision in those affected by the disease.

4. What are some potential treatments for Retinitis Pigmentosa?

Some potential treatments for RP include gene therapy, stem cell therapy, pharmacological interventions, and retinal implants. It's important to consult with a healthcare provider for the best treatment options available.

5. Can Retinitis Pigmentosa be prevented?

RP is a genetic disorder, so it cannot be prevented in the classical sense. However, researchers are working on developing gene therapies that can prevent or slow down the progression of the disease.

6. How does Retinitis Pigmentosa affect daily life?

Living with RP can significantly impact daily life, especially as vision loss progresses. It's important to adapt and modify daily routines, such as using assistive devices like canes or guide dogs, and seeking support from family and friends.

7. What resources are available for those affected by Retinitis Pigmentosa?

There are a variety of resources available for those affected by RP, including support groups, advocacy organizations, and online communities. These resources can provide valuable information, support, and connections with others who understand the challenges of living with the disease.

Symptoms of ichthyosis can include:

* Thickened, scaly skin on the arms, legs, back, and chest
* Redness and itching
* Cracking and splitting of the skin
* Increased risk of infection
* Respiratory problems

Treatment for ichthyosis typically involves the use of topical creams and ointments to help soften and hydrate the skin, as well as oral medications to reduce inflammation and itching. In severe cases, phototherapy or systemic corticosteroids may be necessary.

In addition to these medical treatments, there are also several home remedies and lifestyle modifications that can help manage the symptoms of ichthyosis. These include:

* Moisturizing regularly with a fragrance-free moisturizer
* Avoiding harsh soaps and cleansers
* Using lukewarm water when showering or bathing
* Applying cool compresses to the skin to reduce redness and inflammation
* Wearing loose, breathable clothing to avoid irritating the skin
* Protecting the skin from extreme temperatures and environmental stressors.

Some examples of multiple abnormalities include:

1. Multiple chronic conditions: An individual may have multiple chronic conditions such as diabetes, hypertension, arthritis, and heart disease, which can affect their quality of life and increase their risk of complications.
2. Congenital anomalies: Some individuals may be born with multiple physical abnormalities or birth defects, such as heart defects, limb abnormalities, or facial deformities.
3. Mental health disorders: Individuals may experience multiple mental health disorders, such as depression, anxiety, and bipolar disorder, which can impact their cognitive functioning and daily life.
4. Neurological conditions: Some individuals may have multiple neurological conditions, such as epilepsy, Parkinson's disease, and stroke, which can affect their cognitive and physical functioning.
5. Genetic disorders: Individuals with genetic disorders, such as Down syndrome or Turner syndrome, may experience a range of physical and developmental abnormalities.

The term "multiple abnormalities" is often used in medical research and clinical practice to describe individuals who have complex health needs and require comprehensive care. It is important for healthcare providers to recognize and address the multiple needs of these individuals to improve their overall health outcomes.

* Genetic mutations or chromosomal abnormalities
* Infections during pregnancy, such as rubella or toxoplasmosis
* Exposure to certain medications or chemicals during pregnancy
* Maternal malnutrition or poor nutrition during pregnancy
* Certain medical conditions, such as hypothyroidism or anemia.

Microcephaly can be diagnosed by measuring the baby's head circumference and comparing it to established norms for their age and gender. Other signs of microcephaly may include:

* A small, misshapen head
* Small eyes and ears
* Developmental delays or intellectual disability
* Seizures or other neurological problems
* Difficulty feeding or sucking

There is no cure for microcephaly, but early diagnosis and intervention can help manage the associated symptoms and improve quality of life. Treatment may include:

* Monitoring growth and development
* Physical therapy to improve muscle tone and coordination
* Occupational therapy to develop fine motor skills and coordination
* Speech therapy to improve communication skills
* Medication to control seizures or other neurological problems.

In some cases, microcephaly may be associated with other medical conditions, such as intellectual disability, autism, or vision or hearing loss. It is important for individuals with microcephaly to receive regular monitoring and care from a team of healthcare professionals to address any related medical issues.

The hallmark symptom of EBD is the formation of large, painful blisters that can arise spontaneously or after minor trauma. These blisters can become infected and leave scars, leading to significant disability and reduced quality of life. In addition to skin blistering, individuals with EBD may experience other symptoms such as scarring alopecia, conjunctivitis, and difficulty swallowing.

The diagnosis of EBD is based on clinical findings, family history, and laboratory tests including genetic analysis. Treatment for the condition typically involves wound care and pain management, and may also involve physical therapy to maintain joint mobility and prevent contractures. In severe cases, surgery may be necessary to release tension on the skin or to repair damaged tissue.

Overall, EBD is a rare and debilitating condition that can have a significant impact on an individual's quality of life. With proper management and support, however, many individuals with EBD are able to lead active and fulfilling lives despite their challenges.

There are several types of deafness, including:

1. Conductive hearing loss: This type of deafness is caused by problems with the middle ear, including the eardrum or the bones of the middle ear. It can be treated with hearing aids or surgery.
2. Sensorineural hearing loss: This type of deafness is caused by damage to the inner ear or auditory nerve. It is typically permanent and cannot be treated with medication or surgery.
3. Mixed hearing loss: This type of deafness is a combination of conductive and sensorineural hearing loss.
4. Auditory processing disorder (APD): This is a condition in which the brain has difficulty processing sounds, even though the ears are functioning normally.
5. Tinnitus: This is a condition characterized by ringing or other sounds in the ears when there is no external source of sound. It can be a symptom of deafness or a separate condition.

There are several ways to diagnose deafness, including:

1. Hearing tests: These can be done in a doctor's office or at a hearing aid center. They involve listening to sounds through headphones and responding to them.
2. Imaging tests: These can include X-rays, CT scans, or MRI scans to look for any physical abnormalities in the ear or brain.
3. Auditory brainstem response (ABR) testing: This is a test that measures the electrical activity of the brain in response to sound. It can be used to diagnose hearing loss in infants and young children.
4. Otoacoustic emissions (OAE) testing: This is a test that measures the sounds produced by the inner ear in response to sound. It can be used to diagnose hearing loss in infants and young children.

There are several ways to treat deafness, including:

1. Hearing aids: These are devices that amplify sound and can be worn in or behind the ear. They can help improve hearing for people with mild to severe hearing loss.
2. Cochlear implants: These are devices that are implanted in the inner ear and can bypass damaged hair cells to directly stimulate the auditory nerve. They can help restore hearing for people with severe to profound hearing loss.
3. Speech therapy: This can help people with hearing loss improve their communication skills, such as speaking and listening.
4. Assistive technology: This can include devices such as captioned phones, alerting systems, and assistive listening devices that can help people with hearing loss communicate more effectively.
5. Medications: There are several medications available that can help treat deafness, such as antibiotics for bacterial infections or steroids to reduce inflammation.
6. Surgery: In some cases, surgery may be necessary to treat deafness, such as when there is a blockage in the ear or when a tumor is present.
7. Stem cell therapy: This is a relatively new area of research that involves using stem cells to repair damaged hair cells in the inner ear. It has shown promising results in some studies.
8. Gene therapy: This involves using genes to repair or replace damaged or missing genes that can cause deafness. It is still an experimental area of research, but it has shown promise in some studies.
9. Implantable devices: These are devices that are implanted in the inner ear and can help restore hearing by bypassing damaged hair cells. Examples include cochlear implants and auditory brainstem implants.
10. Binaural hearing: This involves using a combination of hearing aids and technology to improve hearing in both ears, which can help improve speech recognition and reduce the risk of falls.

It's important to note that the best treatment for deafness will depend on the underlying cause of the condition, as well as the individual's age, overall health, and personal preferences. It's important to work with a healthcare professional to determine the best course of treatment.

There are several types of hypotrichosis, including:

1. Congenital hypotrichosis: This type is present at birth and is caused by genetic mutations.
2. Acquired hypotrichosis: This type can develop later in life due to various factors such as hormonal imbalances, nutritional deficiencies, or certain medical conditions like thyroid disorders or anemia.
3. Localized hypotrichosis: This type affects only a specific area of the body, such as the scalp or eyebrows.
4. Generalized hypotrichosis: This type affects the entire body.

Hypotrichosis can have a significant impact on an individual's self-esteem and quality of life, especially if it results in noticeable hair loss or thinning. Treatment options for hypotrichosis include medications such as minoxidil (Rogaine) and finasteride (Propecia), as well as non-medical treatments like hair transplantation and low-level laser therapy (LLLT). In some cases, hypotrichosis may be a sign of an underlying medical condition, so it is important to consult with a healthcare professional for proper diagnosis and treatment.

There are various causes of intellectual disability, including:

1. Genetic disorders, such as Down syndrome, Fragile X syndrome, and Turner syndrome.
2. Congenital conditions, such as microcephaly and hydrocephalus.
3. Brain injuries, such as traumatic brain injury or hypoxic-ischemic injury.
4. Infections, such as meningitis or encephalitis.
5. Nutritional deficiencies, such as iron deficiency or iodine deficiency.

Intellectual disability can result in a range of cognitive and functional impairments, including:

1. Delayed language development and difficulty with communication.
2. Difficulty with social interactions and adapting to new situations.
3. Limited problem-solving skills and difficulty with abstract thinking.
4. Slow learning and memory difficulties.
5. Difficulty with fine motor skills and coordination.

There is no cure for intellectual disability, but early identification and intervention can significantly improve outcomes. Treatment options may include:

1. Special education programs tailored to the individual's needs.
2. Behavioral therapies, such as applied behavior analysis (ABA) and positive behavior support (PBS).
3. Speech and language therapy.
4. Occupational therapy to improve daily living skills.
5. Medications to manage associated behaviors or symptoms.

It is essential to recognize that intellectual disability is a lifelong condition, but with appropriate support and resources, individuals with ID can lead fulfilling lives and reach their full potential.

The symptoms of ichthyosiform erythroderma congenital typically appear at birth or within the first few days of life, and may include:

* Redness and scaling of the skin, particularly on the face, scalp, and extremities
* Thickening of the skin, which can be more noticeable on the palms and soles
* Cracking and fissuring of the skin, which can lead to infection and scarring
* Dry, flaky skin that may peel off in large scales
* Redness and inflammation of the eyes and mouth

Ichthyosiform erythroderma congenital is usually diagnosed based on the characteristic appearance of the skin and the presence of other symptoms such as eye and mouth inflammation. Genetic testing may also be used to confirm the diagnosis and identify the specific genetic mutations that are responsible for the condition.

There is no cure for ichthyosiform erythroderma congenital, but treatment can help manage the symptoms and prevent complications. Treatment may include:

* Topical medications such as corticosteroids and retinoids to reduce inflammation and thin the skin
* Oral antibiotics to treat infections and prevent scarring
* Moisturizers and lubricants to keep the skin hydrated and flexible
* Phototherapy with ultraviolet light to improve skin appearance and reduce inflammation
* Surgery to remove scar tissue or repair damaged areas of the skin.

The prognosis for ichthyosiform erythroderma congenital varies depending on the severity of the condition and the presence of any complications. With appropriate treatment, many people with this condition can lead active and fulfilling lives, but some may experience ongoing symptoms and disability. It is important for individuals with ichthyosiform erythroderma congenital to work closely with their healthcare team to manage their symptoms and prevent complications.

Explanation: Genetic predisposition to disease is influenced by multiple factors, including the presence of inherited genetic mutations or variations, environmental factors, and lifestyle choices. The likelihood of developing a particular disease can be increased by inherited genetic mutations that affect the functioning of specific genes or biological pathways. For example, inherited mutations in the BRCA1 and BRCA2 genes increase the risk of developing breast and ovarian cancer.

The expression of genetic predisposition to disease can vary widely, and not all individuals with a genetic predisposition will develop the disease. Additionally, many factors can influence the likelihood of developing a particular disease, such as environmental exposures, lifestyle choices, and other health conditions.

Inheritance patterns: Genetic predisposition to disease can be inherited in an autosomal dominant, autosomal recessive, or multifactorial pattern, depending on the specific disease and the genetic mutations involved. Autosomal dominant inheritance means that a single copy of the mutated gene is enough to cause the disease, while autosomal recessive inheritance requires two copies of the mutated gene. Multifactorial inheritance involves multiple genes and environmental factors contributing to the development of the disease.

Examples of diseases with a known genetic predisposition:

1. Huntington's disease: An autosomal dominant disorder caused by an expansion of a CAG repeat in the Huntingtin gene, leading to progressive neurodegeneration and cognitive decline.
2. Cystic fibrosis: An autosomal recessive disorder caused by mutations in the CFTR gene, leading to respiratory and digestive problems.
3. BRCA1/2-related breast and ovarian cancer: An inherited increased risk of developing breast and ovarian cancer due to mutations in the BRCA1 or BRCA2 genes.
4. Sickle cell anemia: An autosomal recessive disorder caused by a point mutation in the HBB gene, leading to defective hemoglobin production and red blood cell sickling.
5. Type 1 diabetes: An autoimmune disease caused by a combination of genetic and environmental factors, including multiple genes in the HLA complex.

Understanding the genetic basis of disease can help with early detection, prevention, and treatment. For example, genetic testing can identify individuals who are at risk for certain diseases, allowing for earlier intervention and preventive measures. Additionally, understanding the genetic basis of a disease can inform the development of targeted therapies and personalized medicine."


This type of hearing loss cannot be treated with medication or surgery, and it is usually permanent. However, there are various assistive devices and technology available to help individuals with sensorineural hearing loss communicate more effectively, such as hearing aids, cochlear implants, and FM systems.

There are several causes of sensorineural hearing loss, including:

1. Exposure to loud noises: Prolonged exposure to loud noises can damage the hair cells in the inner ear and cause permanent hearing loss.
2. Age: Sensorineural hearing loss is a common condition that affects many people as they age. It is estimated that one-third of people between the ages of 65 and 74 have some degree of hearing loss, and nearly half of those over the age of 75 have significant hearing loss.
3. Genetics: Some cases of sensorineural hearing loss are inherited and run in families.
4. Viral infections: Certain viral infections, such as meningitis or encephalitis, can damage the inner ear and cause permanent hearing loss.
5. Trauma to the head or ear: A head injury or a traumatic injury to the ear can cause sensorineural hearing loss.
6. Tumors: Certain types of tumors, such as acoustic neuroma, can cause sensorineural hearing loss by affecting the auditory nerve.
7. Ototoxicity: Certain medications, such as certain antibiotics, chemotherapy drugs, and aspirin at high doses, can be harmful to the inner ear and cause permanent hearing loss.

It is important to note that sensorineural hearing loss cannot be cured, but there are many resources available to help individuals with this condition communicate more effectively and improve their quality of life.

The term "Osteochondrodysplasias" comes from the Greek words "osteo," meaning bone; "chondro," meaning cartilage; and "dysplasia," meaning abnormal growth or development. These disorders can affect people of all ages, but are most commonly seen in children and young adults.

There are many different types of OCDs, each with its own unique set of symptoms and characteristics. Some of the most common types include:

* Brittle bone disease (osteogenesis imperfecta): This is a condition in which the bones are prone to fractures, often without any obvious cause.
* Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome: This is a rare condition that affects the hands, feet, and joints, causing stiffness, pain, and limited mobility.
* Diaphyseal dysplasia: This is a condition in which the bones in the arms and legs are abnormally short and brittle.
* Epiphyseal dysplasia: This is a condition in which the growth plates at the ends of the long bones are abnormal, leading to short stature and other skeletal deformities.

There is no cure for OCDs, but treatment options are available to manage symptoms and improve quality of life. These may include physical therapy, braces or orthotics, medications to manage pain and inflammation, and in some cases, surgery. Early diagnosis and intervention are important to help manage the condition and prevent complications.

Causes:

* Genetic mutations or deletions
* Infections such as meningitis or encephalitis
* Stroke or bleeding in the brain
* Traumatic head injury
* Multiple sclerosis or other demyelinating diseases
* Brain tumors
* Cerebellar degeneration due to aging

Symptoms:

* Coordination difficulties, such as stumbling or poor balance
* Tremors or shaky movements
* Slurred speech and difficulty with fine motor skills
* Nystagmus (involuntary eye movements)
* Difficulty with gait and walking
* Fatigue, weakness, and muscle wasting

Diagnosis:

* Physical examination and medical history
* Neurological examination to test coordination, balance, and reflexes
* Imaging studies such as MRI or CT scans to rule out other conditions
* Genetic testing to identify inherited forms of cerebellar ataxia
* Electromyography (EMG) to test muscle activity and nerve function

Treatment:

* Physical therapy to improve balance, coordination, and gait
* Occupational therapy to help with daily activities and fine motor skills
* Speech therapy to address slurred speech and communication difficulties
* Medications to manage symptoms such as tremors or spasticity
* Assistive devices such as canes or walkers to improve mobility

Prognosis:

* The prognosis for cerebellar ataxia varies depending on the underlying cause. In some cases, the condition may be slowly progressive and lead to significant disability over time. In other cases, the condition may remain stable or even improve with treatment.

Living with cerebellar ataxia can be challenging, but there are many resources available to help individuals with the condition manage their symptoms and maintain their quality of life. These resources may include:

* Physical therapy to improve balance and coordination
* Occupational therapy to assist with daily activities
* Speech therapy to address communication difficulties
* Assistive devices such as canes or walkers to improve mobility
* Medications to manage symptoms such as tremors or spasticity
* Support groups for individuals with cerebellar ataxia and their families

Overall, the key to managing cerebellar ataxia is early diagnosis and aggressive treatment. With proper management, individuals with this condition can lead active and fulfilling lives despite the challenges they face.

A rare inherited disorder characterized by thick, plate-like scales on the skin, especially on the limbs and torso. These scales can be darker or lighter than normal skin color and may crack and split, leading to infection and other complications. The condition is caused by mutations in the filaggrin gene and tends to run in families. Treatment includes topical medications, phototherapy, and systemic medications such as corticosteroids or retinoids. Also known as ichthyosis lamellar, this disorder affects approximately 1 in 185,000 people worldwide.

Note: Ichthyosis, Lamellar is a type of ichthyosis, a group of genetic disorders that affect the skin's ability to produce natural oils and cause dry, scaly skin.

1. Medical Definition: In medicine, dwarfism is defined as a condition where an individual's height is significantly below the average range for their age and gender. The term "dwarfism" is often used interchangeably with "growth hormone deficiency," but the two conditions are not the same. Growth hormone deficiency is a specific cause of dwarfism, but there can be other causes as well, such as genetic mutations or chromosomal abnormalities.
2. Genetic Definition: From a genetic perspective, dwarfism can be defined as a condition caused by a genetic mutation or variation that results in short stature. There are many different genetic causes of dwarfism, including those caused by mutations in the growth hormone receptor gene, the insulin-like growth factor 1 (IGF1) gene, and other genes involved in growth and development.
3. Anthropological Definition: In anthropology, dwarfism is defined as a physical characteristic that is considered to be outside the normal range for a particular population or culture. This can include individuals who are short-statured due to various causes, including genetics, nutrition, or environmental factors.
4. Social Definition: From a social perspective, dwarfism can be defined as a condition that is perceived to be different or abnormal by society. Individuals with dwarfism may face social stigma, discrimination, and other forms of prejudice due to their physical appearance.
5. Legal Definition: In some jurisdictions, dwarfism may be defined as a disability or a medical condition that is protected by anti-discrimination laws. This can provide legal protections for individuals with dwarfism and ensure that they have access to the same rights and opportunities as others.

In summary, the definition of dwarfism can vary depending on the context in which it is used, and it may be defined differently by different disciplines and communities. It is important to recognize and respect the diversity of individuals with dwarfism and to provide support and accommodations as needed to ensure their well-being and inclusion in society.

These disorders are caused by changes in specific genes that fail to function properly, leading to a cascade of effects that can damage cells and tissues throughout the body. Some inherited diseases are the result of single gene mutations, while others are caused by multiple genetic changes.

Inherited diseases can be diagnosed through various methods, including:

1. Genetic testing: This involves analyzing a person's DNA to identify specific genetic changes that may be causing the disease.
2. Blood tests: These can help identify certain inherited diseases by measuring enzyme levels or identifying specific proteins in the blood.
3. Imaging studies: X-rays, CT scans, and MRI scans can help identify structural changes in the body that may be indicative of an inherited disease.
4. Physical examination: A healthcare provider may perform a physical examination to look for signs of an inherited disease, such as unusual physical features or abnormalities.

Inherited diseases can be treated in various ways, depending on the specific condition and its causes. Some treatments include:

1. Medications: These can help manage symptoms and slow the progression of the disease.
2. Surgery: In some cases, surgery may be necessary to correct physical abnormalities or repair damaged tissues.
3. Gene therapy: This involves using genes to treat or prevent inherited diseases.
4. Rehabilitation: Physical therapy, occupational therapy, and other forms of rehabilitation can help individuals with inherited diseases manage their symptoms and improve their quality of life.

Inherited diseases are a significant public health concern, as they affect millions of people worldwide. However, advances in genetic research and medical technology have led to the development of new treatments and management strategies for these conditions. By working with healthcare providers and advocacy groups, individuals with inherited diseases can access the resources and support they need to manage their conditions and improve their quality of life.

There are several types of muscular dystrophies, including:

1. Duchenne muscular dystrophy (DMD): This is the most common form of muscular dystrophy, affecting males primarily. It is caused by a mutation in the dystrophin gene and is characterized by progressive muscle weakness, wheelchair dependence, and shortened lifespan.
2. Becker muscular dystrophy (BMD): This is a less severe form of muscular dystrophy than DMD, affecting both males and females. It is caused by a mutation in the dystrophin gene and is characterized by progressive muscle weakness, but with a milder course than DMD.
3. Limb-girdle muscular dystrophy (LGMD): This is a group of disorders that affect the muscles around the shoulders and hips, leading to progressive weakness and degeneration. There are several subtypes of LGMD, each with different symptoms and courses.
4. Facioscapulohumeral muscular dystrophy (FSHD): This is a rare form of muscular dystrophy that affects the muscles of the face, shoulder, and upper arm. It is caused by a mutation in the D4Z4 repeat on chromosome 4.
5. Myotonic dystrophy: This is the most common adult-onset form of muscular dystrophy, affecting both males and females. It is characterized by progressive muscle stiffness, weakness, and wasting, as well as other symptoms such as cataracts, myotonia, and cognitive impairment.

There is currently no cure for muscular dystrophies, but various treatments are available to manage the symptoms and slow the progression of the disease. These include physical therapy, orthotics and assistive devices, medications to manage pain and other symptoms, and in some cases, surgery. Researchers are actively working to develop new treatments and a cure for muscular dystrophies, including gene therapy, stem cell therapy, and small molecule therapies.

It's important to note that muscular dystrophy can be inherited in an autosomal dominant, autosomal recessive, or X-linked manner, depending on the specific type of dystrophy. This means that the risk of inheriting the condition depends on the mode of inheritance and the presence of mutations in specific genes.

In summary, muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and degeneration. There are several types of muscular dystrophy, each with different symptoms and courses. While there is currently no cure for muscular dystrophy, various treatments are available to manage the symptoms and slow the progression of the disease. Researchers are actively working to develop new treatments and a cure for muscular dystrophy.

1. Osteogenesis imperfecta (OI): This is a genetic disorder that affects the formation of collagen, which is essential for bone strength and density. People with OI have brittle bones that are prone to fractures, often from minimal trauma.
2. Achondroplasia: This is the most common form of short-limbed dwarfism, caused by a genetic mutation that affects the development of cartilage and bone. People with achondroplasia have short stature, short limbs, and characteristic facial features.
3. Cleidocranial dysostosis: This is a rare genetic disorder that affects the development of the skull and collarbones. People with cleidocranial dysostosis may have misshapen or absent collarbones, as well as other skeletal abnormalities.
4. Fibrous dysplasia: This is a benign bone tumor that can affect any bone in the body. It is caused by a genetic mutation that causes an overgrowth of fibrous tissue in the bone, leading to deformity and weakness.
5. Multiple epiphyseal dysplasia (MED): This is a group of disorders that affect the growth plates at the ends of long bones, leading to irregular bone growth and deformity. MED can be caused by genetic mutations or environmental factors.

These are just a few examples of developmental bone diseases. There are many other conditions that can affect the formation and development of bones during fetal life or childhood, each with its own unique set of symptoms and characteristics.

There are several types of EB, classified based on the severity of symptoms and the age of onset. The most severe form, EB simplex, is the most common and affects approximately 1 in 20,000 to 1 in 50,000 births. Other forms of EB include junctional EB, dystrophic EB, and Kindler syndrome.

Symptoms of EB typically appear within the first few weeks of life and may include:

* Blisters and sores on the skin and mucous membranes
* Skin that is thin and fragile, with a characteristic "velvety" texture
* Delayed healing of wounds and scars
* Increased risk of infection
* Poor wound closure

Treatment for EB is focused on managing symptoms and preventing complications. This may include:

* Wound care and dressing changes
* Antibiotics to prevent infection
* Pain management
* Physical therapy to maintain joint mobility and prevent deformities
* Phototherapy to promote healing

There is currently no cure for EB, but researchers are working to develop new treatments and gene therapies to improve the lives of those affected by the condition. With proper management and support, however, many people with EB can lead active and fulfilling lives.

1. Retinitis pigmentosa (RP): a group of degenerative diseases that affect the retina and cause progressive vision loss.
2. Leber congenital amaurosis (LCA): a rare inherited disorder that causes blindness or severe visual impairment at birth or in early childhood.
3. Stargardt disease: a genetic disorder that affects the retina and can cause progressive vision loss, usually starting in childhood.
4. Juvenile macular degeneration (JMD): a group of inherited conditions that affect the macula, the part of the retina responsible for central vision.
5. Persistent hyperplastic primary vitreous (PHPV): a rare inherited condition where abnormal development of the eye can cause vision loss or blindness.
6. Anophthalmia/microphthalmia: a rare inherited condition where one or both eyes are absent or severely underdeveloped.
7. ocular albinism: a genetic condition that affects the development of pigment in the eye, leading to visual impairment and increased risk of eye conditions such as cataracts and glaucoma.
8. Peter's anomaly: a rare inherited condition where there is an abnormal development of the cornea and lens of the eye, leading to vision loss or blindness.
9. cone-rod dystrophy: a group of inherited conditions that affect the retina and can cause progressive vision loss, usually starting in childhood.
10. Retinal dystrophy: a general term for a group of inherited disorders that affect the retina and can cause progressive vision loss, usually starting in adulthood.

These are just a few examples of hereditary eye diseases. There are many other conditions that can be inherited and affect the eyes. Genetic testing and counseling can help identify the risk of inheriting these conditions and provide information on how to manage and treat them.

The word "osteopetrosis" comes from the Greek words "osteon," meaning bone, and "petros," meaning rock or stone. This name reflects the dense and hard nature of the bones affected by the disorder.

Osteopetrosis can be caused by mutations in several genes that are involved in bone development and growth. The condition is usually inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. However, some cases may be caused by spontaneous mutations or other factors.

Symptoms of osteopetrosis can vary depending on the severity of the disorder and the specific affected bones. Common symptoms include bone pain, limited mobility, and an increased risk of fractures. Other symptoms may include fatigue, fever, and difficulty swallowing or breathing.

Treatment for osteopetrosis usually involves a combination of medications and surgery. Medications such as bisphosphonates and denintuzumab mafodotin can help reduce bone pain and the risk of fractures, while surgery may be necessary to correct deformities or repair broken bones. In some cases, bone marrow transplantation may be recommended to replace damaged bone marrow with healthy cells.

Overall, osteopetrosis is a rare and debilitating disorder that can have a significant impact on quality of life. Early diagnosis and appropriate treatment are important for managing symptoms and preventing complications.

Examples of inborn errors of metabolism include:

1. Phenylketonuria (PKU): A disorder that affects the body's ability to break down the amino acid phenylalanine, leading to a buildup of this substance in the blood and brain.
2. Hypothyroidism: A condition in which the thyroid gland does not produce enough thyroid hormones, leading to developmental delays, intellectual disability, and other health problems.
3. Maple syrup urine disease (MSUD): A disorder that affects the body's ability to break down certain amino acids, leading to a buildup of these substances in the blood and urine.
4. Glycogen storage diseases: A group of disorders that affect the body's ability to store and use glycogen, a form of carbohydrate energy.
5. Mucopolysaccharidoses (MPS): A group of disorders that affect the body's ability to produce and break down certain sugars, leading to a buildup of these substances in the body.
6. Citrullinemia: A disorder that affects the body's ability to break down the amino acid citrulline, leading to a buildup of this substance in the blood and urine.
7. Homocystinuria: A disorder that affects the body's ability to break down certain amino acids, leading to a buildup of these substances in the blood and urine.
8. Tyrosinemia: A disorder that affects the body's ability to break down the amino acid tyrosine, leading to a buildup of this substance in the blood and liver.

Inborn errors of metabolism can be diagnosed through a combination of physical examination, medical history, and laboratory tests such as blood and urine tests. Treatment for these disorders varies depending on the specific condition and may include dietary changes, medication, and other therapies. Early detection and treatment can help manage symptoms and prevent complications.

The symptoms of myotonia congenita can vary in severity and may include:

* Muscle stiffness and rigidity, especially in the legs, arms, and neck
* Difficulty relaxing muscles after contraction, leading to prolonged muscle tensing
* Muscle cramps and spasms
* Weakness and fatigue of the muscles
* Delayed or absent deep tendon reflexes
* Abnormal posture or gait
* Difficulty with speech and swallowing in severe cases

Myotonia congenita can be diagnosed through a combination of clinical evaluation, electromyography (EMG), and genetic testing. Treatment for the condition typically involves physical therapy, massage, and relaxation techniques to help manage muscle stiffness and improve mobility. In severe cases, medications such as sodium channel blockers or chloride channel activators may be prescribed to help regulate muscle contraction and relaxation.

Myotonia congenita is a rare condition, and its prevalence is not well established. However, it is estimated to affect approximately 1 in 100,000 to 1 in 200,000 individuals worldwide. The condition can be inherited in an autosomal dominant manner, meaning that a single copy of the mutated gene is enough to cause the condition. However, some cases may be sporadic, meaning they are not inherited from either parent.

Overall, myotonia congenita is a rare and complex genetic disorder that affects the muscles and can significantly impact an individual's quality of life. With proper diagnosis and management, individuals with myotonia congenita can lead fulfilling lives despite the challenges posed by the condition.

CMT is caused by mutations in genes that are responsible for producing proteins that support the structure and function of the peripheral nerves. These mutations lead to a progressive loss of nerve fibers, particularly in the legs and feet, but also in the hands and arms. As a result, people with CMT often experience muscle weakness, numbness or tingling sensations, and foot deformities such as hammertoes and high arches. They may also have difficulty walking, balance problems, and decreased reflexes.

There are several types of Charcot-Marie-Tooth disease, each with different symptoms and progression. Type 1 is the most common form and typically affects children, while type 2 is more severe and often affects adults. Other types include type 3, which causes muscle weakness and atrophy, and type 4, which affects the hands and feet but not the legs.

There is no cure for Charcot-Marie-Tooth disease, but there are several treatments available to manage its symptoms. These may include physical therapy, braces or orthotics, pain medication, and surgery. In some cases, a stem cell transplant may be recommended to replace damaged nerve cells with healthy ones.

Early diagnosis of Charcot-Marie-Tooth disease is important to ensure proper management and prevention of complications. Treatment can help improve quality of life and slow the progression of the disease. With appropriate support and accommodations, people with CMT can lead active and fulfilling lives.

There are three main types of hearing loss: conductive, sensorineural, and mixed. Conductive hearing loss occurs when there is a problem with the middle ear and its ability to transmit sound waves to the inner ear. Sensorineural hearing loss occurs when there is damage to the inner ear or the auditory nerve, which can lead to permanent hearing loss. Mixed hearing loss is a combination of conductive and sensorineural hearing loss.

Symptoms of hearing loss may include difficulty hearing speech, especially in noisy environments, muffled or distorted sound, ringing or buzzing in the ears (tinnitus), and difficulty hearing high-pitched sounds. If you suspect you have hearing loss, it is important to seek medical advice as soon as possible, as early treatment can help improve communication and quality of life.

Hearing loss is diagnosed through a series of tests, including an audiometric test, which measures the softest sounds that can be heard at different frequencies. Treatment options for hearing loss include hearing aids, cochlear implants, and other assistive devices, as well as counseling and support to help manage the condition and improve communication skills.

Overall, hearing loss is a common condition that can have a significant impact on daily life. If you suspect you or someone you know may be experiencing hearing loss, it is important to seek medical advice as soon as possible to address any underlying issues and improve communication and quality of life.

Some examples of ectodermal dysplasias include:

* Epidermolysis bullosa (EB), a group of rare genetic disorders that cause fragile skin and mucous membranes.
* Ichthyosis, a group of genetic disorders that cause dry, scaly skin.
* Hereditary neurological and muscular atrophy (HNMA), a condition characterized by progressive loss of nerve cells and muscle wasting.

Ectodermal dysplasias can be caused by mutations in genes that are important for ectodermal development, such as genes involved in cell signaling, differentiation, and growth. These disorders can be inherited in an autosomal dominant, autosomal recessive, or X-linked manner, depending on the specific gene mutation.

There is no cure for ectodermal dysplasias, but treatment may involve managing symptoms and preventing complications. This can include using protective clothing and devices to prevent skin injury, managing infections and inflammation, and addressing any related psychosocial issues. In some cases, surgery or other procedures may be necessary to correct physical abnormalities or improve function.

Overall, ectodermal dysplasias are a diverse group of rare genetic disorders that can have a significant impact on quality of life. Early diagnosis and intervention can help manage symptoms and prevent complications, and ongoing research is focused on understanding the underlying causes of these disorders and developing new treatments.

There are many different types of chromosome disorders, including:

1. Trisomy: This is a condition in which there is an extra copy of a chromosome. For example, Down syndrome is caused by an extra copy of chromosome 21.
2. Monosomy: This is a condition in which there is a missing copy of a chromosome.
3. Turner syndrome: This is a condition in which there is only one X chromosome instead of two.
4. Klinefelter syndrome: This is a condition in which there are three X chromosomes instead of the typical two.
5. Chromosomal translocations: These are abnormalities in which a piece of one chromosome breaks off and attaches to another chromosome.
6. Inversions: These are abnormalities in which a segment of a chromosome is reversed end-to-end.
7. Deletions: These are abnormalities in which a portion of a chromosome is missing.
8. Duplications: These are abnormalities in which there is an extra copy of a segment of a chromosome.

Chromosome disorders can have a wide range of effects on the body, depending on the type and severity of the condition. Some common features of chromosome disorders include developmental delays, intellectual disability, growth problems, and physical abnormalities such as heart defects or facial anomalies.

There is no cure for chromosome disorders, but treatment and support are available to help manage the symptoms and improve the quality of life for individuals with these conditions. Treatment may include medications, therapies, and surgery, as well as support and resources for families and caregivers.

Preventive measures for chromosome disorders are not currently available, but research is ongoing to understand the causes of these conditions and to develop new treatments and interventions. Early detection and diagnosis can help identify chromosome disorders and provide appropriate support and resources for individuals and families.

In conclusion, chromosome disorders are a group of genetic conditions that affect the structure or number of chromosomes in an individual's cells. These conditions can have a wide range of effects on the body, and there is no cure, but treatment and support are available to help manage symptoms and improve quality of life. Early detection and diagnosis are important for identifying chromosome disorders and providing appropriate support and resources for individuals and families.

There are several types of malformed nails, including:

1. Onycholysis: This occurs when the nail plate separates from the nail bed, causing the nail to become loose and fragile.
2. Onchomycosis: This is a type of fungal infection that affects the nail, causing it to become thickened, discolored, and brittle.
3. Onychoptosis: This is the abnormal shedding of the nail plate, which can be caused by a variety of factors such as injury or infection.
4. Onychogryphosis: This is a condition where the nail becomes curved or twisted, causing it to press against the surrounding skin and cause discomfort.
5. Onychomycosis: This is a fungal infection that affects the nail, causing it to become thickened, discolored, and brittle.

Malformed nails can be caused by a variety of factors, including:

1. Injury or trauma to the nail bed
2. Fungal infections such as onychomycosis
3. Bacterial infections such as paronychia
4. Viral infections such as herpes simplex
5. Underlying medical conditions such as diabetes, nerve damage, or circulatory problems
6. Poor nutrition or deficiencies
7. Exposure to certain chemicals or substances
8. Aging or wear and tear over time.

Treatment for malformed nails depends on the underlying cause and may include:

1. Topical creams or ointments to treat fungal infections
2. Oral antifungal medications
3. Antibiotics to treat bacterial infections
4. Pain management for discomfort or pain
5. Debridement of the nail plate to remove dead skin and promote healing
6. Nail avulsion, where the entire nail is removed
7. Surgical correction of underlying conditions such as nerve damage or circulatory problems
8. Changes to footwear or protective gear to prevent further injury or irritation.

In some cases, malformed nails may be a sign of an underlying medical condition, so it is important to consult a healthcare professional for proper evaluation and treatment.

There are many different types of retinal degeneration, each with its own set of symptoms and causes. Some common forms of retinal degeneration include:

1. Age-related macular degeneration (AMD): This is the most common form of retinal degeneration and affects the macula, the part of the retina responsible for central vision. AMD can cause blind spots or distorted vision.
2. Retinitis pigmentosa (RP): This is a group of inherited conditions that affect the retina and can lead to night blindness, loss of peripheral vision, and eventually complete vision loss.
3. Leber congenital amaurosis (LCA): This is a rare inherited condition that causes severe vision loss or blindness at birth or within the first few years of life.
4. Stargardt disease: This is a rare inherited condition that causes progressive vision loss and can lead to blindness.
5. Retinal detachment: This occurs when the retina becomes separated from the underlying tissue, causing vision loss.
6. Diabetic retinopathy (DR): This is a complication of diabetes that can cause damage to the blood vessels in the retina and lead to vision loss.
7. Retinal vein occlusion (RVO): This occurs when a blockage forms in the small veins that carry blood away from the retina, causing vision loss.

There are several risk factors for retinal degeneration, including:

1. Age: Many forms of retinal degeneration are age-related and become more common as people get older.
2. Family history: Inherited conditions such as RP and LCA can increase the risk of retinal degeneration.
3. Genetics: Some forms of retinal degeneration are caused by genetic mutations.
4. Diabetes: Diabetes is a major risk factor for diabetic retinopathy, which can cause vision loss.
5. Hypertension: High blood pressure can increase the risk of retinal vein occlusion and other forms of retinal degeneration.
6. Smoking: Smoking has been linked to an increased risk of several forms of retinal degeneration.
7. UV exposure: Prolonged exposure to UV radiation from sunlight can increase the risk of retinal degeneration.

There are several treatment options for retinal degeneration, including:

1. Vitamin and mineral supplements: Vitamins A, C, and E, as well as zinc and selenium, have been shown to slow the progression of certain forms of retinal degeneration.
2. Anti-vascular endothelial growth factor (VEGF) injections: These medications can help reduce swelling and slow the progression of diabetic retinopathy and other forms of retinal degeneration.
3. Photodynamic therapy: This involves the use of a light-sensitive medication and low-intensity laser light to damage and shrink abnormal blood vessels in the retina.
4. Retinal implants: These devices can be used to restore some vision in people with advanced forms of retinal degeneration.
5. Stem cell therapy: Research is ongoing into the use of stem cells to repair damaged retinal cells and restore vision.

It's important to note that early detection and treatment of retinal degeneration can help to slow or stop the progression of the disease, preserving vision for as long as possible. Regular eye exams are crucial for detecting retinal degeneration in its early stages, when treatment is most effective.

The symptoms of oculocutaneous albinism (OCA) can vary in severity depending on the type of mutation and the extent of melanin reduction. Common symptoms include:

* Pale skin, hair, and eyes that are highly sensitive to the sun
* Vision problems such as nystagmus (involuntary eye movements), photophobia (sensitivity to light), and poor depth perception
* Increased risk of developing skin cancer due to lack of melanin
* Poor response to immunizations and increased risk of infections
* Delayed development of motor skills such as sitting, standing, and walking
* Delayed speech and language development
* Learning disabilities and intellectual disability in some cases

There is no cure for oculocutaneous albinism, but treatments can help manage the symptoms. These may include:

* Protective clothing and sunscreen to protect the skin from the sun's harmful rays
* Eyewear to correct vision problems
* Medication to reduce sensitivity to light and glare
* Regular check-ups with an ophthalmologist and dermatologist to monitor for signs of skin cancer and other complications
* Speech and language therapy to help with communication skills
* Physical therapy to improve motor skills and coordination
* Special education to address learning disabilities and intellectual disability

It is important for individuals with oculocutaneous albinism to receive early and accurate diagnosis, as well as ongoing medical care and support. With proper management, many individuals with this condition can lead fulfilling lives.

The symptoms of microphthalmos may include:

* Small eyes with reduced visual acuity
* Difficulty with depth perception and peripheral vision
* Squinting or crossing of the eyes (strabismus)
* Poor eye movement
* Increased sensitivity to light (photophobia)
* Reduced pupillary reflexes

The causes of microphthalmos can include:

* Genetic mutations or chromosomal abnormalities
* Infections such as rubella, syphilis, or toxoplasmosis during pregnancy
* Maternal exposure to certain medications or chemicals during pregnancy
* Trauma or injury to the eye during fetal development
* Tumors or cysts in the eye or surrounding tissues

Diagnosis of microphthalmos typically involves a comprehensive eye exam, including measurements of the eye's size and visual acuity. Imaging tests such as ultrasound or MRI may also be used to evaluate the structure of the eye and surrounding tissues.

Treatment for microphthalmos depends on the underlying cause and severity of the condition. In some cases, corrective glasses or contact lenses may be sufficient to improve vision. Surgery may be necessary in more severe cases to realign the eyes or remove tumors or cysts. In cases where the microphthalmos is due to a genetic mutation, there may be no effective treatment other than managing the symptoms.

The condition is caused by a variety of genetic mutations that can affect the development of the nervous system, muscles, or connective tissue. The symptoms of arthrogryposis can vary widely depending on the specific type and severity of the condition. They may include:

* Joint contractures: The joints become stiff and fixed in place, which can limit movement and cause deformities.
* Muscle weakness: The muscles may be weak or paralyzed, leading to difficulty moving the affected limbs.
* Delayed motor development: Children with arthrogryposis may experience delays in reaching developmental milestones such as sitting, standing, and walking.
* Limited range of motion: The joints may have a limited range of motion, making it difficult to move the affected limbs through their full range of motion.
* Muscle wasting: The muscles may waste away due to lack of use, leading to a weakened appearance.

There is no cure for arthrogryposis, but treatment options are available to help manage the symptoms and improve quality of life. These may include:

* Physical therapy: To maintain or improve muscle strength and range of motion.
* Occupational therapy: To assist with daily activities and fine motor skills.
* Surgery: To release contracted joints and improve mobility.
* Bracing and orthotics: To support weakened joints and improve posture.
* Medications: To manage pain and spasticity.

It is important to note that arthrogryposis is a complex condition, and the specific treatment plan will depend on the type and severity of the condition, as well as the individual needs of the patient. Early diagnosis and intervention are key to improving outcomes for individuals with arthrogryposis.

Syndactyly is caused by an abnormality during embryonic development, which can be hereditary or due to certain genetic syndromes. It is usually diagnosed at birth and may be detected on physical examination. Imaging studies such as ultrasound or MRI may also be used to confirm the diagnosis.

Treatment for syndactyly depends on the severity of the condition. In mild cases, no treatment may be necessary, while in more severe cases, surgery may be required to separate the joined digits. The goal of surgery is to improve hand or foot function and appearance.

Syndactyly can also occur as a part of other congenital conditions such as polydactyly (extra fingers or toes) or postaxial polydactyly (extra finger on the little finger side). In these cases, treatment may involve a combination of surgery and physical therapy to improve hand or foot function.

In summary, syndactyly is a congenital condition where two or more fingers or toes are joined together by a flap of skin, it can be mild or severe, and treatment may include surgery and/or physical therapy depending on the severity of the condition and other associated congenital conditions.

There are several types of cutis laxa, including:

1. Oculocutaneous type: This is the most common form of the disorder, and it is characterized by wrinkled skin, loose folds, and skin fragility. People with this type may also have vision loss, cataracts, or other eye problems.
2. Dermato-skeletal type: This type is characterized by loose skin and joint hypermobility, as well as skeletal abnormalities such as short stature, bowed legs, or ribcage deformities.
3. Neurological type: This type is characterized by developmental delay, intellectual disability, and seizures. People with this type may also have other neurological symptoms such as weakness or paralysis of certain muscle groups.
4. Cardiac type: This type is characterized by heart defects, such as ventricular septal defect or atrial septal defect.

There is no cure for cutis laxa, and treatment is focused on managing the symptoms. This may include surgery to correct skin and joint deformities, physical therapy to improve muscle strength and flexibility, and other supportive measures such as glasses or contact lenses to correct vision problems. Early diagnosis and intervention are important to help manage the condition and improve quality of life for individuals with cutis laxa.

The prognosis for individuals with cutis laxa varies depending on the type and severity of the disorder. Some people with mild forms of the condition may lead relatively normal lives, while others with more severe forms may have significant challenges and may require ongoing medical care and support. With appropriate management, many people with cutis laxa can lead fulfilling lives, but it is important to be aware of the potential complications and to seek medical attention if symptoms worsen or new symptoms develop.

There are several types of kidney diseases that are classified as cystic, including:

1. Autosomal dominant polycystic kidney disease (ADPKD): This is the most common form of cystic kidney disease and is caused by a genetic mutation. It is characterized by the growth of numerous cysts in both kidneys, which can lead to kidney damage and failure.
2. Autosomal recessive polycystic kidney disease (ARPKD): This is a rare form of cystic kidney disease that is also caused by a genetic mutation. It is characterized by the growth of numerous cysts in both kidneys, as well as other organs such as the liver and pancreas.
3. Cystinosis: This is a rare genetic disorder that causes the accumulation of cystine crystals in the kidneys and other organs. It can lead to the formation of cysts and damage to the kidneys.
4. Medullary cystic kidney disease (MCKD): This is a rare genetic disorder that affects the medulla, the innermost layer of the kidney. It is characterized by the growth of cysts in the medulla, which can lead to kidney damage and failure.
5. Other rare forms of cystic kidney disease: There are several other rare forms of cystic kidney disease that can be caused by genetic mutations or other factors. These include hereditary cystic papillary necrosis, familial juvenile nephropathy, and others.

The symptoms of kidney diseases, cystic can vary depending on the specific type of disease and the severity of the condition. Common symptoms include:

* High blood pressure
* Proteinuria (excess protein in the urine)
* Hematuria (blood in the urine)
* Decreased kidney function
* Abdominal pain
* Weight loss
* Fatigue
* Swelling in the legs and ankles

If you suspect that you or your child may have a cystic kidney disease, it is important to seek medical attention as soon as possible. A healthcare provider can perform a physical examination, take a medical history, and order diagnostic tests such as urinalysis, blood tests, and imaging studies (such as ultrasound or CT scans) to determine the cause of the symptoms.

Treatment for cystic kidney disease will depend on the specific type of disease and the severity of the condition. Treatment options may include:

* Medications to control high blood pressure and proteinuria
* Medications to slow the progression of kidney damage
* Dialysis or kidney transplantation in advanced cases
* Cyst aspiration or surgical removal of cysts in some cases

It is important to note that there is no cure for cystic kidney disease, and the best treatment approach is to slow the progression of the disease and manage its symptoms. Early detection and aggressive management can help improve quality of life and delay the need for dialysis or transplantation.

In addition to medical treatment, there are some lifestyle modifications that may be helpful in managing cystic kidney disease. These include:

* Maintaining a healthy diet with low salt and protein intake
* Staying hydrated by drinking plenty of water
* Engaging in regular physical activity
* Avoiding harmful substances such as tobacco and alcohol
* Monitoring blood pressure and weight regularly

It is important to note that cystic kidney disease can be a serious condition, and it is important to work closely with a healthcare provider to manage the disease and slow its progression. With appropriate treatment and lifestyle modifications, many people with cystic kidney disease are able to lead active and fulfilling lives.

There are different types of SMA, ranging from mild to severe, with varying degrees of muscle wasting and weakness. The condition typically becomes apparent during infancy or childhood and can progress rapidly or slowly over time. Symptoms may include muscle weakness, spinal curvature (scoliosis), respiratory problems, and difficulty swallowing.

SMA is caused by a defect in the Survival Motor Neuron 1 (SMN1) gene, which is responsible for producing a protein that protects motor neurons from degeneration. The disorder is usually inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the defective gene - one from each parent - to develop the condition.

There is currently no cure for SMA, but various treatments are available to manage its symptoms and slow its progression. These may include physical therapy, occupational therapy, bracing, and medications to improve muscle strength and function. In some cases, stem cell therapy or gene therapy may be considered as potential treatment options.

Prognosis for SMA varies depending on the type and severity of the condition, but it is generally poor for those with the most severe forms of the disorder. However, with appropriate management and support, many individuals with SMA can lead fulfilling lives and achieve their goals despite physical limitations.

Some common types of eye abnormalities include:

1. Refractive errors: These are errors in the way the eye focuses light, causing blurry vision. Examples include myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision).
2. Amblyopia: This is a condition where the brain favors one eye over the other, causing poor vision in the weaker eye.
3. Cataracts: A cataract is a clouding of the lens in the eye that can cause blurry vision and increase the risk of glaucoma.
4. Glaucoma: This is a group of eye conditions that can damage the optic nerve and lead to vision loss.
5. Macular degeneration: This is a condition where the macula, the part of the retina responsible for central vision, deteriorates, leading to vision loss.
6. Diabetic retinopathy: This is a complication of diabetes that can damage the blood vessels in the retina and lead to vision loss.
7. Retinal detachment: This is a condition where the retina becomes separated from the underlying tissue, leading to vision loss.
8. Corneal abnormalities: These are irregularities in the shape or structure of the cornea, such as keratoconus, that can cause blurry vision.
9. Optic nerve disorders: These are conditions that affect the optic nerve, such as optic neuritis, that can cause vision loss.
10. Traumatic eye injuries: These are injuries to the eye or surrounding tissue that can cause vision loss or other eye abnormalities.

Eye abnormalities can be diagnosed through a comprehensive eye exam, which may include visual acuity tests, refraction tests, and imaging tests such as retinal photography or optical coherence tomography (OCT). Treatment for eye abnormalities depends on the specific condition and may include glasses or contact lenses, medication, surgery, or other therapies.

There are several types of RTA, including:

1. Type 1 RTA: This is caused by a defect in the genes that code for the proteins involved in acid secretion in the renal tubules.
2. Type 2 RTA: This is caused by damage to the renal tubules, such as from exposure to certain drugs or toxins.
3. Type 4 RTA: This is caused by a deficiency of the hormone aldosterone, which helps regulate electrolyte levels in the body.

Symptoms of RTA can include:

* Nausea and vomiting
* Abdominal pain
* Fatigue
* Weakness
* Dehydration
* Increased heart rate
* Decreased urine production

RTA can be diagnosed through blood tests that measure the pH levels in the body, as well as tests that assess kidney function and electrolyte levels. Treatment for RTA typically involves correcting any underlying causes, such as stopping certain medications or addressing electrolyte imbalances. In some cases, medications may be prescribed to help regulate acid levels in the body.

Prevention of RTA includes maintaining proper hydration, avoiding exposure to harmful substances, and managing any underlying medical conditions that may increase the risk of developing RTA. Early detection and treatment can help prevent complications and improve outcomes for individuals with RTA.

There are many different types of congenital foot deformities, including:

1. Clubfoot (also known as talipes equinovarus): This is a condition in which the foot is twisted inward and downward, so that the heel is next to the ankle bone and the toes are pointing upwards.
2. Cavus foot (also known as high arch foot): This is a condition in which the arch of the foot is raised and rigid, making it difficult to walk or stand.
3. Flatfoot (also known as fallen arch foot): This is a condition in which the arch of the foot is low or nonexistent, causing the foot to appear flat.
4. Metatarsus adductus: This is a condition in which the forefoot is turned inward so that the toes are pointing towards the other foot.
5. Cleft foot: This is a rare condition in which the foot is misshapen and has a cleft or divide in the soft tissue.
6. Polydactyly (extra digits): This is a condition in which there are extra toes or fingers present.
7. Posterior tibial dysfunction: This is a condition in which the tendon that supports the arch of the foot is weakened or injured, leading to a flatfoot deformity.
8. Hereditary conditions: Some congenital foot deformities can be inherited from parents or grandparents.
9. Genetic syndromes: Certain genetic syndromes, such as Down syndrome, can increase the risk of developing congenital foot deformities.
10. Environmental factors: Exposure to certain medications or chemicals during pregnancy can increase the risk of congenital foot deformities.

Congenital foot deformities can be diagnosed through a physical examination, X-rays, and other imaging tests. Treatment options depend on the specific type and severity of the deformity, but may include:

1. Observation and monitoring: Mild cases of congenital foot deformities may not require immediate treatment and can be monitored with regular check-ups to see if any changes occur.
2. Orthotics and shoe inserts: Customized shoe inserts or orthotics can help redistribute pressure and support the foot in a more neutral position.
3. Casting or bracing: In some cases, casting or bracing may be used to help straighten the foot and promote proper alignment.
4. Surgery: In severe cases of congenital foot deformities, surgery may be necessary to correct the deformity. This can involve cutting or realigning bones, tendons, or other soft tissue to achieve a more normal foot position.
5. Physical therapy: After treatment, physical therapy may be recommended to help improve strength and range of motion in the affected foot.

1. Alopecia areata: This is a condition where patches of hair fall out, resulting in bald spots on the scalp or other parts of the body.
2. Androgenetic alopecia: This is the most common form of hair loss, also known as male pattern baldness or female pattern baldness. It occurs when hormones cause hair to thin and fall out, leading to a receding hairline in men and a gradual thinning of hair on the top of the head in women.
3. Telogen effluvium: This is a condition where there is a sudden increase in the number of hair follicles that stop growing and enter the resting phase, leading to excessive hair shedding.
4. Trichotillomania: This is a psychological disorder characterized by an irresistible urge to pull out one's own hair, often resulting in noticeable hair loss.
5. Lichen planus: This is a skin condition that can cause hair loss, as well as itching and inflammation on the scalp.
6. Tinea capitis: This is a fungal infection of the scalp that can cause hair loss and inflammation.
7. Folliculitis: This is an inflammation of the hair follicles, which can cause hair loss and scarring.
8. Traction alopecia: This is a condition where hair loss occurs due to constant pulling or tugging on the hair, such as with tight hairstyles like braids or ponytails.
9. Chemical damage: Exposure to harsh chemicals in hair products can damage the hair and lead to hair loss.
10. Hair thinning: This is a condition where hair becomes thinner over time, often due to hormonal imbalances or nutritional deficiencies.

These are just a few examples of hair diseases that can affect people. It's important to note that many of these conditions can be treated with medical care and changes to one's lifestyle and diet. If you suspect you have a hair disease, it's important to consult a dermatologist or other qualified healthcare professional for proper diagnosis and treatment.

There are several types of HSANs, each with distinct clinical features and modes of inheritance. Some of the most common forms of HSANs include:

1. Hereditary sensory and autonomic neuropathy type I (HSANI): This is the most common form of HSAN, also known as Familial Dysautonomia (Riley-Day syndrome). It is caused by a mutation in the IVS gene and affects primarily the sensory and autonomic nerves.
2. Hereditary sensory and autonomic neuropathy type II (HSANII): This form of HSAN is caused by mutations in the PMP22 gene and is characterized by progressive weakness and loss of sensation in the limbs, as well as abnormalities in the functioning of the autonomic nervous system.
3. Hereditary sensory and autonomic neuropathy type III (HSANIII): This form of HSAN is caused by mutations in the GRM1 gene and is characterized by progressive loss of sensation and muscle weakness, as well as abnormalities in the functioning of the autonomic nervous system.
4. Hereditary sensory and autonomic neuropathy type IV (HSANIV): This form of HSAN is caused by mutations in the MAG gene and is characterized by progressive loss of sensation and muscle weakness, as well as abnormalities in the functioning of the autonomic nervous system.

The symptoms of HSANs vary depending on the specific type of disorder and can include:

* Progressive loss of sensation in the hands and feet
* Muscle weakness and wasting
* Abnormalities in the functioning of the autonomic nervous system, such as dysfunction of the cardiovascular and gastrointestinal systems
* Abnormalities in the functioning of the sensory nerves, leading to numbness, tingling, or pain
* Abnormalities in the functioning of the motor nerves, leading to weakness and muscle wasting
* Eye problems, such as optic atrophy or difficulty moving the eyes
* Hearing loss or other ear abnormalities
* Cognitive impairment or developmental delays

There is currently no cure for HSANs, but various treatments can help manage the symptoms. These may include:

* Physical therapy to maintain muscle strength and mobility
* Occupational therapy to improve daily functioning and independence
* Pain management medications and other treatments for neuropathic pain
* Assistive devices, such as canes or wheelchairs, to aid with mobility
* Speech therapy to improve communication skills
* Cognitive and behavioral therapies to help manage cognitive impairment and developmental delays

The progression of HSANs can vary depending on the specific type of disorder and the individual affected. Some forms of HSANs may progress slowly over many years, while others may progress more quickly and have a more severe impact on daily functioning. In some cases, HSANs can be associated with other conditions or diseases that can affect the progression of the disorder. For example, some individuals with HSANs may also have other neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) or Alzheimer's disease.

HSANs are rare disorders, and there is currently no cure. However, research into the genetic causes of these disorders is ongoing, and new treatments and therapies are being developed to help manage the symptoms and slow the progression of the disorders. With proper management and support, individuals with HSANs can lead fulfilling lives and achieve their goals.

There are several types of inborn errors of amino acid metabolism, including:

1. Phenylketonuria (PKU): This is the most common inborn error of amino acid metabolism and is caused by a deficiency of the enzyme phenylalanine hydroxylase. This enzyme is needed to break down the amino acid phenylalanine, which is found in many protein-containing foods. If phenylalanine is not properly broken down, it can build up in the blood and brain and cause serious health problems.
2. Maple syrup urine disease (MSUD): This is a rare genetic disorder that affects the breakdown of the amino acids leucine, isoleucine, and valine. These amino acids are important for growth and development, but if they are not properly broken down, they can build up in the blood and cause serious health problems.
3. Homocystinuria: This is a rare genetic disorder that affects the breakdown of the amino acid methionine. Methionine is important for the body's production of proteins and other compounds, but if it is not properly broken down, it can build up in the blood and cause serious health problems.
4. Arginase deficiency: This is a rare genetic disorder that affects the breakdown of the amino acid arginine. Arginine is important for the body's production of nitric oxide, a compound that helps to relax blood vessels and improve blood flow.
5. Citrullinemia: This is a rare genetic disorder that affects the breakdown of the amino acid citrulline. Citrulline is important for the body's production of proteins and other compounds, but if it is not properly broken down, it can build up in the blood and cause serious health problems.
6. Tyrosinemia: This is a rare genetic disorder that affects the breakdown of the amino acid tyrosine. Tyrosine is important for the body's production of proteins and other compounds, but if it is not properly broken down, it can build up in the blood and cause serious health problems.
7. Maple syrup urine disease (MSUD): This is a rare genetic disorder that affects the breakdown of the amino acids leucine, isoleucine, and valine. These amino acids are important for growth and development, but if they are not properly broken down, they can build up in the blood and cause serious health problems.
8. PKU (phenylketonuria): This is a rare genetic disorder that affects the breakdown of the amino acid phenylalanine. Phenylalanine is important for the body's production of proteins and other compounds, but if it is not properly broken down, it can build up in the blood and cause serious health problems.
9. Methionine adenosyltransferase (MAT) deficiency: This is a rare genetic disorder that affects the breakdown of the amino acid methionine. Methionine is important for the body's production of proteins and other compounds, but if it is not properly broken down, it can build up in the blood and cause serious health problems.
10. Homocystinuria: This is a rare genetic disorder that affects the breakdown of the amino acid homocysteine. Homocysteine is important for the body's production of proteins and other compounds, but if it is not properly broken down, it can build up in the blood and cause serious health problems.

It is important to note that these disorders are rare and affect a small percentage of the population. However, they can be serious and potentially life-threatening, so it is important to be aware of them and seek medical attention if symptoms persist or worsen over time.

The hallmark symptoms of SPH are difficulty walking (ataxia), weakness or paralysis of the lower limbs, and spasms or twitching of the muscles. Other common features may include:

1. Intellectual disability: Some individuals with SPH may have mild to moderate intellectual disability, which can range from learning difficulties to more severe cognitive impairments.
2. Autism spectrum disorder: Some individuals with SPH may also have autism spectrum disorder (ASD), which is characterized by difficulties in social interaction and communication, as well as repetitive behaviors or interests.
3. Seizures: Some people with SPH may experience seizures, which can be a significant source of concern for families and caregivers.
4. Vision problems: Some individuals with SPH may have vision loss or other eye problems, such as nystagmus (involuntary eye movements).
5. Scoliosis: Some people with SPH may develop scoliosis, a condition in which the spine curves abnormally to one side.
6. Other health issues: Depending on the specific type of SPH, individuals may also experience other health problems, such as kidney or liver disease, or gastrointestinal issues.

SPH is caused by mutations in various genes, including those involved in the functioning of nerve cells and the formation of the nervous system. These mutations can be inherited from one's parents or may occur spontaneously. There is currently no cure for SPH, but various treatments can help manage the symptoms and improve quality of life. These treatments may include:

1. Physical therapy: To help maintain muscle strength and flexibility, as well as to improve mobility and balance.
2. Occupational therapy: To develop skills for daily living and to assist with adapting to vision loss or other disabilities.
3. Speech therapy: To address communication difficulties and swallowing problems.
4. Medications: To control seizures, muscle spasms, or other symptoms.
5. Assistive technology: Such as canes, walkers, or wheelchairs, to assist with mobility.
6. Surgery: May be necessary to correct eye problems, such as cataracts or strabismus (crossed eyes), or to relieve pressure on the brain caused by hydrocephalus.

It is essential for individuals with SPH to receive regular medical care and monitoring from a multidisciplinary team of healthcare professionals, including neurologists, ophthalmologists, orthopedists, and other specialists as needed. With appropriate management and support, many people with SPH can lead fulfilling lives and achieve their goals.

Examples of X-linked genetic diseases include:

* Hemophilia A and B
* Duchenne muscular dystrophy
* Connexin 26 (GJB2) deafness
* Fragile X syndrome
* X-linked mental retardation
* Juvenile primary lateral sclerosis
* Myotonic dystrophy type 1

X-linked diseases can be caused by mutations in various genes, including those involved in blood clotting, muscle function, and hearing. These conditions often have a significant impact on quality of life and can be inherited from one generation to the next. However, advances in medical technology and research offer hope for improved treatments and potential cures.

Prevention of X-linked diseases is challenging but possible through various methods such as:

1. Genetic counseling: Providing information about the risks and inheritance patterns of X-linked conditions to families can help them make informed decisions about their reproductive options.
2. Prenatal testing: Testing the fetus during pregnancy can identify X-linked mutations and allow for appropriate planning and decision-making.
3. Carrier testing: Identifying carriers of X-linked conditions can help families understand their risk and make informed decisions about their reproductive options.
4. Gene therapy: Experimental treatments that correct or replace the faulty gene responsible for the condition offer hope for improved outcomes.
5. Treatment and management: Various therapeutic approaches, including medication, physical therapy, and surgery, can help manage symptoms and improve quality of life.

In conclusion, X-linked genetic diseases are a significant portion of inherited disorders that have a profound impact on families and individuals affected by them. While there is no cure for these conditions, advances in medical technology and research offer hope for improved treatments and potential cures. By understanding the causes, symptoms, diagnosis, and prevention methods, families can make informed decisions about their reproductive options and receive appropriate care and support.

There are two main types of PKD: autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD). ADPKD is the most common form of PKD and accounts for about 90% of all cases. It is caused by mutations in the PKD1 or PKD2 genes, which are inherited from one's parents. ARPKD is less common and is caused by mutations in the PKHD1 gene.

The symptoms of PKD can vary depending on the severity of the disease and the age of onset. Common symptoms include high blood pressure, back pain, kidney stones, urinary tract infections, and frequent urination. As the cysts grow, they can also cause complications such as kidney damage, anemia, and electrolyte imbalances.

PKD is typically diagnosed through a combination of imaging tests such as ultrasound, CT scans, and MRI, as well as genetic testing to identify the presence of the disease-causing mutations. There is no cure for PKD, but treatment options are available to manage the symptoms and slow the progression of the disease. These may include medications to control high blood pressure, pain management, and dialysis in advanced cases.

In conclusion, polycystic kidney disease (PKD) is a genetic disorder that affects the kidneys and can lead to chronic kidney disease and eventually kidney failure. It is important to be aware of the symptoms and risk factors for PKD, as well as to seek medical attention if they are present, in order to receive proper diagnosis and treatment.

There are two forms of cystinosis: neonatal and adult. Neonatal cystinosis is present at birth and can cause a range of symptoms including failure to gain weight, diarrhea, and difficulty feeding. Adult cystinosis typically develops in adulthood and may cause symptoms such as kidney damage, blindness, and skin rashes.

Cystinosis is diagnosed through a combination of physical examination, medical history, and laboratory tests. Treatment for the disorder typically involves managing the symptoms and preventing complications. For neonatal cystinosis, this may involve feeding tubes and medication to help the baby gain weight. For adult cystinosis, treatment may include medication to lower cystine levels in the body and manage any associated complications such as kidney damage or blindness.

In some cases, a stem cell transplant may be recommended to treat cystinosis. This involves replacing the affected cells with healthy ones from a donor. The procedure is typically performed in children with neonatal cystinosis and can help improve their quality of life and prevent complications.

Overall, cystinosis is a rare and debilitating genetic disorder that affects the kidneys and eyes. While there is currently no cure for the disorder, treatment options are available to manage the symptoms and prevent complications. With proper management and care, individuals with cystinosis can lead fulfilling lives.

Optic atrophy is a condition where there is a degeneration or loss of the optic nerve fibers, leading to vision loss. It can be caused by various factors such as trauma, inflammation, tumors, and certain medical conditions like multiple sclerosis.

The symptoms of optic atrophy may include:

1. Blind spots in the visual field
2. Difficulty perceiving colors
3. Difficulty adjusting to bright light
4. Double vision or other abnormalities in binocular vision
5. Eye pain or discomfort
6. Loss of peripheral vision
7. Nausea and vomiting
8. Sensitivity to light
9. Tunnel vision
10. Weakness or numbness in the face or extremities.

The diagnosis of optic atrophy is based on a comprehensive eye exam, which includes a visual acuity test, dilated eye exam, and other specialized tests such as an OCT (optical coherence tomography) scan.

Treatment for optic atrophy depends on the underlying cause and may include medications to manage inflammation or infection, surgery to remove a tumor or repair damaged tissue, or management of associated conditions such as diabetes or multiple sclerosis. In some cases, vision loss due to optic atrophy may be permanent and cannot be reversed, but there are strategies to help improve remaining vision and adapt to any visual impairment.

Here are some examples of how the term "facies" may be used in a medical context:

1. Facial asymmetry: A patient with facial asymmetry may have one side of their face that is noticeably different from the other, either due to a birth defect or as a result of trauma or surgery.
2. Facial dysmorphia: This is a condition in which a person has a distorted perception of their own facial appearance, leading them to seek repeated cosmetic procedures or to feel self-conscious about their face.
3. Facies of a particular syndrome: Certain medical conditions, such as Down syndrome or Turner syndrome, can have distinctive facial features that are used to help diagnose the condition.
4. Facial trauma: A patient who has suffered an injury to their face may have a facies that is disrupted or misshapen as a result of the trauma.
5. Facial aging: As people age, their facial features can change in predictable ways, such as sagging of the skin, deepening of wrinkles, and loss of fat volume. A doctor might use the term "facies" to describe these changes and plan appropriate treatments, such as a facelift or dermal fillers.

In general, the term "facies" is used by healthcare professionals to describe any aspect of a patient's facial appearance that may be relevant to their diagnosis or treatment. It is a useful way to communicate information about a patient's face in a precise and objective manner.

Hypotonia is a state of decreased muscle tone, which can be caused by various conditions, such as injury, disease, or disorders that affect the nervous system. It is characterized by a decrease in muscle stiffness and an increase in joint range of motion. Muscle hypotonia can result in difficulty with movement, coordination, and balance.

There are several types of muscle hypotonia, including:

1. Central hypotonia: This type is caused by dysfunction in the central nervous system and results in a decrease in muscle tone throughout the body.
2. Peripheral hypotonia: This type is caused by dysfunction in the peripheral nervous system and results in a selective decrease in muscle tone in specific muscle groups.
3. Mixed hypotonia: This type combines central and peripheral hypotonia.

Muscle hypotonia can be associated with a variety of symptoms, such as fatigue, weakness, poor coordination, and difficulty with speech and swallowing. Treatment options vary depending on the underlying cause of the condition and may include physical therapy, medication, and lifestyle modifications.

Muscle hypotonia is a common condition that can affect people of all ages, from children to adults. Early diagnosis and treatment are important to help manage symptoms and improve quality of life. If you suspect you or your child may have muscle hypotonia, consult with a healthcare professional for proper evaluation and treatment.

There are currently no cures for Fanconi anemia, but bone marrow transplantation and other supportive therapies can help manage some of the symptoms and improve quality of life. Research into the genetics and molecular biology of Fanconi anemia is ongoing to better understand the disorder and develop new treatments.

Some of the common symptoms of Fanconi anemia include short stature, limb deformities, hearing loss, vision problems, and an increased risk of infections and cancer. Children with Fanconi anemia may also experience developmental delays, learning disabilities, and social and emotional challenges.

The diagnosis of Fanconi anemia is typically made based on a combination of clinical findings, laboratory tests, and genetic analysis. Treatment options for Fanconi anemia depend on the severity of the disorder and may include bone marrow transplantation, blood transfusions, antibiotics, and other supportive therapies.

Fanconi anemia is a rare disorder that affects approximately 1 in 160,000 births worldwide. It is more common in certain populations, such as Ashkenazi Jews and individuals of Spanish descent. Fanconi anemia can be inherited in an autosomal recessive pattern, meaning that a child must inherit two copies of the mutated gene (one from each parent) to develop the disorder.

Overall, Fanconi anemia is a complex and rare genetic disorder that requires specialized medical care and ongoing research to better understand its causes and develop effective treatments. With appropriate management and supportive therapies, individuals with Fanconi anemia can lead fulfilling lives despite the challenges associated with the disorder.

The term "keratoderma" comes from the Greek words "keras," meaning "horn," and "derma," meaning "skin." It refers to the characteristic thickening of the skin that is seen in these disorders. The term "palmoplantar" refers to the fact that the condition affects the palms and soles of the feet.

Keratoderma, palmoplantar can be caused by a variety of genetic mutations, including autosomal dominant, autosomal recessive, and X-linked inheritance patterns. The disorder is usually diagnosed based on the appearance of the skin and may require a biopsy or genetic testing to confirm the diagnosis.

Treatment for keratoderma, palmoplantar typically focuses on managing the symptoms and preventing complications. This may include topical medications, physical therapy, and lifestyle modifications such as wearing gloves or protective footwear to reduce friction and irritation. In some cases, surgery may be necessary to remove thickened skin or repair damaged tissue.

Overall, keratoderma, palmoplantar is a rare and debilitating condition that can significantly impact an individual's quality of life. With proper diagnosis and management, however, it is possible to alleviate symptoms and improve functioning.

Types of Sex Chromosome Aberrations:

1. Turner Syndrome: A condition where a female has only one X chromosome instead of two (45,X).
2. Klinefelter Syndrome: A condition where a male has an extra X chromosome (47,XXY) or an extra Y chromosome (47,XYYY).
3. XXX Syndrome: A rare condition where a female has three X chromosomes instead of two.
4. XYY Syndrome: A rare condition where a male has an extra Y chromosome (48,XYY).
5. Mosaicism: A condition where a person has a mixture of cells with different numbers of sex chromosomes.

Effects of Sex Chromosome Aberrations:

Sex chromosome aberrations can cause a range of physical and developmental abnormalities, such as short stature, infertility, and reproductive problems. They may also increase the risk of certain health conditions, including:

1. Congenital heart defects
2. Cognitive impairments
3. Learning disabilities
4. Developmental delays
5. Increased risk of infections and autoimmune disorders

Diagnosis of Sex Chromosome Aberrations:

Sex chromosome aberrations can be diagnosed through various methods, including:

1. Karyotyping: A test that involves analyzing the number and structure of an individual's chromosomes.
2. Fluorescence in situ hybridization (FISH): A test that uses fluorescent probes to detect specific DNA sequences on chromosomes.
3. Chromosomal microarray analysis: A test that looks for changes in the number or structure of chromosomes by analyzing DNA from blood or other tissues.
4. Next-generation sequencing (NGS): A test that analyzes an individual's entire genome to identify specific genetic variations, including sex chromosome aberrations.

Treatment and Management of Sex Chromosome Aberrations:

There is no cure for sex chromosome aberrations, but there are various treatments and management options available to help alleviate symptoms and improve quality of life. These may include:

1. Hormone replacement therapy (HRT): To address hormonal imbalances and related symptoms.
2. Assisted reproductive technologies (ART): Such as in vitro fertilization (IVF) or preimplantation genetic diagnosis (PGD), to help individuals with infertility or pregnancy complications.
3. Prenatal testing: To identify sex chromosome aberrations in fetuses, allowing parents to make informed decisions about their pregnancies.
4. Counseling and support: To help individuals and families cope with the emotional and psychological impact of a sex chromosome abnormality diagnosis.
5. Surgeries or other medical interventions: To address related health issues, such as infertility, reproductive tract abnormalities, or genital ambiguity.

It's important to note that each individual with a sex chromosome aberration may require a unique treatment plan tailored to their specific needs and circumstances. A healthcare provider can work with the individual and their family to develop a personalized plan that takes into account their medical, emotional, and social considerations.

In conclusion, sex chromosome aberrations are rare genetic disorders that can have significant implications for an individual's physical, emotional, and social well-being. While there is no cure for these conditions, advances in diagnostic testing and treatment options offer hope for improving the lives of those affected. With proper medical care, support, and understanding, individuals with sex chromosome aberrations can lead fulfilling lives.

Types of Craniofacial Abnormalities:

1. Cleft lip and palate: A congenital deformity that affects the upper jaw, nose, and mouth.
2. Premature fusion of skull bones: Can result in an abnormally shaped head or face.
3. Distraction osteogenesis: A condition where the bones fail to grow properly, leading to abnormal growth patterns.
4. Facial asymmetry: A condition where one side of the face is smaller or larger than the other.
5. Craniosynostosis: A condition where the skull bones fuse together too early, causing an abnormally shaped head.
6. Micrognathia: A condition where the lower jaw is smaller than normal, which can affect breathing and feeding.
7. Macroglossia: A condition where the tongue is larger than normal, which can cause difficulty swallowing and breathing.
8. Oculofacial dysostosis: A condition that affects the development of the eyes and face.
9. Treacher Collins syndrome: A rare genetic disorder that affects the development of the face, particularly the eyes, ears, and jaw.

Causes of Craniofacial Abnormalities:

1. Genetics: Many craniofacial abnormalities are inherited from one or both parents.
2. Environmental factors: Exposure to certain drugs, alcohol, or infections during pregnancy can increase the risk of craniofacial abnormalities.
3. Premature birth: Babies born prematurely are at a higher risk for craniofacial abnormalities.
4. Trauma: Head injuries or other traumatic events can cause craniofacial abnormalities.
5. Infections: Certain infections, such as meningitis or encephalitis, can cause craniofacial abnormalities.

Treatment of Craniofacial Abnormalities:

1. Surgery: Many craniofacial abnormalities can be treated with surgery to correct the underlying deformity.
2. Orthodontic treatment: Braces or other orthodontic devices can be used to align teeth and improve the appearance of the face.
3. Speech therapy: Certain craniofacial abnormalities, such as micrognathia, can affect speech development. Speech therapy can help improve communication skills.
4. Medication: In some cases, medication may be prescribed to manage symptoms associated with craniofacial abnormalities, such as pain or breathing difficulties.
5. Rehabilitation: Physical therapy and occupational therapy can help individuals with craniofacial abnormalities regain function and mobility after surgery or other treatments.

It is important to note that the treatment of craniofacial abnormalities varies depending on the specific condition and its severity. A healthcare professional, such as a pediatrician, orthodontist, or plastic surgeon, should be consulted for proper diagnosis and treatment.

It is also important to remember that craniofacial abnormalities can have a significant impact on an individual's quality of life, affecting their self-esteem, social relationships, and ability to function in daily activities. Therefore, it is essential to provide appropriate support and resources for individuals with these conditions, including psychological counseling, social support groups, and education about the condition.

Causes: There are several causes of night blindness, including:

1. Vitamin A deficiency: Vitamin A is essential for the health of the retina, and a deficiency can lead to night blindness.
2. Retinitis pigmentosa: This is a group of inherited conditions that can cause progressive damage to the retina and result in night blindness.
3. Cataracts: A cataract can cause a person to become night blind by blocking the light that enters the eye.
4. Glaucoma: This is a group of eye conditions that can damage the optic nerve and lead to vision loss, including night blindness.
5. Other medical conditions: Certain medical conditions such as diabetes, multiple sclerosis, and stroke can cause night blindness.

Symptoms: The symptoms of night blindness can vary depending on the underlying cause, but common symptoms include:

1. Difficulty seeing in low light environments
2. Blind spots or missing areas of vision
3. Sensitivity to light
4. Glare or halos around lights
5. Difficulty adjusting to changes in light levels

Diagnosis: Night blindness is typically diagnosed through a comprehensive eye exam, which may include a visual acuity test, refraction test, and retinal examination. Imaging tests such as an OCT scan or retinal photography may also be used to evaluate the retina and optic nerve.

Treatment: The treatment of night blindness depends on the underlying cause. For example, vitamin A supplements may be prescribed for a vitamin A deficiency, while cataract surgery may be recommended for cataracts. In some cases, no treatment may be necessary, and the condition may resolve on its own over time.

Prevention: While some cases of night blindness are unavoidable, there are steps you can take to reduce your risk of developing the condition. These include:

1. Maintaining a healthy diet that includes foods rich in vitamin A and other essential nutrients for eye health.
2. Wearing sunglasses with UV protection to protect your eyes from excessive sunlight.
3. Avoiding smoking and excessive alcohol consumption, which can damage the optic nerve and retina.
4. Getting regular eye exams to detect any underlying eye problems early on.
5. Wearing protective eyewear when engaging in activities that could potentially harm your eyes, such as sports or working with hazardous materials.

1. Muscular dystrophy: A group of genetic disorders characterized by progressive muscle weakness and degeneration.
2. Myopathy: A condition where the muscles become damaged or diseased, leading to muscle weakness and wasting.
3. Fibromyalgia: A chronic condition characterized by widespread pain, fatigue, and muscle stiffness.
4. Rhabdomyolysis: A condition where the muscle tissue is damaged, leading to the release of myoglobin into the bloodstream and potentially causing kidney damage.
5. Polymyositis/dermatomyositis: Inflammatory conditions that affect the muscles and skin.
6. Muscle strain: A common injury caused by overstretching or tearing of muscle fibers.
7. Cervical dystonia: A movement disorder characterized by involuntary contractions of the neck muscles.
8. Myasthenia gravis: An autoimmune disorder that affects the nerve-muscle connection, leading to muscle weakness and fatigue.
9. Oculopharyngeal myopathy: A condition characterized by weakness of the muscles used for swallowing and eye movements.
10. Inclusion body myositis: An inflammatory condition that affects the muscles, leading to progressive muscle weakness and wasting.

These are just a few examples of the many different types of muscular diseases that can affect individuals. Each condition has its unique set of symptoms, causes, and treatment options. It's important for individuals experiencing muscle weakness or wasting to seek medical attention to receive an accurate diagnosis and appropriate care.

Note: The medical information provided here is for general purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. If you suspect that your child may have a congenital limb deformity, it is important to consult with a qualified healthcare provider as soon as possible.

1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.

2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.

3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.

4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.

5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.

6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.

7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.

8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.

9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.

10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.

There are several types of ataxia, each with different symptoms and causes. Some common forms of ataxia include:

1. Spinocerebellar ataxia (SCA): This is the most common form of ataxia and is caused by a degeneration of the cerebellum and spinal cord. It can cause progressive weakness, loss of coordination, and difficulty with speaking and swallowing.
2. Friedreich's ataxia: This is the second most common form of ataxia and is caused by a deficiency of vitamin E in the body. It can cause weakness in the legs, difficulty walking, and problems with speech and language.
3. Ataxia-telangiectasia (AT): This is a rare form of ataxia that is caused by a gene mutation. It can cause progressive weakness, loss of coordination, and an increased risk of developing cancer.
4. Acute cerebellar ataxia: This is a sudden and temporary form of ataxia that can be caused by a variety of factors such as infections, injuries, or certain medications.
5. Drug-induced ataxia: Certain medications can cause ataxia as a side effect.
6. Vitamin deficiency ataxia: Deficiencies in vitamins such as vitamin B12 or folate can cause ataxia.
7. Metabolic disorders: Certain metabolic disorders such as hypothyroidism, hyperthyroidism, and hypoglycemia can cause ataxia.
8. Stroke or brain injury: Ataxia can be a result of a stroke or brain injury.
9. Multiple system atrophy (MSA): This is a rare progressive neurodegenerative disorder that can cause ataxia, parkinsonism, and autonomic dysfunction.
10. Spinocerebellar ataxia (SCA): This is a group of rare genetic disorders that can cause progressive cerebellar ataxia, muscle wasting, and other signs and symptoms.

It's important to note that this is not an exhaustive list and there may be other causes of ataxia not mentioned here. If you suspect you or someone you know may have ataxia, it is important to consult a healthcare professional for proper diagnosis and treatment.

Congenital hand deformities are present at birth and can be caused by genetic mutations or environmental factors during fetal development. They can affect any part of the hand, including the fingers, thumb, or wrist. Some common congenital hand deformities include:

1. Clubhand: A deformity characterized by a shortened hand with the fingers and thumb all bent towards the palm.
2. Clinodactyly: A deformity characterized by a curved or bent finger.
3. Postaxial polydactyly: A deformity characterized by an extra digit on the little finger side of the hand.
4. Preaxial polydactyly: A deformity characterized by an extra digit on the thumb side of the hand.
5. Symbrachydactyly: A deformity characterized by a shortened or missing hand with no or only a few fingers.

The symptoms of congenital hand deformities can vary depending on the type and severity of the deformity. Some common symptoms include:

1. Limited range of motion in the affected hand.
2. Difficulty grasping or holding objects.
3. Pain or stiffness in the affected hand.
4. Abnormal finger or thumb position.
5. Aesthetic concerns.

The diagnosis of congenital hand deformities is usually made through a combination of physical examination, medical history, and imaging studies such as X-rays or ultrasound. Treatment options for congenital hand deformities can vary depending on the type and severity of the deformity and may include:

1. Surgery to correct the deformity.
2. Physical therapy to improve range of motion and strength.
3. Bracing or splinting to support the affected hand.
4. Orthotics or assistive devices to help with daily activities.
5. Medications to manage pain or inflammation.

It is important to seek medical attention if you suspect that your child may have a congenital hand deformity, as early diagnosis and treatment can improve outcomes and reduce the risk of complications.

The most common Parkinsonian disorder is Parkinson's disease, which affects approximately 1% of the population over the age of 60. Other Parkinsonian disorders include:

1. Dystonia: A movement disorder that causes involuntary muscle contractions and spasms.
2. Huntington's disease: An inherited disorder that causes progressive damage to the brain, leading to movement, cognitive, and psychiatric problems.
3. Progressive supranuclear palsy (PSP): A rare degenerative disorder that affects movement, balance, and eye movements.
4. Multiple system atrophy (MSA): A rare degenerative disorder that affects the autonomic nervous system, leading to symptoms such as tremors, rigidity, and difficulty with movement and coordination.
5. Corticobasal degeneration: A rare progressive neurodegenerative disorder that affects movement, cognition, and behavior.

Parkinsonian disorders can be difficult to diagnose, as the symptoms can be similar to other conditions such as essential tremor or dystonia. However, certain features can help distinguish one condition from another. For example, Parkinson's disease is characterized by a characteristic resting tremor, bradykinesia, and rigidity, while dystonia is characterized by sustained or intermittent muscle contractions that can cause abnormal postures or movements.

There is no cure for Parkinsonian disorders, but various medications and therapies can help manage the symptoms. These may include dopaminergic drugs to replace lost dopamine, muscle relaxants to reduce rigidity, and physical therapy to improve movement and coordination. In some cases, surgery may be recommended to regulate abnormal brain activity or to implant a deep brain stimulator to deliver electrical impulses to specific areas of the brain.

Overall, Parkinsonian disorders can have a significant impact on quality of life, but with proper diagnosis and treatment, many people are able to manage their symptoms and maintain their independence.

There are several types of spinal muscular atrophies, including:

Type 1 (Werdnig-Hoffmann disease): This is the most severe form of SMA, characterized by complete paralysis and life-threatening respiratory problems. It is usually diagnosed in infancy and children typically die before the age of two.

Type 2 (Dubowitz disease): This type of SMA is less severe than Type 1, but still causes significant muscle weakness and wasting. Children with this condition may be able to sit, stand, and walk with support, but will eventually lose these abilities as the disease progresses.

Type 3 (Kugelberg-Welander disease): This is an adult-onset form of SMA that causes slowly progressive muscle weakness and wasting. It can be mild or severe and may affect individuals in their teens to mid-life.

The symptoms of spinal muscular atrophies vary depending on the type and severity of the disorder, but may include:

* Muscle weakness and wasting, particularly in the limbs and trunk
* Difficulty breathing and swallowing
* Delayed development of motor skills such as sitting, standing, and walking
* Weakness of facial muscles, leading to a "floppy" appearance
* Poor reflexes and decreased muscle tone

The exact cause of spinal muscular atrophies is not fully understood, but genetics play a role. The disorders are caused by mutations in a gene called the survival motor neuron (SMN) gene, which is responsible for producing a protein that helps maintain the health of nerve cells. Without this protein, nerve cells die, leading to muscle weakness and wasting.

There is currently no cure for spinal muscular atrophies, but treatment options are available to help manage symptoms and improve quality of life. These may include:

* Physical therapy to maintain muscle strength and flexibility
* Occupational therapy to develop coping strategies and assist with daily activities
* Medications to manage muscle spasms and other symptoms
* Respiratory support, such as ventilation, for individuals with severe forms of the disorder
* Nutritional support to ensure adequate nutrition and hydration

Overall, spinal muscular atrophies are a group of rare genetic disorders that can cause muscle weakness and wasting, particularly in the limbs and trunk. While there is currently no cure, treatment options are available to help manage symptoms and improve quality of life. With appropriate care and support, individuals with spinal muscular atrophies can lead fulfilling lives.

1. Vision loss or blindness
2. Developmental delays and intellectual disability
3. Speech and language difficulties
4. Poor coordination and balance
5. Skeletal abnormalities such as short stature, short arms, and curved spine
6. Kidney problems
7. Hearing loss
8. Increased risk of infections
9. Cleft palate or other facial defects
10. Delayed puberty or absent menstruation in females

The syndrome is caused by mutations in the Bardet-Biedl genes, which are responsible for the development and function of the body's sensory and motor systems. It is inherited in an autosomal recessive pattern, meaning that a child must inherit two copies of the mutated gene - one from each parent - to develop the condition.

There is currently no cure for Bardet-Biedl Syndrome, but treatment and management options are available to help manage the symptoms and improve quality of life. These may include:

1. Vision aids such as glasses or contact lenses
2. Speech and language therapy
3. Physical therapy to improve coordination and balance
4. Occupational therapy to develop daily living skills
5. Medications to manage infections, seizures, or other complications
6. Surgery to correct physical abnormalities such as cleft palate or spinal deformities
7. Hormone replacement therapy for delayed puberty or absent menstruation in females.

The prognosis for individuals with Bardet-Biedl Syndrome varies depending on the severity of the symptoms and the presence of any additional health issues. With appropriate management and support, many individuals with the condition are able to lead fulfilling lives and achieve their goals. However, the syndrome can be associated with a higher risk of certain health complications, such as kidney disease or respiratory infections, which can impact life expectancy.

1. Bone fractures: The most common symptom of OI is an increased risk of fractures, which can occur with minimal trauma or even without any apparent cause.
2. Dental problems: People with OI may have poorly formed teeth, tooth decay, and gum disease.
3. Short stature: Many individuals with OI are short in stature, due to the effects of chronic fractures and pain on growth and development.
4. Muscle weakness: Some people with OI may experience muscle weakness, particularly in the limbs.
5. Joint problems: OI can cause issues with joint mobility and stability, leading to arthritis and other degenerative conditions.
6. Scoliosis: Curvature of the spine is common in people with OI, which can lead to back pain and respiratory problems.
7. Blue sclerae: A distinctive feature of OI is the presence of blue-colored sclerae (the white part of the eye).
8. Other symptoms: Some people with OI may experience hearing loss, vision problems, and delayed development.

There are several types of OI, each caused by a mutation in a specific gene. The most common forms of OI are type I, type II, and type III. Type I is the mildest form and type III is the most severe. There is no cure for OI, but treatment focuses on managing symptoms and preventing complications. This may include:

1. Bracing and orthotics: To support weakened bones and improve posture.
2. Physical therapy: To maintain muscle strength and flexibility.
3. Pain management: To reduce the risk of chronic pain and improve quality of life.
4. Dental care: Regular dental check-ups and appropriate treatment to prevent tooth decay and gum disease.
5. Respiratory care: To manage breathing problems and prevent respiratory infections.
6. Monitoring for hearing loss: Regular hearing tests to detect any hearing loss and provide appropriate intervention.
7. Early intervention: To help children with OI develop skills and abilities to their full potential.
8. Genetic counseling: For families with a history of OI, to understand the risks and implications for future pregnancies.

It's important for people with OI to work closely with their healthcare provider to manage their condition and prevent complications. With proper care and support, many people with OI can lead active and fulfilling lives.

There are different types of cataracts, including:

1. Nuclear cataract: This is the most common type of cataract and affects the center of the lens.
2. Cortical cataract: This type of cataract affects the outer layer of the lens and can cause a "halo" effect around lights.
3. Posterior subcapsular cataract: This type of cataract affects the back of the lens and is more common in younger people and those with diabetes.
4. Congenital cataract: This type of cataract is present at birth and can be caused by genetic factors or other conditions.

Symptoms of cataracts can include:

* Blurred vision
* Double vision
* Sensitivity to light
* Glare
* Difficulty seeing at night
* Fading or yellowing of colors

Cataracts can be diagnosed with a comprehensive eye exam, which includes a visual acuity test, dilated eye exam, and imaging tests such as ultrasound or optical coherence tomography (OCT).

Treatment for cataracts typically involves surgery to remove the clouded lens and replace it with an artificial one called an intraocular lens (IOL). The type of IOL used will depend on the patient's age, visual needs, and other factors. In some cases, cataracts may be removed using a laser-assisted procedure.

In addition to surgery, there are also non-surgical treatments for cataracts, such as glasses or contact lenses, which can help improve vision. However, these treatments do not cure the underlying condition and are only temporary solutions.

It's important to note that cataracts are a common age-related condition and can affect anyone over the age of 40. Therefore, it's important to have regular eye exams to monitor for any changes in vision and to detect cataracts early on.

In summary, cataracts are a clouding of the lens in the eye that can cause blurred vision, double vision, sensitivity to light, and other symptoms. Treatment typically involves surgery to remove the clouded lens and replace it with an artificial one, but non-surgical treatments such as glasses or contact lenses may also be used. Regular eye exams are important for detecting cataracts early on and monitoring vision health.

1. Congenital abnormalities: These are present at birth and may be caused by genetic factors or environmental influences during fetal development. Examples include hypodontia (absence of one or more teeth), hyperdontia (extra teeth), or anodontia (absence of all teeth).
2. Acquired abnormalities: These can occur at any time during life, often as a result of trauma, infection, or other conditions. Examples include tooth decay, gum disease, or tooth wear and tear.
3. Developmental abnormalities: These occur during the development of teeth and may be caused by genetic factors, nutritional deficiencies, or exposure to certain medications or chemicals. Examples include enamel hypoplasia (thinning of tooth enamel) or peg-shaped teeth.
4. Structural abnormalities: These are irregularities in the shape or structure of teeth, such as anomalies in the size, shape, or position of teeth. Examples include crowded or misaligned teeth, or teeth that do not erupt properly.
5. Dental caries (tooth decay): This is a bacterial infection that causes the breakdown of tooth structure, often leading to cavities and tooth loss if left untreated.
6. Periodontal disease: This is an inflammatory condition that affects the supporting tissues of teeth, including the gums and bone, and can lead to tooth loss if left untreated.
7. Tooth wear: This refers to the wear and tear of teeth over time, often due to habits such as bruxism (teeth grinding) or acid reflux.
8. Dental anomalies: These are rare, genetic conditions that affect the development and structure of teeth, such as peg-shaped teeth or geminated teeth (two teeth fused together).

These are just a few examples of tooth abnormalities, and there are many more conditions that can affect the health and appearance of teeth. Regular dental check-ups can help detect and address any issues early on to ensure good oral health.

The hallmark symptoms of AT are:

1. Ataxia: difficulty with coordination, balance, and gait.
2. Telangiectasias: small, red blood vessels visible on the skin, particularly on the face, neck, and arms.
3. Ocular telangiectasias: small, red blood vessels visible in the eyes.
4. Cognitive decline: difficulty with memory, learning, and concentration.
5. Seizures: episodes of abnormal electrical activity in the brain.
6. Increased risk of cancer: particularly lymphoma, myeloid leukemia, and breast cancer.

The exact cause of AT is not yet fully understood, but it is thought to be due to mutations in the ATM gene, which is involved in DNA damage response and repair. There is currently no cure for AT, but various treatments are available to manage its symptoms and prevent complications. These may include:

1. Physical therapy: to improve coordination and balance.
2. Occupational therapy: to assist with daily activities and fine motor skills.
3. Speech therapy: to improve communication and swallowing difficulties.
4. Medications: to control seizures, tremors, and other symptoms.
5. Cancer screening: regular monitoring for the development of cancer.

AT is a rare disorder, and it is estimated that only about 1 in 40,000 to 1 in 100,000 individuals are affected worldwide. It is important for healthcare providers to be aware of AT and its symptoms, as early diagnosis and intervention can improve outcomes for patients with this condition.

The Usher syndromes are a group of rare genetic disorders that affect both hearing and vision. They are caused by mutations in specific genes and can be inherited in an autosomal recessive or X-linked manner. The syndromes are characterized by progressive retinal degeneration, hearing loss, and vestibular dysfunction.

Source: National Institute on Deafness and Other Communication Disorders (NIDCD)

Note: This is a medical definition, and the term "Usher Syndromes" is not commonly used in everyday conversation. It is used primarily in the medical field to describe this specific group of disorders.

Also known as: chronic granulomatous disease, CGD.

Ectromelia can be caused by genetic mutations or exposure to certain chemicals during pregnancy. Treatment for ectromelia typically involves managing the symptoms and addressing any underlying conditions. This may include medication to promote skin growth, physical therapy to improve mobility and strength, and speech and language therapy to improve communication skills. In severe cases, surgery may be necessary to repair malformed limbs or other physical abnormalities.

Ectromelia is also known as ectodermal dysplasia, a group of disorders that affect the ectodermal layers of the body (skin, hair, nails, and nervous system). The condition is relatively rare, occurring in approximately 1 in 100,000 births. With appropriate medical care and support, many individuals with ectromelia are able to lead fulfilling lives despite their physical limitations.

1. Sensitive teeth: Teeth with AI may be sensitive to hot or cold temperatures due to the lack of enamel.
2. Tooth decay: Without adequate enamel, teeth with AI are more susceptible to decay.
3. Discolored teeth: Teeth with AI may appear grayish, yellowish, or brownish due to the defective enamel.
4. Difficulty chewing: Depending on the severity of the condition, people with AI may experience difficulty chewing or biting due to the sensitive teeth.
5. Aesthetic concerns: The discoloration and irregular shape of teeth can cause self-esteem issues and affect the overall appearance of the smile.
6. Dental problems: Teeth with AI are more prone to dental problems such as cavities, gum disease, and tooth loss.
7. Speech difficulties: In severe cases, AI can affect the development of the palate and cause speech difficulties.
8. Jaw pain: The improper alignment of teeth can lead to jaw pain and temporomandibular joint (TMJ) disorders.
9. Increased risk of oral infections: The lack of enamel can make teeth more susceptible to bacterial infections.
10. Dental anxiety: People with AI may experience dental anxiety due to the fear of undergoing dental procedures or the stigma associated with the condition.

There is no cure for AI, but various treatments can help manage the symptoms and prevent complications. These may include fluoride applications, dental fillings, crowns, and other restorative procedures to protect the teeth and improve their appearance. In some cases, orthodontic treatment or oral surgery may be necessary to correct bite problems and improve jaw alignment.

There are several subtypes of LGMD, each caused by mutations in different genes that code for proteins involved in muscle function and structure. The most common forms of LGMD include:

1. Muscular dystrophy-dystroglycanopathy type A (MDDGA): This is a severe form of LGMD caused by mutations in the DAG1 gene, which codes for the protein dystroglycan. Symptoms typically appear in infancy and progress rapidly, leading to early death.
2. Limb-girdle muscular dystrophy type 1A (LGMD1A): This is a mild form of LGMD caused by mutations in the LAMA2 gene, which codes for the protein laminin alpha 2 chain. Symptoms typically appear in childhood and progress slowly over time.
3. Limb-girdle muscular dystrophy type 2B (LGMD2B): This is a severe form of LGMD caused by mutations in the CAV3 gene, which codes for the protein caveolin-3. Symptoms typically appear in childhood and progress rapidly, leading to early death.

There is currently no cure for LGMD, but various treatments are available to manage symptoms and slow disease progression. These may include physical therapy, orthotics and assistive devices, pain management medications, and respiratory support as needed. Research into the genetic causes of LGMD is ongoing, with the goal of developing new and more effective treatments for this debilitating group of disorders.

There are multiple types of SCA, each caused by an expansion of a specific DNA repeat sequence in the genome. This expansion leads to a loss of function in the protein produced by that gene, which is involved in various cellular processes that are essential for the proper functioning of the nervous system.

The symptoms of SCA typically begin in adulthood and can vary in severity and progression depending on the specific type of disorder. They may include:

1. Coordination problems and balance difficulties, leading to a wide, unsteady gait.
2. Slurred speech and difficulty with swallowing.
3. Difficulty with fine motor movements, such as writing or using utensils.
4. Loss of vision, including blindness in some cases.
5. Cognitive decline and dementia.
6. Seizures and other neurological problems.

There is currently no cure for SCA, and treatment is focused on managing symptoms and improving quality of life. This may include physical therapy, occupational therapy, speech therapy, and medication to control seizures or other neurological problems. In some cases, surgery may be necessary to relieve pressure on the brain or spinal cord.

Genetic testing can help diagnose SCA by detecting the expansion of the specific DNA repeat sequence that causes the disorder. This information can also be used to inform family members about their risk of inheriting the condition.

In summary, spinocerebellar ataxias are a group of inherited disorders that affect the brain and spinal cord, leading to progressive degeneration of the nervous system and a range of symptoms including coordination problems, slurred speech, and loss of vision. While there is currently no cure for SCA, treatment can help manage symptoms and improve quality of life. Genetic testing can help diagnose the condition and inform family members about their risk of inheriting it.

The term "agenesis" refers to the failure of a structure to develop properly during fetal development. The corpus callosum is one of the largest white matter structures in the brain and plays a critical role in integrating sensory, motor, and cognitive information from both hemispheres.

Agenesis of Corpus Callosum can be caused by various genetic or environmental factors, such as:

1. Genetic mutations or deletions
2. Fetal exposure to certain drugs or infections during pregnancy
3. Maternal diabetes or other metabolic disorders
4. Trauma during pregnancy or childbirth
5. Brain injury or infection during early childhood.

Symptoms of Agenesis of Corpus Callosum can vary depending on the severity and location of the agenesis, but may include:

1. Delayed development of motor skills such as sitting, standing, and walking
2. Difficulty with language processing and speech articulation
3. Poor coordination and balance
4. Seizures or other neurological problems
5. Intellectual disability or developmental delays
6. Behavioral problems such as anxiety, depression, or autism spectrum disorder.

Diagnosis of Agenesis of Corpus Callosum typically involves a combination of physical examination, imaging studies such as MRI or CT scans, and genetic testing. Treatment for the condition may involve a multidisciplinary approach, including physical therapy, speech therapy, occupational therapy, and medication to control seizures or other symptoms. In some cases, surgery may be necessary to relieve pressure on the brain or to correct anatomical abnormalities.

Prognosis for individuals with Agenesis of Corpus Callosum varies depending on the severity of the condition and the presence of any additional health problems. However, early diagnosis and intervention can significantly improve outcomes and quality of life for these individuals. With appropriate treatment and support, many individuals with Agenesis of Corpus Callosum are able to lead fulfilling lives and achieve their goals.

There are several types of retinal dystrophies, each with different symptoms and causes. Some common forms of retinal dystrophies include:

1. Retinitis pigmentosa (RP): This is a group of genetic disorders that affect the retina and cause progressive vision loss, usually starting in childhood or adolescence.
2. Leber congenital amaurosis (LCA): This is a rare form of retinal dystrophy that causes blindness or severe visual impairment at birth or during early childhood.
3. Stargardt disease: This is an inherited disorder that affects the retina and causes vision loss, usually starting in childhood or adolescence.
4. Macular degeneration: This is a condition that affects the macula, the part of the retina responsible for central vision. It can cause vision loss and blindness, especially in older adults.

Retinal dystrophies are caused by genetic mutations that affect the structure and function of the retina. They can be inherited from one's parents or occur spontaneously due to a genetic mutation during fetal development. There is currently no cure for retinal dystrophies, but there are various treatments available to slow down the progression of the disease and manage symptoms. These include vitamin supplements, medications, and surgery.

Retinal dystrophies can have a significant impact on an individual's quality of life, affecting their ability to perform daily activities, socialize, and maintain independence. However, advances in medical technology and research have led to new treatments and therapies that offer hope for those affected by these diseases.

The main symptoms of PXE include:

1. Skin changes: Pigmented spots or patches on the skin, particularly on the neck, face, and arms. These spots can become more prominent with age.
2. Eye problems: PXE can cause a range of eye problems, including cataracts, glaucoma, and retinal degeneration.
3. Cardiovascular disease: PXE is associated with an increased risk of cardiovascular disease, including high blood pressure, peripheral artery disease, and aneurysms.
4. Other symptoms: PXE can also cause a range of other symptoms, including fatigue, muscle weakness, and cognitive decline.

PXE is diagnosed through a combination of clinical examination, laboratory tests, and genetic analysis. There is no cure for PXE, but treatment can help manage the symptoms. Treatment options may include medications to control high blood pressure, glaucoma, and other eye problems, as well as physical therapy to maintain muscle strength and mobility.

The prognosis for PXE varies depending on the severity of the symptoms and the presence of any complications. With proper management, many people with PXE can lead active and fulfilling lives. However, the condition can be debilitating and can significantly impact quality of life if left untreated or inadequately managed.

Overall, pseudoxanthoma elasticum is a rare and complex disorder that requires careful management and monitoring to minimize its impact on daily life. With appropriate treatment and support, many people with PXE can lead fulfilling lives.

There are two types of polydactyly:

1. Postaxial polydactyly: This is the most common type, where an extra finger is located on the little finger side of the hand.
2. Preaxial polydactyly: This type occurs when an extra finger is located on the thumb side of the hand.

Polydactyly can be caused by genetic mutations or environmental factors during fetal development. In some cases, it may be associated with other genetic syndromes or conditions such as Down syndrome or Turner syndrome.

Treatment for polydactyly usually involves surgical removal of the extra digits to improve function and appearance. The procedure is typically performed in early childhood, as it can be more difficult to perform later in life. In some cases, polydactyly may not require treatment if the extra digits are not causing any problems or if they are fully formed and functional.

In summary, polydactyly is a congenital condition where an individual has more than five fingers or toes, and it can be treated with surgical removal of the extra digits.

The main symptoms of FMF include:

1. Recurrent fever, usually during childhood and adolescence, which can range from 38°C to 40°C (100°F to 104°F).
2. Serositis, which can involve the heart (endocarditis), lungs (pleuritis), and/or peritoneum (peritonitis).
3. Painful joints, particularly in the hands, knees, and ankles.
4. Abdominal pain, diarrhea, and vomiting.
5. Rash, which may be present during fever episodes.
6. Enlarged spleen and liver.
7. Elevated levels of inflammatory markers in the blood, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).
8. Skin rashes or lesions, which may be present during fever episodes.
9. Kidney problems, such as kidney stones or chronic kidney disease.
10. Eye problems, such as uveitis or retinal vasculitis.

There is no cure for FMF, but the symptoms can be managed with medications and other therapies. Treatment typically involves colchicine, a drug that reduces inflammation and prevents flares. Other medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, may also be used to manage symptoms. In some cases, surgery may be necessary to remove the affected organ or to repair damaged tissue.

It is important for individuals with FMF to work closely with their healthcare provider to develop a treatment plan that is tailored to their specific needs and symptoms. With proper management, many people with FMF are able to lead active and fulfilling lives. However, it is important to note that FMF can be a chronic condition, and ongoing management is typically necessary to control symptoms and prevent complications.

There are different types of blindness, including:

1. Congenital blindness: Blindness that is present at birth, often due to genetic mutations or abnormalities in the development of the eye and brain.
2. Acquired blindness: Blindness that develops later in life due to injury, disease, or other factors.
3. Amblyopia: A condition where one eye has reduced vision due to misalignment or other causes.
4. Glaucoma: A group of eye conditions that can damage the optic nerve and lead to blindness if left untreated.
5. Retinitis pigmentosa: A degenerative disease that affects the retina and can cause blindness.
6. Cataracts: A clouding of the lens in the eye that can impair vision and eventually cause blindness if left untreated.
7. Macular degeneration: A condition where the macula, a part of the retina responsible for central vision, deteriorates and causes blindness.

There are various treatments and therapies for blindness, depending on the underlying cause. These may include medications, surgery, low vision aids, and assistive technology such as braille and audio books, screen readers, and voice-controlled software. Rehabilitation programs can also help individuals adapt to blindness and lead fulfilling lives.

The term "Leber" refers to the fact that the disorder was first described by the German ophthalmologist Theodor Leber in 1869. The word "congenital" indicates that the condition is present at birth, and "amaurosis" means darkness or blindness.

LCA is caused by mutations in genes that are essential for normal retinal development and function, such as the RPE65 gene, the LCA2 gene, or the CRB1 gene. The inheritance pattern of LCA is usually autosomal recessive, meaning that a child must inherit two copies of the defective gene, one from each parent, to develop the condition.

There is currently no cure for LCA, and treatment is limited to managing associated complications such as cataracts or glaucoma. Low vision aids and mobility training can also help individuals with LCA to make the most of their remaining vision. Research into gene therapy and stem cell-based treatments holds promise for improving the prognosis for individuals with LCA in the future.

The exact cause of lipoid proteinosis of Urbach and Wiethe is not known, but it is believed to be related to genetic mutations, sun exposure, and hormonal influences. The condition typically presents in adulthood, and women are more commonly affected than men.

The symptoms of lipoid proteinosis of Urbach and Wiethe can vary in severity and may include:

1. Yellow or brown macules or nodules on the skin, which can be flat or raised.
2. Skin thickening and textural changes.
3. Itching or tenderness.
4. Pain or discomfort in the affected areas.
5. Increased risk of skin cancer.

There is no cure for lipoid proteinosis of Urbach and Wiethe, but treatment options are available to manage the symptoms and prevent complications. These may include:

1. Topical medications, such as retinoids or corticosteroids, to reduce inflammation and promote skin cell turnover.
2. Oral antibiotics or anti-inflammatory drugs to control infection and inflammation.
3. Laser therapy to improve the appearance of the skin and reduce the risk of skin cancer.
4. Surgical excision of affected skin areas, if necessary.

Early diagnosis and treatment can help manage the symptoms of lipoid proteinosis of Urbach and Wiethe and improve the patient's quality of life. However, the condition can be challenging to diagnose, as it can resemble other skin conditions such as xanthomas or neurofibromatosis. A dermatologist or other qualified healthcare professional should be consulted for an accurate diagnosis and appropriate treatment.

There are several possible causes of methemoglobinemia, including:

1. Exposure to certain medications or chemicals, such as nitrates or aniline dyes.
2. Genetic disorders that affect the production or function of hemoglobin.
3. Infections, such as bacterial infections of the blood or respiratory tract.
4. Poor nutrition or malnutrition.
5. Certain chronic medical conditions, such as sickle cell anemia or thalassemia.

Methemoglobinemia can be diagnosed through a variety of tests, including:

1. Complete blood count (CBC) to measure the levels of methemoglobin in the blood.
2. Blood gas analysis to measure the partial pressure of oxygen and carbon dioxide in the blood.
3. Co-oximetry to measure the levels of methemoglobin and other forms of hemoglobin.
4. Urine tests to check for the presence of abnormal hemoglobin.
5. Genetic testing to identify inherited disorders that may be causing the condition.

Treatment of methemoglobinemia depends on the underlying cause and may include:

1. Administration of oxygen therapy to increase the amount of oxygen in the blood.
2. Use of medications to reduce the levels of methemoglobin and increase the levels of normal hemoglobin.
3. Transfusions of red blood cells to replace abnormal hemoglobin with normal hemoglobin.
4. Management of underlying medical conditions, such as infections or genetic disorders.
5. Dietary changes to address any nutritional deficiencies that may be contributing to the condition.

In severe cases of methemoglobinemia, hospitalization may be necessary to provide oxygen therapy and other treatments. In some cases, patients with methemoglobinemia may require long-term management and follow-up care to prevent complications and manage the underlying cause of the condition.

Examples of Immunologic Deficiency Syndromes include:

1. Primary Immunodeficiency Diseases (PIDDs): These are a group of genetic disorders that affect the immune system's ability to function properly. Examples include X-linked agammaglobulinemia, common variable immunodeficiency, and severe combined immunodeficiency.
2. Acquired Immunodeficiency Syndrome (AIDS): This is a condition that results from the human immunodeficiency virus (HIV) infection, which destroys CD4 cells, a type of immune cell that fights off infections.
3. Immune Thrombocytopenic Purpura (ITP): This is an autoimmune disorder that causes the immune system to attack and destroy platelets, which are blood cells that help the blood to clot.
4. Autoimmune Disorders: These are conditions in which the immune system mistakenly attacks and damages healthy cells and tissues in the body. Examples include rheumatoid arthritis, lupus, and multiple sclerosis.
5. Immunosuppressive Therapy-induced Immunodeficiency: This is a condition that occurs as a side effect of medications used to prevent rejection in organ transplant patients. These medications can suppress the immune system, increasing the risk of infections.

Symptoms of Immunologic Deficiency Syndromes can vary depending on the specific disorder and the severity of the immune system dysfunction. Common symptoms include recurrent infections, fatigue, fever, and swollen lymph nodes. Treatment options for these syndromes range from medications to suppress the immune system to surgery or bone marrow transplantation.

In summary, Immunologic Deficiency Syndromes are a group of disorders that result from dysfunction of the immune system, leading to recurrent infections and other symptoms. There are many different types of these syndromes, each with its own set of symptoms and treatment options.

The most common symptoms of albinism include:

* Pale or white skin, hair, and eyes
* Sensitivity to the sun and risk of sunburn
* Poor vision, including nystagmus (involuntary eye movements) and photophobia (sensitivity to light)
* Increased risk of eye problems, such as strabismus (crossed eyes) and amblyopia (lazy eye)
* Increased risk of skin cancer and other skin problems
* Delayed development of motor skills and coordination
* Increased risk of infection and other health problems due to a weakened immune system

Albinism is caused by mutations in genes that code for enzymes involved in the production of melanin. These mutations can be inherited from one or both parents, or they can occur spontaneously. There is no cure for albinism, but there are treatments available to help manage some of the associated symptoms and vision problems.

Diagnosis of albinism is typically made based on a combination of physical examination, medical history, and genetic testing. Treatment may include sun protection measures, glasses or contact lenses to improve vision, and medication to manage eye problems. In some cases, surgery may be necessary to correct eye alignment or other physical abnormalities.

It's important for people with albinism to receive regular medical care and monitoring to ensure early detection and treatment of any associated health problems. With proper care and support, many people with albinism can lead normal, fulfilling lives.

There are several types of spinocerebellar degenerations, including:

1. Spinocerebellar ataxia (SCA): This is the most common type of spinocerebellar degeneration, and it is caused by a mutation in one of several genes that code for proteins involved in the function of the cerebellum and spinal cord.
2. Spinocerebellar neurodegeneration with axonal degeneration (SCN1A): This type of spinocerebellar degeneration is caused by a mutation in the SCN1A gene, which codes for a protein that regulates the flow of sodium ions in and out of nerve cells.
3. Spinocerebellar neurodegeneration with Purkinje cell loss (SCN2): This type of spinocerebellar degeneration is caused by a mutation in the SCN2 gene, which codes for a protein that plays a role in the regulation of the cytoskeleton in nerve cells.
4. Spinocerebellar neurodegeneration with optic atrophy (SCN3): This type of spinocerebellar degeneration is caused by a mutation in the SCN3 gene, which codes for a protein that plays a role in the regulation of the cytoskeleton in nerve cells.

The symptoms of spinocerebellar degenerations can vary depending on the specific type of disorder and the age at which they appear. In general, these disorders are characterized by:

1. Progressive loss of motor function: Patients with spinocerebellar degenerations may experience weakness, tremors, and difficulty with coordination and balance.
2. Cognitive decline: Spinocerebellar degenerations can also cause cognitive decline, including memory loss, confusion, and difficulty with language processing.
3. Seizures: Some patients with spinocerebellar degenerations may experience seizures.
4. Vision loss: Spinocerebellar degenerations can cause progressive vision loss, including blindness.
5. Sleep disturbances: Patients with spinocerebellar degenerations may experience sleep disturbances, including insomnia and restlessness.
6. Emotional changes: Spinocerebellar degenerations can also cause emotional changes, such as depression, anxiety, and mood swings.

The diagnosis of spinocerebellar degeneration is based on a combination of clinical examination, imaging studies, and genetic testing. Imaging studies, such as magnetic resonance imaging (MRI) and positron emission tomography (PET), can help to identify the specific type of disorder and the extent of brain damage. Genetic testing can help to confirm the diagnosis by identifying a mutation in one of the genes associated with spinocerebellar degeneration.

There is currently no cure for spinocerebellar degenerations, but there are several treatments available that can help to manage the symptoms and slow the progression of the disease. These include:

1. Physical therapy: Physical therapy can help to improve motor function and balance.
2. Occupational therapy: Occupational therapy can help patients to adapt to their condition and maintain independence.
3. Speech therapy: Speech therapy can help to improve communication and swallowing difficulties.
4. Medications: Various medications, such as anticonvulsants, muscle relaxants, and pain relievers, can be used to manage seizures, muscle spasms, and pain.
5. Deep brain stimulation: Deep brain stimulation is a surgical procedure that involves implanting an electrode in the brain to deliver electrical impulses to specific areas of the brain. This can help to improve motor function and reduce symptoms.
6. Stem cell therapy: Stem cell therapy is a promising area of research for the treatment of spinocerebellar degenerations. Stem cells have the ability to differentiate into different types of cells, including neurons, and may help to replace damaged cells in the brain.
7. Gene therapy: Gene therapy involves using genes to treat or prevent diseases. This can involve replacing a faulty gene with a healthy one or silencing a faulty gene. Gene therapy is still in its infancy for spinocerebellar degenerations, but it is an area of active research.
8. Physical activity: Regular physical activity has been shown to improve motor function and overall health in patients with spinocerebellar degenerations.
9. Cognitive rehabilitation: Cognitive rehabilitation can help to improve cognitive function and independence in daily activities.
10. Supportive care: Supportive care, such as physical therapy, occupational therapy, and speech therapy, can help to improve quality of life and manage symptoms.

It's important to note that the most effective treatment plan for spinocerebellar degenerations will depend on the specific type of disease, the severity of symptoms, and the individual needs of each patient. It is best to work with a healthcare provider to develop a personalized treatment plan.

Cystinuria is caused by mutations in the SLC7A9 gene, which codes for a protein involved in the transport of cystine across the brush border membrane of renal tubular cells. The disorder is inherited in an autosomal recessive pattern, meaning that affected individuals must inherit two copies of the mutated gene (one from each parent) to develop symptoms.

There is no cure for cystinuria, but various treatments can help manage its symptoms. These may include medications to reduce the acidity of the urine and prevent infection, as well as surgical procedures to remove stones or repair damaged kidneys. In some cases, a kidney transplant may be necessary.

It's important for individuals with cystinuria to drink plenty of water and maintain good hydration to help flush out the urinary tract and prevent stone formation. They should also avoid certain foods that may increase the risk of stone formation, such as oxalate-rich foods like spinach and rhubarb.

Overall, while there is no cure for cystinuria, with proper management and care, individuals with this disorder can lead relatively normal lives and minimize the complications associated with it.

There are several types of hereditary corneal dystrophies, each with different clinical features and modes of inheritance. Some of the most common forms include:

1. Keratoconus: This is a progressive thinning of the cornea, which can cause irregular astigmatism and visual distortion. It is the most common form of corneal dystrophy and usually affects both eyes.
2. Familial Corneal Dystrophy Type 1 (FCD1): This is an autosomal dominant disorder that affects the central cornea, causing progressive opacification and visual loss.
3. Familial Corneal Dystrophy Type 2 (FCD2): This is an autosomal recessive disorder that affects both eyes and causes progressive opacification of the peripheral cornea.
4. Granular Corneal Dystrophy (GCD): This is a rare form of corneal dystrophy characterized by the accumulation of granular material in the cornea, leading to vision loss.
5. Avellar Corneal Dystrophy: This is a rare autosomal recessive disorder that affects both eyes and causes progressive opacification of the central cornea.

The diagnosis of hereditary corneal dystrophies is based on a combination of clinical examination, imaging studies (such as optical coherence tomography), and genetic testing. Treatment options vary depending on the specific type of dystrophy and the severity of symptoms, but may include glasses or contact lenses, corneal transplantation, or phototherapeutic keratectomy.

In conclusion, hereditary corneal dystrophies are a group of genetic disorders that affect the cornea and can cause significant vision loss and blindness. Early diagnosis and treatment are crucial to prevent or slow down the progression of these diseases. Ophthalmologists play a key role in the diagnosis and management of hereditary corneal dystrophies, and genetic testing may be useful in identifying the specific type of dystrophy and guiding treatment decisions.

There are several types of chromosome aberrations, including:

1. Chromosomal deletions: Loss of a portion of a chromosome.
2. Chromosomal duplications: Extra copies of a chromosome or a portion of a chromosome.
3. Chromosomal translocations: A change in the position of a chromosome or a portion of a chromosome.
4. Chromosomal inversions: A reversal of a segment of a chromosome.
5. Chromosomal amplifications: An increase in the number of copies of a particular chromosome or gene.

Chromosome aberrations can be detected through various techniques, such as karyotyping, fluorescence in situ hybridization (FISH), or array comparative genomic hybridization (aCGH). These tests can help identify changes in the chromosomal makeup of cells and provide information about the underlying genetic causes of disease.

Chromosome aberrations are associated with a wide range of diseases, including:

1. Cancer: Chromosome abnormalities are common in cancer cells and can contribute to the development and progression of cancer.
2. Birth defects: Many birth defects are caused by chromosome abnormalities, such as Down syndrome (trisomy 21), which is caused by an extra copy of chromosome 21.
3. Neurological disorders: Chromosome aberrations have been linked to various neurological disorders, including autism and intellectual disability.
4. Immunodeficiency diseases: Some immunodeficiency diseases, such as X-linked severe combined immunodeficiency (SCID), are caused by chromosome abnormalities.
5. Infectious diseases: Chromosome aberrations can increase the risk of infection with certain viruses, such as human immunodeficiency virus (HIV).
6. Ageing: Chromosome aberrations have been linked to the ageing process and may contribute to the development of age-related diseases.
7. Radiation exposure: Exposure to radiation can cause chromosome abnormalities, which can increase the risk of cancer and other diseases.
8. Genetic disorders: Many genetic disorders are caused by chromosome aberrations, such as Turner syndrome (45,X), which is caused by a missing X chromosome.
9. Rare diseases: Chromosome aberrations can cause rare diseases, such as Klinefelter syndrome (47,XXY), which is caused by an extra copy of the X chromosome.
10. Infertility: Chromosome abnormalities can contribute to infertility in both men and women.

Understanding the causes and consequences of chromosome aberrations is important for developing effective treatments and improving human health.

Bloom syndrome is a rare genetic disorder that affects approximately 1 in 100,000 individuals worldwide. It is caused by a mutation in the BLM gene, which codes for the Bloom syndrome protein (BLM). This protein plays a crucial role in the repair of DNA double-strand breaks and other types of genetic damage.

Characteristics:

Individuals with Bloom syndrome typically have short stature, small head size, and delicate features. They may also experience a range of health problems, including:

1. Increased risk of cancer: People with Bloom syndrome have an increased risk of developing various types of cancer, such as ovarian, breast, skin, and colon cancer.
2. Immune system problems: Individuals with Bloom syndrome may experience immune deficiency and autoimmune disorders, such as allergies and lupus.
3. Infertility: Many people with Bloom syndrome experience infertility or have difficulty conceiving.
4. Developmental delays: Children with Bloom syndrome may experience delayed development, including speech and language difficulties.
5. Skin changes: Individuals with Bloom syndrome may develop skin changes, such as thinning of the skin, easy bruising, and an increased risk of skin cancer.
6. Eye problems: Bloom syndrome can cause a range of eye problems, including cataracts, glaucoma, and detached retinas.
7. Increased risk of infections: People with Bloom syndrome may be more susceptible to infections due to their weakened immune system.
8. Other health problems: Individuals with Bloom syndrome may experience other health issues, such as hearing loss, kidney disease, and gastrointestinal problems.

Diagnosis:

Bloom syndrome can be diagnosed through a combination of clinical evaluation, family history, and genetic testing. Genetic testing can identify the presence of the BLM mutation that causes the disorder. Prenatal testing is also available for pregnant women who have a family history of Bloom syndrome.

Treatment:

There is no cure for Bloom syndrome, but treatment can help manage the symptoms and prevent complications. Treatment options may include:

1. Skin cancer screening and prevention: Regular skin exams can help detect skin cancer at an early stage, and preventive measures such as avoiding excessive sun exposure and using protective clothing and sunscreen can reduce the risk of skin cancer.
2. Eye care: Regular eye exams can help detect eye problems early, and prompt treatment can prevent vision loss.
3. Immune system support: Individuals with Bloom syndrome may be at increased risk of infections, so it's important to take steps to support the immune system, such as getting vaccinated against common illnesses and practicing good hygiene.
4. Developmental support: Children with Bloom syndrome may require extra support in school and at home to help them reach their full potential.
5. Managing other health problems: Depending on the specific health issues experienced by an individual with Bloom syndrome, treatment may involve medication, lifestyle changes, or other interventions to manage these conditions.

Prognosis:

The prognosis for individuals with Bloom syndrome varies depending on the specific health problems they experience. Some individuals may have a relatively mild course of the condition, while others may experience more severe health issues. With appropriate medical care and support, many individuals with Bloom syndrome can lead fulfilling lives. However, the condition can be associated with a shorter life expectancy compared to the general population.

Lifestyle Changes:

There are several lifestyle changes that can help manage the symptoms of Bloom syndrome and improve overall health. These may include:

1. Protecting the skin from the sun: Avoid excessive sun exposure, especially during peak hours, and use protective clothing and sunscreen to prevent skin damage.
2. Eating a healthy diet: A balanced diet that includes plenty of fruits, vegetables, whole grains, and lean protein can help support overall health.
3. Staying hydrated: Drinking plenty of water can help prevent dehydration, which can be a common issue for individuals with Bloom syndrome.
4. Avoiding smoking and excessive alcohol consumption: Both smoking and excessive alcohol consumption can worsen the symptoms of Bloom syndrome and increase the risk of certain health problems.
5. Getting regular exercise: Regular physical activity can help improve overall health and reduce the risk of certain health problems.
6. Managing stress: Stress can exacerbate the symptoms of Bloom syndrome, so it's important to find healthy ways to manage stress, such as through relaxation techniques or therapy.
7. Getting enough sleep: Adequate sleep is essential for overall health and well-being, and can help reduce the risk of certain health problems.
8. Avoiding exposure to toxins: Individuals with Bloom syndrome may be more susceptible to the effects of toxins, so it's important to avoid exposure to chemicals and other toxins whenever possible.
9. Keeping up-to-date on medical care: Regular check-ups with a healthcare provider can help identify any health issues early on and prevent complications.

Support Groups:

There are several support groups and organizations that provide information, resources, and support for individuals with Bloom syndrome and their families. These include:

1. The National Organization for Rare Disorders (NORD) - Provides information and resources on rare diseases, including Bloom syndrome.
2. The Bloom Syndrome Foundation - A non-profit organization dedicated to supporting research and providing information and resources for individuals with Bloom syndrome and their families.
3. The Rare Disease United Foundation - Provides information and resources on rare diseases, including Bloom syndrome, as well as support for individuals and families affected by these conditions.

Online Resources:

There are several online resources available to help individuals with Bloom syndrome and their families learn more about the condition, connect with others, and find support. These include:

1. The National Organization for Rare Disorders (NORD) - Provides information and resources on rare diseases, including Bloom syndrome, as well as a directory of healthcare providers and researchers.
2. The Bloom Syndrome Foundation - Offers information and resources on Bloom syndrome, as well as a registry for individuals with the condition to connect with others and receive updates on research and treatments.
3. Rare Disease United - Provides information and resources on rare diseases, including Bloom syndrome, as well as a directory of support groups and advocacy organizations.
4. The Global Bloom Syndrome Registry - A registry for individuals with Bloom syndrome to connect with others and receive updates on research and treatments.
5. The Bloom Syndrome Community - A Facebook group for individuals with Bloom syndrome and their families to connect, share information, and support one another.

These online resources can provide valuable information and support for individuals with Bloom syndrome and their families. It is important to note that while these resources can be helpful, they should not replace the advice of a qualified healthcare professional.

People with Ellis-van Creveld syndrome typically have a range of physical features, including:

1. Short stature: Adults with EVC are usually under 5 feet (152 cm) tall.
2. Small teeth: The teeth are typically small and crowded, with some people having few or no wisdom teeth.
3. Distinctive facial features: The face is narrow and elongated, with widely spaced eyes and a short nose.
4. Skin changes: Some people with EVC may have skin changes such as wrinkling or thinning of the skin.
5. Nail abnormalities: The nails may be thin, brittle, or misshapen.
6. Bone abnormalities: The bones may be shortened or deformed, leading to joint problems and other complications.
7. Heart defects: Some people with EVC may have heart defects, such as narrowing of the aorta or ventricular septal defect.
8. Other health problems: People with EVC may also experience other health problems, such as hearing loss, vision loss, and developmental delays.

Ellis-van Creveld syndrome is usually diagnosed based on physical examination and genetic testing. There is no cure for the condition, but treatment may involve managing related health problems, such as dental care, orthotics or prosthetics, and surgery to correct bone deformities. With appropriate management, people with EVC can lead active and fulfilling lives.

The disease is caused by mutations in the DNA of genes that are involved in the development and maintenance of the liver and bile ducts. It is usually diagnosed in children or young adults, and treatment options may include surgery to remove cysts, antibiotics to treat infections, and medication to manage symptoms such as pain and itching.

The disease is named after the Italian physician, Angelo Caroli, who first described it in 1892. It is also known as Caroli's disease or congenital hepatic fibrosis.

The hallmark feature of CTX is the presence of xanthomas, which are fatty deposits that accumulate in the brain and spinal cord. These deposits can cause inflammation and damage to the surrounding tissue, leading to a range of neurological symptoms.

CTX is usually diagnosed through a combination of clinical evaluation, imaging studies such as MRI or CT scans, and laboratory tests to identify the genetic mutations responsible for the condition. There is currently no cure for CTX, but treatment options may include medications to manage seizures and other symptoms, as well as surgery to remove xanthomas in some cases.

The main symptoms of Hermanski-Pudlak syndrome include:

1. Vision loss: People with this condition often experience progressive vision loss, starting in childhood or adolescence, which can lead to blindness in early adulthood.
2. Skin abnormalities: The skin of people with Hermanski-Pudlak syndrome is typically pale and has a characteristic "marbled" appearance due to the presence of white patches.
3. Neurological problems: Some individuals with this condition may experience neurological symptoms such as seizures, learning disabilities, and difficulty with balance and coordination.
4. Hearing loss: Hearing loss is a common feature of Hermanski-Pudlak syndrome, and can range from mild to profound.
5. Other signs: People with this condition may also experience other symptoms such as hair loss, thinning or brittle nails, and an increased risk of infections.

Hermanski-Pudlak syndrome is a rare disorder, and the exact prevalence is not known. However, it is estimated to affect approximately 1 in 1 million people worldwide. The condition is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated HPS gene (one from each parent) to develop the syndrome.

There is currently no cure for Hermanski-Pudlak syndrome, and treatment is focused on managing the symptoms. This can include medications to control seizures, physical therapy to improve balance and coordination, and assistive devices such as glasses or hearing aids to help with vision and hearing loss.

Overall, Hermanski-Pudlak syndrome is a rare and complex disorder that affects multiple systems in the body. While there is currently no cure, early diagnosis and ongoing management can help improve the quality of life for individuals affected by this condition.

Examples of retinal diseases include:

1. Age-related macular degeneration (AMD): a leading cause of vision loss in people over the age of 50, AMD affects the macula, the part of the retina responsible for central vision.
2. Diabetic retinopathy (DR): a complication of diabetes that damages blood vessels in the retina and can cause blindness.
3. Retinal detachment: a condition where the retina becomes separated from the underlying tissue, causing vision loss.
4. Macular edema: swelling of the macula that can cause vision loss.
5. Retinal vein occlusion (RVO): a blockage of the small veins in the retina that can cause vision loss.
6. Retinitis pigmentosa (RP): a group of inherited disorders that affect the retina and can cause progressive vision loss.
7. Leber congenital amaurosis (LCA): an inherited disorder that causes blindness or severe visual impairment at birth or in early childhood.
8. Stargardt disease: a rare inherited disorder that affects the retina and can cause progressive vision loss, usually starting in childhood.
9. Juvenile macular degeneration: a rare inherited disorder that causes vision loss in young adults.
10. Retinal dystrophy: a group of inherited disorders that affect the retina and can cause progressive vision loss.

Retinal diseases can be diagnosed with a comprehensive eye exam, which includes a visual acuity test, dilated eye exam, and imaging tests such as optical coherence tomography (OCT) or fluorescein angiography. Treatment options vary depending on the specific disease and can include medication, laser surgery, or vitrectomy.

It's important to note that many retinal diseases can be inherited, so if you have a family history of eye problems, it's important to discuss your risk factors with your eye doctor. Early detection and treatment can help preserve vision and improve quality of life for those affected by these diseases.

Ciliary motility disorders can affect any part of the body where cilia are found, but they most commonly affect the respiratory, gastrointestinal, and urogenital systems. These conditions can cause a range of symptoms, including recurring infections, chronic inflammation, and difficulty with breathing or swallowing.

Examples of ciliary motility disorders include primary ciliary dyskinesia (PCD), which is caused by defects in the structure and function of cilia, and other less common conditions such as ciliary abnormalities, which can be caused by genetic mutations or environmental factors.

Diagnosis of ciliary motility disorders typically involves a combination of clinical evaluation, laboratory tests, and imaging studies. Treatment for these conditions often focuses on managing symptoms and preventing complications, and may involve medications, breathing exercises, or other interventions. In some cases, surgery may be necessary to correct anatomical abnormalities or remove blockages in the respiratory or gastrointestinal tracts.

There are two main types of myotonia:

1. Thomsen's disease: This is an inherited form of myotonia that affects the muscles of the face, neck, and limbs. It is caused by mutations in the CLCN1 gene and can be severe, causing difficulty with speaking, swallowing, and breathing.
2. Becker's muscular dystrophy: This is a form of muscular dystrophy that affects both the skeletal and cardiac muscles. It is caused by mutations in the DMPK gene and can cause myotonia, muscle weakness, and heart problems.

The symptoms of myotonia can vary depending on the severity of the condition and may include:

* Muscle stiffness and rigidity
* Spasms or twitches
* Difficulty with movement and mobility
* Fatigue and weakness
* Cramps
* Muscle wasting

Myotonia can be diagnosed through a combination of physical examination, medical history, and diagnostic tests such as electromyography (EMG) and muscle biopsy. There is no cure for myotonia, but treatment options may include:

* Physical therapy to improve movement and mobility
* Medications to relax muscles and reduce spasms
* Lifestyle modifications such as avoiding triggers and taking regular breaks to rest
* Surgery in severe cases to release or lengthen affected muscles.

It is important to note that myotonia can be a symptom of other underlying conditions, so proper diagnosis and management by a healthcare professional is essential to determine the best course of treatment.

Some common types of skin abnormalities include:

1. Birthmarks: These are benign growths that can be present at birth or appear later in life. They can be flat or raised, and can be made up of different types of cells, such as blood vessels or pigment-producing cells.
2. Moles: These are small, dark spots on the skin that are usually benign but can occasionally become cancerous.
3. Warts: These are small, rough bumps on the skin that are caused by the human papillomavirus (HPV).
4. Psoriasis: This is a chronic condition that causes red, scaly patches on the skin.
5. Eczema: This is a chronic condition that causes dry, itchy skin and can lead to inflammation and skin thickening.
6. Acne: This is a common condition that causes blackheads, whiteheads, and other types of blemishes on the skin.
7. Scars: These are areas of damaged skin that can be caused by injury, surgery, or infection.
8. Vitiligo: This is a condition in which the skin loses its pigment, leading to white patches.
9. Impetigo: This is a bacterial infection that causes red sores on the skin.
10. Molluscum contagiosum: This is a viral infection that causes small, painless bumps on the skin.

Skin abnormalities can be diagnosed through a combination of physical examination, medical history, and diagnostic tests such as biopsies or imaging studies. Treatment options vary depending on the specific type of abnormality and its underlying cause, but may include topical creams or ointments, medications, laser therapy, or surgery. It is important to seek medical attention if you notice any changes in your skin, as early diagnosis and treatment can help prevent complications and improve outcomes.

Wachtel, Stephen S.; Basrur, Parvathi; Koo, Gloria C. (1978-09-01). "Recessive male-determining genes". Cell. 15 (1): 279-281. ... "Recessive male-determining genes" (1978, with Stephen S. Wachtel and Gloria C. Koo) "Morphological and hormonal features of an ...
... genes can cancel each other out, or "cross", removing all color and producing a white recessive gene, essentially a white ... Dapple genes, which are dominant genes, are considered "dilution" genes, meaning whatever color the dog would have originally ... "Recessive and Dominant Genes". Weatherly's Miniature Dachshunds. Retrieved 19 November 2009. Adamson, Eve (2007). Dachshunds ... "Brittle Bone" Gene in Dachshunds Discovered" (PDF). Newsletter. Dachshund Club of America. Archived (PDF) from the original on ...
It is a recessive gene. If there is only one copy of the gene, it has no effect on black, bay or chestnut horses. If there are ... is a dilution gene at the same locus as the cream gene, which somewhat resembles the cream gene and the champagne gene but is ... gene. The Pearl gene is also known to interact with the cream gene to enhance its effects and, in horses with only one copy of ... Initially, the gene in Paints and Quarter Horses was thought to be a different allele than that in the Iberian breeds, but ...
February 2004). "PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal ... Sweeney, William (1993). "Polycystic Kidney Disease, Autosomal Recessive". Polycystic kidney Disease. NIH. Gene Review. PMID ... Autosomal recessive polycystic kidney disease (ARPKD) is the recessive form of polycystic kidney disease. It is associated with ... The cause of ARPKD is linked to mutations in the PKHD1 gene. PKHD1 gene codes forfibrocystin. Fibrocystin is found in the ...
Since this is an autosomal recessive disease, two copies of the gene that contain the mutation must be present for one to show ... It is of autosomal recessive inheritance. It may be caused by a mutation on the SLURP1 gene, located on chromosome 8. The ... A gene mutation would be caused by the chromosome 8qter, which codes for the SLURP1 gene, to be cut, thus causing a mutation in ... "Autosomal recessive inheritance pattern". Mayo Clinic. Retrieved 2019-12-14. "SLURP1 gene". Reference, Genetics Home. "SLURP1 ...
". "NCBI OMIM db; Autosomal Recessive Deafness 51". (Genes on human chromosome 11, Human proteins) ... It is located between the genes DEPDC7 and PRRG4 and is 500,000 bp downstream from the Wilms Tumor 1 gene (WT1), which is ... "High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative ... The QSER1 gene is found on the short arm of chromosome 11 (11p13), beginning at 32,914,792 bp and ending at 33,001,816 bp. It ...
". "E-Locus (Recessive Yellow, Melanistic Mask Allele)". www.animalgenetics.us. Retrieved 2017-11-08. Wu CC, Gupta T, Garcia V ... A gene is said to be polymorphic if more than one allele occupies that gene's locus within a population. In addition to having ... Most notably, the genes coding for the major histocompatibility complex (MHC) are in fact the most polymorphic genes known. MHC ... For example, a polymorphic variant of the gene encoding the enzyme CYP4A11, in which thymidine replaces cytosine at the gene's ...
Autosomal recessive hearing loss is when both parents carry the recessive gene, and pass it on to their child. The autosomal ... Duman, Duygu; Tekin, Mustafa (2012-06-01). "Autosomal recessive nonsyndromic deafness genes: a review". Frontiers in Bioscience ... Most of genetic factors are caused by an autosomal recessive hearing loss or an autosomal dominant hearing loss. ... dominant hearing loss is when an abnormal gene from one parent is able to cause hearing loss even though the matching gene from ...
Additionally, recessive mutations of the gene result in both a loss of TMC1 function as well as profound deafness indicating ... Duman D, Tekin M (2012). "Autosomal recessive nonsyndromic deafness genes: a review". Front Biosci. 17 (7): 2213-36. doi: ... This gene is considered a member of a gene family predicted to encode transmembrane proteins. Until recently, the specific ... Keresztes G, Mutai H, Heller S (2003). "TMC and EVER genes belong to a larger novel family, the TMC gene family encoding ...
"Entrez Gene: Spastic paraplegia 23 (autosomal recessive)". "SPG23 Symbol Report , HUGO Gene Nomenclature Committee". www. ... Spastic paraplegia 23 (SPG autosomal recessive) is a 25cM gene locus at 1q24-q32. A genome-wide linkage screen has associated ... v t e (Articles with short description, Short description matches Wikidata, Genes on human chromosome, Proteins, All stub ...
This complementation is rare with autosomal recessive inheritance. The inherited methionine synthase functional deficiency ... The exact MTRR gene location was mapped to 5p15.3-p15.2. The MTRR gene is associated with a family of electron transferases ... Exact gene cytogenic position was determined by mapping to an artificial chromosomal construct containing the gene via ... Gene. 629: 59-63. doi:10.1016/j.gene.2017.07.081. PMID 28778621. G">"NM_002454.2(MTRR):c.1049A>G (p.Lys350Arg) AND not ...
... in rat model shows that a recessive mutation in a receptor tyrposine kinase gene, mertk results in a premature stop codon and ... Immune response to gene therapy vectors is what has caused previous attempts at gene therapy to fail, and is considered a key ... In retinal gene therapy, the most widely used vectors for ocular gene delivery are based on adeno-associated virus. The great ... Retina Gene therapy Retinitis pigmentosa Macular degeneration Gene therapy for color blindness Maguire A. M.; Simonelli F.; ...
2000). "Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large ... Periaxin is a protein that in humans is encoded by the PRX gene. The PRX gene encodes L- and S-periaxin, proteins of ... Genes on human chromosome 19, All stub articles, Human chromosome 19 gene stubs). ... "Entrez Gene: PRX periaxin". Sherman DL, Brophy PJ (2000). "A tripartite nuclear localization signal in the PDZ-domain protein L ...
Avr genotypes are either dominant (AVR) or recessive (avr). On the other end, resistance genes determine the ability of the ... Gene-for-Gene theory involves two types of genes. One comes from the host and the other from the pathogen. Resistance (R) genes ... Gene-for-gene interactions helps determine the evolutionary dynamics of rust fungi. Pecanka found that gene-for-gene exerts a ... There are implications of gene-for-gene interactions for fitness in real world populations. Co-evolution due to gene-for-gene ...
... is a gene that in humans encodes a protein necessary for homologous recombination of chromosomes. Biallelic mutations in ... Wang J, Zhang W, Jiang H, Wu BL (March 2014). "Mutations in HFM1 in recessive primary ovarian insufficiency". The New England ... HFM1 cause recessive primary ovarian insufficiency. GRCh38: Ensembl release 89: ENSG00000162669 - Ensembl, May 2017 GRCm38: ...
In the recessive form, the DTDST gene, also known as SLC26A2, is mutated in almost 90% of the patients, causing diastrophic ... However, there is an autosomal recessive form. Associated genes include COL9A1, COL9A2, COL9A3, COMP, and MATN3. Types include ... All those genes are involved in the production of the extracellular matrix (ECM). The role of COMP gene remains unclear. It is ... a mutation cannot be identified in any of the five genes above, suggesting that mutations in other as-yet unidentified genes ...
The inheritance pattern of Spondylocostal dysostosis is autosomal recessive. The HES7 transcription factor belongs to the Hairy ... The HES7 gene is self-regulated by a negative feedback loop in which the gene product can bind to its own promoter. This causes ... The HES7 gene product functions to repress expression of genes with promoters containing an N-box or E-box. HES7 also has been ... Genes to Cells. 6 (2): 175-85. doi:10.1046/j.1365-2443.2001.00409.x. PMID 11260262. S2CID 30436382. "Gene: HES7 ( ...
"Entrez Gene: RP2 retinitis pigmentosa 2 (X-linked recessive)". Li L, Rao KN, Zheng-Le Y, Hurd TW, Lillo C, Khanna H (Sep 2015 ... Protein XRP2 is a protein that in humans is encoded by the RP2 gene. The RP2 locus has been implicated as one cause of X-linked ... The predicted gene product shows homology with human cofactor C, a protein involved in the ultimate step of beta-tubulin ... Wada Y, Nakazawa M, Abe T, Tamai M (2000). "A new Leu253Arg mutation in the RP2 gene in a Japanese family with X-linked ...
Chen, X.M.; R.F. Line (1999). "Recessive genes for resistance to Puccinia striiformis f. sp. hordei in barley". Phytopathology ...
Bi-black is recessive. A bi-black Sheltie carries two bi-black genes; thus any dog with a bi-black parent is always bi-factored ... including the bi gene, the merling gene, the sable gene, and the tricolour gene. According to the College of Veterinary ... A tricolor with the merling gene. May have blue eyes. Bi-blue-blue and white. A bi-black with the merling gene. May have blue ... May be pure for sable (two sable genes) or may be tri-factored or bi-factored (carrying one sable gene and one tricolor or ...
To their shock, the non-Ginger parents of the Ginger kids, who each carry a recessive gene that has caused them to have Ginger ... Asians don't carry the recessive gene. I know a guy who's marrying a Japanese woman very soon for just that reason." This is an ... The father of the Ginger kids informs Kyle that marrying an Asian woman ensures that the recessive gene is not passed down, and ...
This is a simple recessive gene. DNA testing, known as "Optigen Testing", can identify dogs carrying the gene for progressive ... Juvenile dilated cardiomyopathy is a fatal condition caused by an autosomal recessive gene. Affected puppies die suddenly or ... "Normal" or "A" dogs do not carry the gene. "Carriers" or "B" dogs carry one copy of the gene and will not express the disease, ... but pass the gene to 50% of their offspring. "Affected" or "C" dogs have two copies of the progressive retinal atrophy gene and ...
The alleles of genes can either be dominant or recessive. A dominant allele needs only one copy to be expressed while a ... These paired genes that control the same trait is classified as an allele. In an individual, the allelic genes that are ... Chemical information that is transported and encoded by each gene is referred to as a trait. Many organisms possess two genes ... These inherited traits are passed down mechanistically with one gene from one parent and the second gene from another parent in ...
X-linked genes are found on the sex X chromosome. X-linked genes just like autosomal genes have both dominant and recessive ... For a recessive trait or disease to be displayed two copies of the trait or disorder needs to be presented. The trait or gene ... Recessive X-linked disorders are rarely seen in females and usually only affect males. This is because males inherit their X ... Genes are the common factor of the qualities of most human-inherited traits. Study of human genetics can answer questions about ...
If you know the genotypes of the organisms, you can determine which alleles are dominant and which are recessive. For example, ... Gene dosage Gene expression Gene family Gene nomenclature Gene patent Gene pool Gene redundancy Genetic algorithm Haplotype ... There are two types of molecular genes: protein-coding genes and noncoding genes. During gene expression, the DNA is first ... "good genes," "hair color gene") typically refers to containing a different allele of the same, shared gene. Genes evolve due to ...
"ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathy". Ann. Neurol. 79 (2): 231-43. doi:10.1002/ana ... Adenylosuccinate synthase like 1 is a protein that in humans is encoded by the ADSS1 gene. This gene encodes a member of the ... "Entrez Gene: Adenylosuccinate synthase like 1". Retrieved 2018-04-09. "Cure ADSSL1". Retrieved 2022-01-30. Sun H, Li N, Wang X ... provided by RefSeq, Feb 2016]. Currently there is no treatment for the distal myopathy caused by the mutation in ADSSL1 gene. ...
Melanism with Richardson's ground squirrels is due to recessive genes. With regard to black squirrels and melanism, two major ... If a black squirrel has two copies of the mutant gene it will be jet black. If it has one copy of a mutant gene and one normal ... A study published by FEBS Letters in 2014 demonstrated how a pigment gene missing a piece of DNA, can be a determinant of an ... Gray squirrels have two copies of a normal pigment gene and black squirrels have either one or two copies of a mutant pigment ...
... (MKS) is an autosomal recessive lethal malformation. Recently, two MKS genes, MKS1 and MKS3, have been ... The MKS1 gene has been identified as being associated with a ciliopathy. Dysplastic kidneys are prevalent in over 95% of all ... Kyttälä, Mira (May 2006). "Identification of the Meckel Syndrome Gene (MKS1) Exposes a Novel Ciliopathy" (PDF). National Public ... encoded by these genes. The malfunction of this protein production is mainly responsible for this lethal disorder.[citation ...
The Parkin gene is linked with mutations associated with autosomal recessive juvenile parkinsonism (previous state of Parkinson ... More gene therapy trials have been conducted for PD (with the adeno-associated virus 2 gene), the objectives and strategies ... The mutations in the Parkin gene are responsible for the development of the autosomal recessive juvenile parkinsonism. ... "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism". Nature. 392 (6676): 605-8. Bibcode:1998Natur.392 ...
For the recessive albino trait to be expressed in a mammal, the offspring must inherit a recessive gene from both parents. ... Mammals have a gene that codes for the presence of tyrosinase in cells - called the TYR gene. If this gene is altered or ... In mice, a total of 100 genes are known to affect albinism. All the genetic traits for albinism are recessive traits. This ... Besides the TYR gene, several other genes can cause albinism. This is because other hormones and proteins are involved in ...
Gene. 394 (1-2): 78-86. doi:10.1016/j.gene.2007.02.009. PMID 17383832. Lin T, Suttle DP (May 1995). "UMP synthase activity ... Deficiency of this enzyme is an inherited autosomal recessive trait in Holstein cattle, and it will cause death before birth. ... In humans, the gene that codes for this enzyme is located on the long arm of chromosome 3 (3q13). This bifunctional enzyme has ... Ichikawa W, Uetake H, Shirota Y, Yamada H, Takahashi T, Nihei Z, Sugihara K, Sasaki Y, Hirayama R (Oct 2003). "Both gene ...
... is an autosomal recessive metabolic disorder affecting enzymes involved in bilirubin metabolism. It is ... A defect in the UGT1A1-gene, also linked to Crigler-Najjar syndrome and Gilbert's syndrome, is responsible for the congenital ... Autosomal recessive disorders, Syndromes, Heme metabolism disorders, All stub articles, Genetic disorder stubs). ...
Both exhibit a single recessive gene, nsv, which is reported to control the only resistance found to MNSV in melon. Although ...
Mutations in this gene lead to impaired cell division during early development. Mitosis has been found to take longer when ... Strømme syndrome is a very rare autosomal recessive genetic condition characterised by intestinal atresia (in which part of the ... Several of the nonsense mutations that have led to this syndrome have been in exon 12 of the gene (out of 20), but mutations in ... Mutations in the gene result in slower cell division and some embryonic developmental processes being disrupted or not ...
The same study revealed that his albinism was caused by a mutation of the SLC45A2 gene. Snowflake received the recessive gene ... for the albino gene. Half of his grandchildren likely carry the albino gene. If both parents were albino gene carriers, they ... None of Snowflake's offspring was albino, but all should be heterozygous, recessive carriers, ... Gene Sequence Shows". The Huffington Post. Archived from the original on June 6, 2014. Retrieved June 6, 2014. anuaris.cat ...
Li H, Bishop KM, O'Leary DD (October 2006). "Potential target genes of EMX2 include Odz/Ten-M and other gene families with ... A case study reports a family with autosomal recessive colobomatous microphthalmia in two children of third-cousin parents. ... Ben-Zur, T.; Feige, E.; Motro, B.; Wides, R. (2000). "The Mammalian Odz Gene Family: Homologs of a Drosophila Pair-Rule Gene ... The Ten-m3 gene, along with Ten-m2 and Ten-m4, is expressed throughout the neocortex in a low rostral to high caudal and a high ...
"Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy". Cell. 78 (4): 625-33. doi:10.1016/ ... "Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D)". Journal ... "Adhalin gene mutations in patients with autosomal recessive childhood onset muscular dystrophy with adhalin deficiency". The ... "Entrez Gene: SGCA sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)". Bowe MA, Mendis DB, Fallon JR (Feb 2000). " ...
The parents of an individual with an autosomal recessive disorder both carry one copy of the defective gene, but usually do not ... Hyperlysinemia is inherited in an autosomal recessive manner. This means the defective gene responsible for the disorder is ... Hyperlysinemia is an autosomal recessive metabolic disorder characterized by an abnormal increase of lysine in the blood, but ... "Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia". American ...
... (SLC25A32 deficiency) is a rare disorder caused by mutations of the SLC25A32 gene ... v t e (Autosomal recessive disorders, Congenital disorders, All stub articles, Medicine stubs). ...
These white matter lesions are also seen in asymptomatic individuals with the mutated gene. While MRI is not used to diagnose ... Proteopathy CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy) Joutel A, ... Autosomal dominant mutations in the Notch 3 gene (on the long arm of chromosome 19) cause an abnormal accumulation of Notch 3 ... The definitive test is sequencing the whole Notch 3 gene, which can be done from a sample of blood. However, as this is quite ...
It is caused by a mutation in the ESCO2 gene. It is one of the rarest autosomal recessive disorders, affecting approximately ... In order to contract Roberts syndrome, a child must inherit the defective gene in an autosomal recessive manner. In other words ... the child must inherit two copies of the defective gene (one from each parent). The ESCO2 gene has a specific effect on cell ... has been labeled as the gene responsible for Roberts syndrome. In fact, ESCO2 is the only known gene that has demonstrated RBS- ...
... recessive Charcot-Marie-Tooth disease, X-linked type 3, recessive Charcot-Marie-Tooth peroneal muscular atrophy, X-linked ... familial dilated Cardiomyopathy due to anthracyclines Cardiomyopathy hearing loss type t RNA lysine gene mutation Hypertrophic ... recessive type 1 Cutis laxa, recessive type 2 Cutis marmorata telangiectatica congenita Cutis verticis gyrata mental deficiency ... recessive Cutis laxa corneal clouding mental retardation Cutis laxa osteoporosis Cutis laxa with joint laxity and retarded ...
... or RAD51 gene (single gene test or multi-gene panel) CMM has clear severe impacts on a patient's ability to carry out daily ... In contrast to DCC, DNAL4 is thought to have a recessive inheritance pattern for the CMM disorder. In CMM disorder patients, ... Mutations in the above genes account for a total of about 35 percent of cases. Mutations in other genes that have not been ... The genes that currently have evidence to be associated with CMM disorder include DCC (deleted in colorectal carcinoma), DNAL4 ...
X-linked recessive (or sex linked) inheritance occurs when the mother carries the affected gene on the X chromosome that has ... Autosomal recessive inheritance occurs when both parents carry and pass on a copy of the faulty gene, but neither parent show ... Furthermore, gene therapies and bone marrow transplantation may prove to be effective for certain lipid storage disorders. Diet ... Each child born to these parents have a 25 percent chance of inheriting both copies of the defective gene, a 50 percent chance ...
The gene responsible for the OCTN2 carnitine transporter is SLC22A5, located at 5q31.1-32. SLC22A5 is regulated by peroxisome ... SPCD is an autosomal recessive condition, meaning a mutated allele must be inherited from each parent for an individual to be ... The specific transporter involved with SPCD is OCTN2, coded for by the SLC22A5 gene located on chromosome 5. SPCD is inherited ... Although SPCD is an autosomal recessive condition, heterozygotes have been shown to be at an increased risk for developing ...
Recent studies have shown that a critical gene for gender determination in Drosophila known as the sex-lethal gene is highly ... is if one sex chromosome of one species has recessive alleles interacting with autosomal alleles of the mating species. This ... The sex-lethal gene is often abnormally expressed in male hybrids from D. melanogaster mothers as a result of re-localization ... There are about 15,000 genes. Gender is determined in Drosophila not by the presence or absence of the Y chromosome as in ...
The dilute gene can occur naturally in Himalayans when the dilute gene mutates in black Himalayans and produces a blue, however ... Dilute is recessive so you will have fewer dilute kittens in a litter produced by heterozygous parents. Black is the most ... Himalayan rabbits are known for having a double copy of the ch gene and a mutated albinism gene which causes the differences in ... The Himalayan gene (ch) has been bred into many other breeds, but those breeds lack marking modifiers which tends to create ...
Type 6 due to mutations in the CIDEC gene. It is inherited in an autosomal recessive fashion and has been reported in only one ... The gene causing this condition is not yet known. This form was first described in 1975. Type 2 (Dunnigan Variety, FPL2) is the ... Another gene that has been associated with this condition is AGPAT2. This not known with certainty but is estimated to be about ... Type 4 is due to mutations in the PLIN1 gene. It is rare with only a small number of cases reported. Fat loss tends to affect ...
In 1996 Felder and colleagues identified the hemochromatosis gene, HFE gene. Felder found that the HFE gene has two main ... Hereditary hemochromatosis is an autosomal recessive disorder with estimated prevalence in the population of 1 in 200 among ... The gene responsible for hereditary hemochromatosis (known as HFE gene) is located on chromosome 6; the majority of hereditary ... The alleles evaluated by HFE gene analysis are evident in ~80% of patients with hemochromatosis; a negative report for HFE gene ...
Cutis Laxa OMIM entries on ATP6V0A2-Related Autosomal Recessive Cutis Laxa Human ATP6V0A2 genome location and ATP6V0A2 gene ... The subunit encoded by this gene is a component of the V(0) domain. Mutations in this gene are a cause of both cutis laxa type ... "Entrez Gene: ATP6V0A2 ATPase, H+ transporting, lysosomal V0 subunit a2". Nishi T, Forgac M (2002). "The vacuolar (H+)-ATPases-- ... v t e (Articles with short description, Short description matches Wikidata, Genes on human chromosome 12, Wikipedia articles ...
This means that usually a child inherits a copy of the mutated gene from both parents, resulting in a homozygous defect. CHAPLE ... CHAPLE syndrome is primarily inherited in an autosomal recessive manner. ... CHAPLE syndrome is caused by mutations of the complement regulator CD55 gene leading to a loss of protein expression. ...
If the mutation is a recessive trait, it will not reveal itself unless both father and mother share it. Due to the risk that ... Couples that are closely related have an increased chance of sharing genes, including mutations that occurred in their family ... the trait is harmful, children of high-consanguinity parents have an increased risk of recessive genetic disorders. See ...
... stemming from recessive genes to present with greater dominance. An alternative put forth by some Navajo is that the sudden ...
The most common cause of haemophilia is genetic, and is passed on by X-linked recessive inheritance; in other words, it can be ... ISBN 978-0-345-52001-2. Gillham, Nicholas (2011). Genes, Chromosomes, and Disease: From Simple Traits, to Complex Traits, to ... only that the father would have been a haemophiliac himself or would have had a mutated gene. Haemophilia B has been known to ...
Raph blood group system in the BGMUT blood group antigen gene mutation database Human CD151 genome location and CD151 gene ... "Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa with multi-systemic manifestations ... "Entrez Gene: CD151 CD151 molecule (Raph blood group)". Bardhan, Ajoy; Bruckner-Tuderman, Leena; Chapple, Iain L. C.; Fine, Jo- ... The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of ...
This latent or recessive gene theory claims that these non-dominant hereditary factors determine the Object selection, ... "The latent hereditary factors in human beings, the recessive genes, do not remain dormant or inactive within the human organism ... Genotropism is defined as the reciprocal attraction between carriers of the same or related latent recessive genes. Developed ... Genotropism consists of the theory that genes influence human behavior. While identified as entities, genes exist in groups ...
This gene, a beta basic group member, is part of a gene cluster with beta-A4, beta-B1, and beta-B2. GRCh38: Ensembl release 89 ... 2005). "Mutations in betaB3-crystallin associated with autosomal recessive cataract in two Pakistani families". Invest. ... "Entrez Gene: CRYBB3 crystallin, beta B3". Human CRYBB3 genome location and CRYBB3 gene details page in the UCSC Genome Browser ... v t e (Genes on human chromosome 22, All stub articles, Human chromosome 22 gene stubs). ...
But incestuous mating is advantageous because it helps maintain gene complexes within the family which may be important for ... but might lead to inbreeding depression-the reduced fitness of offspring because of the unmasking of deleterious recessive ...
The paraplegin gene is responsible for an autosomal recessive form of hereditary spastic paraplegia. This gene is a candidate ... AFG3 ATPase family gene 3-like 2 (S. cerevisiae) is a protein that in humans is encoded by the AFG3L2 gene. This gene encodes a ... "Entrez Gene: AFG3 ATPase family gene 3-like 2 (S. cerevisiae)". Retrieved 2011-12-30. Pierson TM, Adams D, Bonn F, Martinelli P ... v t e (Genes on human chromosome 18, All stub articles, Human chromosome 18 gene stubs). ...
Autosomal recessive disorders among patients attending the genetics clinic in Alexandria  Mokhtar, M.M.; Kotb, S.M.; Ismail, S ... Alexandria were assessed to determine the frequency of genetic disorders and the proportion of autosomal recessive disorders. ...
... have two of every gene, and why is one dominant and the other recessive? How does my body know which one is dominant? How ... A gene is a section of the DNA strand that acts as a template for an enzyme. The DNA for an E. Coli has 1,000 or so genes -- in ... One gene that controls height is a gene that helps produce a hormone known as gibberelline. A normal plant has two copies of ... The mutated second gene produces a damaged enzyme that has no effect. The plant grows tall because it has one undamaged gene. ...
Mutations in the gene encoding otoferlin cause a non-syndromic recessive auditory neuropathy. The evidence for this assertion ... Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene ... Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene ... Even so, more than 12 recessive genes have been identified primarily from large consanguineous pedigrees (see the Hereditary ...
Gene hunting for recessive hereditary peripheral neuropathies by recent and highly-parallel technologies - Rare Diseases 2009. ... recessive inheritance). Recessive forms are very rare in Switzerland and in Western Europe, while higher numbers are observed ... The aim of our study is to identify and characterize novel disease-genes, by taking advantage of a series of recent and highly- ... Azzedine H, Senderek J, Rivolta C and Chrast R (2012). Molecular genetics of Charcot-Marie-Tooth disease: from genes to genomes ...
Learn about this gene and related health conditions. ... The LPAR6 gene provides instructions for making a protein ... Autosomal recessive hypotrichosis. More than 30 LPAR6 gene mutations have been found to cause autosomal recessive hypotrichosis ... Certain LPAR6 gene mutations cause autosomal recessive woolly hair in some people and autosomal recessive hypotrichosis ( ... Mutations in the LPAR6 gene can also cause a hair condition called autosomal recessive woolly hair. People with this condition ...
Transcription factor Ap2b regulates the mouse autosomal recessive polycystic kidney disease genes, Pkhd1 and Cys1.. Wu, Maoqing ... Based on reporter gene assays performed in mouse renal collecting duct cells (mIMCD-3), TFAP2B activated the Pkhd1 and Cys1 ... These results suggest that Tfap2b participates in a renal epithelial cell gene regulatory network that includes Pkhd1 and Cys1 ... Disruption of this network impairs renal tubular differentiation, causing ductal dilatation that is the hallmark of recessive ...
We have optimized all our processes to accept a wide range of samples, always adapting to each case ...
Autosomal recessive polycystic kidney disease (ARPKD) is the most common heritable cystic renal disease occurring in infancy ... Polycystic Kidney Disease, Autosomal Recessive. Adam MP, Ardinger HH, Pagon RA, et al.,. Gene Reviews. University of Washington ... Autosomal Recessive Polycystic Kidney Disease (ARPKD) Imaging * Sections Autosomal Recessive Polycystic Kidney Disease (ARPKD) ... encoded search term (Autosomal Recessive Polycystic Kidney Disease (ARPKD) Imaging) and Autosomal Recessive Polycystic Kidney ...
An ancestral 10bp repeat expansion in gene encoding component of ECM causes a novel autosomal-recessive peripheral neuropathy ... An ancestral 10bp repeat expansion in gene encoding component of ECM causes a novel autosomal-recessive peripheral neuropathy ...
Genes, BRCA1 [‎1]‎. Genes, MHC Class II [‎4]‎. Genes, Plant [‎1]‎. Genes, Recessive [‎1]‎. ...
Autosomal recessive genetic features. In autosomal recessive inheritance, two parents. have a faulty gene but not the condition ... This is because they still both have one healthy gene. However, their offspring can inherit two copies of the faulty gene. The ... with symptoms of Parkinsons disease have changes in the LRRK2 gene, and around 0.3% have changes in the PRKN gene, according ... People have two copies of each gene. In autosomal dominant inheritance, a child can inherit either a healthy gene or one that ...
autosomal recessive abnormal gene on one of the autosomal chromosomes from each parent, transmission of both abnormal genes is ... AICDA activation-induced cytidine deaminase gene allele alternative form of a gene that exists at a specific gene location ( ... gene therapy treatment of a genetic disorder by replacing, supplementing, or manipulating nonfunctional genes with normal genes ... in a gene or set of genes. Mutations can be inherited or occur de novo. The effect of a mutation on a gene depends on how it ...
Embryonic function of the MFRP gene appears necessary for the eye to reach its full size at birth. Its onset of expression in ... Recessive nanophthalmos is caused by severe mutations in the MFRP gene, which encodes a Frizzled-related transmembrane protein ... Patients without MFRP gene function exhibit no correction of refractive error during childhood, which suggests that this gene ... Conclusions: Embryonic function of the MFRP gene appears necessary for the eye to reach its full size at birth. Its onset of ...
Regular segregation of four recessive marker genes among maternal haploids in maize journal, August 2000 * Chalyk, S. T.; ... Management of the ig gene for haploid induction in maize journal, January 1992 * Pollacsek, M. ... Use of the multi-allelic self-incompatibility gene in apple to assess homozygocity in shoots obtained through haploid induction ... Modulation of expression of one or more additional genes which affect reproductive transition such as zagl1, in conjunction ...
Lots of these mutations are recessive. What this means is that you need two copies of the mutated gene to see the trait. ( ... Similarly to the mutations that can make humans less fit, there are recessive genes that have the potential to cause serious ... It all depends on the founders genes. Too many "bad" genes with too few founders and you end up with a sickly group that ... So, if two people with a working and a mutant copy of the gene get together, then 1 in 4 of their kids will have the trait. ...
primary autosomal recessive microcephaly. IDs. primary autosomal recessive microcephaly DOID:0070296. OMIM:PS251200. ORDO:2512 ... Gene Model ID. Feature Type. Coordinates. Select Strains. C57BL/6J MGI_C57BL6J_1922028. protein coding gene. Chr15:82997634- ... protein coding gene. Chr15:83038478-83049557 (-). BALB/cJ MGP_BALBcJ_G0022123. protein coding gene. Chr15:80861466-80867806 (-) ... protein coding gene. Chr15:83068203-83088221 (-). PWK/PhJ MGP_PWKPhJ_G0021156. protein coding gene. Chr15:80192256-80202765 (-) ...
Doberman Pinscher - Sam - Has Recessive Blue Gene - Large Doberman Pinscher - Sam - Has Recessive Blue Gene - Large Age:7 yrs ...
Genes. *DNA. *Dominant and Recessive Traits. *Punnett Square. *Assignment: Mr. Mars Man Lab ...
MPS III is caused by a recessive gene. If the adult carrying the gene marries another carrier, there will be a one in four ...
For recessive cases, which are less common, there is a 1 in 4 recurrence risk. In-frame mutations of the X-linked E1 alpha gene ... all other causes are due to alterations in recessive genes. ... Since the most common form of the PDCD is X-linked recessive, ... There is a wide range of presentation in the recessive forms of the disease, but most are milder than the X-linked form of the ... There is a wide range of presentation in the recessive forms of the disease, but many are equally as severe as the X-linked ...
Find symptoms and other information about Autosomal recessive spastic paraplegia type 49. ... RareSource offers rare disease gene variant annotations and links to rare disease gene literature. ... Data from Orphanet and Human Phenotype Ontology (HPO) are used to provide information on a diseases symptoms, genes, ... About Autosomal recessive spastic paraplegia type 49. Many rare diseases have limited information. Currently GARD aims to ...
It is a biological discipline that deals with the structure and function of genes, their behavior and patterns of inheritance ... Difference Between Dominant and Recessive Dominant vs Recessive Genetics is the science of heredity, genes, and the differences ... 4.A recessive gene will only show up if the offspring inherits recessive genes from both parents.. 5.Dominant genes are most ... 2.A dominant gene is one which is strong while a recessive gene is one which is weak.. 3.A dominant gene will show up in the ...
His colouring is from a recessive gene. White deer are often mistakenly thought to be albinos, but their unusual condition is ... How long have you been consuming gene-therapied pork?. * Astonishing rise in Britons with an irregular heartbeat - these are ...
... medically actionable mutations in genes not related to the disease phenotype; carrier status for autosomal recessive genes ... Hormone-Based Gene Therapy to Sterilize Domestic Cat A new paper in Nature Communication suggests that gene therapy could be a ... "New gene discoveries are definitely going to drive our diagnostic rate higher," she said. Improving exome coverage will also ... Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene A PNAS paper focuses on a skeleton-related ...
Youve heard of those recessive genes,. And the masterful dominant types?. We could hope Malcolms progressive genes. Throve ... Whereas Abbotts mix of political genes. Seemed extreme, then more extreme when unveiled.. But Malcolms drum-banging terrorism ... His progressive genes are feeling queasy.. Hes Abbott without the flags, so to state. ...
The researchers, however, noted that this trait is recessive. Hence, a fish must have two copies from both its parents to be ... The Status of Gene Editing Regulations in Fish Aquaculture. Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit ... A gene from its gonad was turned off to keep yolk protein, and essential nutrient in egg development, in the liver from being ... Gene Editing to Help Curb Sterility Paradox in Fish Production. October 5, 2022 ...
In Radiation, Genes and Man (1960), 107. Science quotes on: , Already (222) , Assumption (96) , Author (171) , Aversion (8) , ... recessive. The word recessive was chosen because the traits so designated recede or disappear entirely in the hybrids, but ... Science quotes on: , Completely (136) , Conclusion (259) , Curiosity (135) , Devoted (59) , Draw (139) , Enough (341) , Gene ( ... Gene (104) , Gentleman (26) , Incidence (2) , Know (1526) , Marriage (39) , Mate (6) , Mean (808) , Meaning (239) , Means (580) ...
Diagnosis was confirmed by finding a mutated recombination activating gene 2. At 6 months of age, iVDPV1 with 10 VP1 mutations ... There was a history of 2 siblings death from Kostmann syndrome and autosomal-recessive polycystic kidney disease. ... A presumptive diagnosis of SCID was confirmed by detecting a homozygous mutated adenosine deaminase gene. Stool was positive ... we established a final diagnosis of SCID by detecting a homozygous missense mutation in a recombination activating gene 1. ...
  • How does your body know the difference between dominant and recessive genes? (howstuffworks.com)
  • Transcription factor Ap2b regulates the mouse autosomal recessive polycystic kidney disease genes, Pkhd1 and Cys1 . (bvsalud.org)
  • Mice lacking functional Tfap2b gene die in the perinatal or neonatal period with cystic dilatation of the kidney distal tubules and collecting ducts, a phenotype resembling autosomal recessive polycystic kidney disease ( ARPKD ). (bvsalud.org)
  • Autosomal recessive polycystic kidney disease (ARPKD) is the most common heritable cystic renal disease occurring in infancy and childhood. (medscape.com)
  • Ultrasonography is the primary radiologic modality for the evaluation of autosomal recessive polycystic kidney disease (ARPKD), especially during the perinatal and neonatal periods. (medscape.com)
  • More than 30 LPAR6 gene mutations have been found to cause autosomal recessive hypotrichosis, a condition that results in sparse hair growth (hypotrichosis) on the scalp and, less frequently, other parts of the body. (medlineplus.gov)
  • LPAR6 gene mutations lead to the production of an abnormal LPA 6 protein that cannot bind to LPA to regulate cell proliferation and differentiation within hair follicles. (medlineplus.gov)
  • Mutations in the LPAR6 gene can also cause a hair condition called autosomal recessive woolly hair. (medlineplus.gov)
  • Certain LPAR6 gene mutations cause autosomal recessive woolly hair in some people and autosomal recessive hypotrichosis (described above) in others, even among members of the same family. (medlineplus.gov)
  • The autosomal recessive condition results from mutations in genes encoding proteins involved in transporting bile out of the liver, reducing or stopping the outflow of bile acids and causing metabolic cholestasis that can lead to serious liver damage. (medscape.com)
  • Hereditary hemochromatosis (HH) attributable to mutations in the HFE gene is the most common autosomal recessive disorder among adults of northern European origin. (cdc.gov)
  • GS is caused by mutations in the thiazide-sensitive Na-Cl cotransporter gene. (who.int)
  • This genetic material is composed of chromosomes with individual genes or alleles containing specific traits. (differencebetween.net)
  • For each trait, an individual acquires two copies of genes or alleles, one from the mother and the other from the father. (differencebetween.net)
  • Recessive alleles or genes will only show up if the offspring inherits recessive copies of the trait from both parents. (differencebetween.net)
  • There are three combinations of genotypes or alleles: AA (receives dominant traits from both parents), Aa (receives a dominant trait from one parent and a recessive trait from the other), and aa (receives recessive traits from both parents). (differencebetween.net)
  • Individual genes are made up of a recessive and non-recessive gene, called alleles. (naturalnews.com)
  • A total of 660 patients referred to the genetics clinic, Medical Research Institute, Alexandria were assessed to determine the frequency of genetic disorders and the proportion of autosomal recessive disorders. (who.int)
  • What is a gene, and what is genetic engineering? (howstuffworks.com)
  • 11, 14, 15 Hearing loss in some forms of HSMN has been shown to be associated with specific genetic alterations, including 8q23 in HSMN-Lom 16 and a mutation of Thr124Met in the myelin protein zero gene. (bmj.com)
  • The hereditary pattern of the disease is various: it can be transmitted from a healthy mother to her male children (X-linked inheritance), from one affected parent to (on average) 50% of his/her children (dominant inheritance), or from healthy parents, both carrier of a genetic mutation, to 25% of their progeny (recessive inheritance). (grstiftung.ch)
  • The aim of our study is to identify and characterize novel disease-genes, by taking advantage of a series of recent and highly-parallel genetic technologies that are particularly well adapted for the study of consanguineous pedigrees. (grstiftung.ch)
  • Finally, based on the genetic data, we have functionally characterized the identified genes, in hopes of providing new insights into the mechanisms (and hence possible treatments) underlying peripheral neuropathies. (grstiftung.ch)
  • Sickle cell anaemia was the first inherited disorder to be attributed to a specific genetic mutation - a single letter (base) substitution in the DNA of a gene responsible for producing a part of haemoglobin. (thehindu.com)
  • Genetic variants in TNFa, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate -induced asthma. (cdc.gov)
  • A case-control study was conducted to investigate whether genetic variants in inflammatory response genes (TNFa, IL1a, IL1B, IL1RN, IL10, TGFB1, ADAM33, ALOX-5, PTGS1, PTGS2 and NAG-1/GDF15) are associated with increased susceptibility to diisocyanate asthma (DA). (cdc.gov)
  • These results suggest that genetic variations in TNFa, TGFB1, PTGS1 and PTGS2 genes contribute to DA susceptibility. (cdc.gov)
  • Genetics is the science of heredity, genes, and the differences in living organisms. (differencebetween.net)
  • As a result of the rapid advances in genetics technology and the Human Genome Project, most of the estimated 100,000 genes in humans will be identified by the year 2005 (1). (cdc.gov)
  • The results of such a cross should produce offspring that all display the black phenotype, but carry the recessive pearl allele. (k-state.edu)
  • Genes that influence the PHENOTYPE only in the homozygous state. (bvsalud.org)
  • Experts estimate that there are 60,000 to 100,000 genes (made up of DNA) in a human being's 46 chromosomes. (parents.com)
  • The word 'recessive' was chosen because the traits so designated recede or disappear entirely in the hybrids, but reappear unchanged in their progeny, as will be demonstrated later. (todayinsci.com)
  • This second filial generation would therefore produce progeny that are half white-eyed (homozygous recessive) and half black-eyed (homozygous dominant). (k-state.edu)
  • One hundred white progeny and one hundred black progeny then underwent DNA extraction and PCR, amplifying the pearl genes in their genomic libraries. (k-state.edu)
  • This indicates that the white-eyed progeny inherited two copies of the recessive pearl allele whereas the black-eyed progeny inherited only one. (k-state.edu)
  • That is, the fact that all the black-eyed progeny displayed a homozygous recessive genotype for pearl and all the white-eyed progeny displayed a heterozygous genotype indicates that the mutation can be traced to an area of the Tribolium genome that is homologous to the white gene in Drosophila . (k-state.edu)
  • It is a biological discipline that deals with the structure and function of genes, their behavior and patterns of inheritance from the parents to the offspring. (differencebetween.net)
  • One or the other gene from the pair of genes in each chromosome gets passed on to the child. (howstuffworks.com)
  • If there were just one pair of genes involved in selecting eye color, there would be at maximum three shades of eye color -- brown, blue, and perhaps green. (parents.com)
  • Primary immunodeficiency (PI) diseases are a group of primarily single-gene disorders of the immune system. (cdc.gov)
  • How autosomal recessive disorders like sickle cell anaemia and cystic fibrosis are inherited. (thehindu.com)
  • Even so, more than 12 recessive genes have been identified primarily from large consanguineous pedigrees (see the Hereditary Hearing Loss Homepage http://www.uia.ac.be/dnalab/hhh for an overview). (bmj.com)
  • However, the diagnosis was corrected to hereditary ATTR amyloidosis using mass spectrometry and gene sequencing, confirming the important role of mass spectrometry in identifying the amyloid precursor protein and ruling out false-positive result from immunohistochemistry. (bvsalud.org)
  • So whether or not a ram grows big horns will depend on if it inherits the Ho+ or the HoP allele of the RXFP2 gene. (thehindu.com)
  • 1.An individual receives two copies of each trait that he inherits from his parents, one from the mother and one from the father, with one of them dominant and the other recessive. (differencebetween.net)
  • 4.A recessive gene will only show up if the offspring inherits recessive genes from both parents. (differencebetween.net)
  • Selected genomic regions, primarily coding exons and exon-intron boundaries, from the targeted genes are isolated from extracted genomic DNA using a probe-based hybrid capture enrichment workflow. (arupconsult.com)
  • A genomic deletion in the IP 3 R1 gene removes two exons from the IP 3 R1 mRNA but does not interrupt the translational reading frame. (jneurosci.org)
  • In the following discussion those traits that pass into hybrid association entirely or almost entirely unchanged, thus themselves representing the traits of the hybrid, are termed dominating and those that become latent in the association, recessive. (todayinsci.com)
  • As it turns out, most human traits are polygenic -- the result of many genes acting together. (parents.com)
  • To complicate things even further, for some traits -- such as height, weight, and especially personality -- environment also has a significant influence on which genes are expressed and which remain muted. (parents.com)
  • Therefore an individual who is either homozygous wildtype or heterozygous will display the normal black eye pigment, while the homozygous recessive individual will display the mutant white eyes. (k-state.edu)
  • The research began by mating a wildtype mother (homozygous dominant, with black eyes) with a mutant father (homozygous recessive, with white eyes. (k-state.edu)
  • Recent work has shown that mice homozygous for Ahl are not only more sensitive to noise , but also are probably damaged in a different manner by noise than mice containing the wild-type gene. (cdc.gov)
  • 17 The children with AN described here have an autosomal recessive disorder and are distinguished by their lack of any other detectable peripheral neuropathy. (bmj.com)
  • The researchers, however, noted that this trait is recessive. (isaaa.org)
  • 3.A dominant gene will show up in the trait while a recessive gene, although still present, is masked or hidden by the dominant gene. (differencebetween.net)
  • The gene can be transmitted either as an autosomal dominant or autosomal recessive trait, or it can be X-linked. (bvsalud.org)
  • Genes, Neurofibromatosis 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (harvard.edu)
  • Recessive forms are very rare in Switzerland and in Western Europe, while higher numbers are observed in ethnic groups where consanguineous marriages are more frequent. (grstiftung.ch)
  • Of the 49 babies with multiple malformations, 21 (42.8%) had recog- nized syndromes, most of which were autosomal recessive and 17 had chromosomal aberrations. (who.int)
  • The total chromosomal content of a cell involves approximately 105 genes in a specialized macromolecule of deoxyribonucleic acid (DNA). (cdc.gov)
  • A normal plant has two copies of the gibberelline gene, so it produces plenty of gibberelline and grows normally. (howstuffworks.com)
  • If a plant has one copy of the gibberelline gene that is normal, it still produces plenty of gibberelline. (howstuffworks.com)
  • The plant grows tall because it has one undamaged gene. (howstuffworks.com)
  • If a plant happens to inherit two damaged gibberelline genes, it will produce no gibberelline, and the plant will be short. (howstuffworks.com)
  • This has no effect on the plant unless both copies of the gene contain a mutation, in which case the plant gets no gibberelline and cannot grow properly. (howstuffworks.com)
  • 2.A dominant gene is one which is strong while a recessive gene is one which is weak. (differencebetween.net)
  • Back then, you were told that the dominant gene always beats out the recessive one. (parents.com)
  • Because different genes are probably responsible for how much brown pigment you inherit and where it shows up in the eye (more brown or blue can fall in the center or outer edges of the eye) there's a great possibility for a wide variety of hues. (parents.com)
  • One of these genes, white, has the power to correct a common mutation in eye pigment. (k-state.edu)
  • The LPAR6 gene provides instructions for making a protein called lysophosphatidic acid receptor 6 (LPA 6 ). (medlineplus.gov)
  • A lack of LPA 6 protein function in the epidermis likely contributes to the skin problems sometimes seen in individuals with autosomal recessive hypotrichosis. (medlineplus.gov)
  • A gene from its gonad was turned off to keep yolk protein, and essential nutrient in egg development, in the liver from being produced. (isaaa.org)
  • Two years back, a team of scientists identified the gene in sheep that determines horn size. (thehindu.com)
  • On probing , scientists were amazed to find out that the faulty HbS gene was giving people resistance to malaria, a disease with very high mortality in these areas. (thehindu.com)
  • To form the single strand in the sperm or egg, one of the copies of each gene is chosen randomly. (howstuffworks.com)
  • This means they contain two copies of each gene - one inherited from each parent. (thehindu.com)
  • Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene. (grstiftung.ch)
  • There are several genes in the Drosophila genome that control the eye color of the individual. (k-state.edu)
  • The autosomal recessive opisthotonos ( opt ) mutant is a single-gene mouse mutation displaying epileptic-like behaviors. (jneurosci.org)
  • The purpose of this was to denature each insect's copy of the pearl gene (wildtype or mutant) and check to see which allele was inherited by which insect. (k-state.edu)
  • These genes were selected based on their role in asthmatic inflammatory processes and previously reported associations with asthma phenotypes. (cdc.gov)
  • Of these mediators, cytokines play a single nucleotide polymorphisms (SNP) in pro-inflammatory cytokine genes and asthma phenotypes (Che et al. (cdc.gov)
  • Remember learning about genes and fruit flies in high school biology? (parents.com)
  • The sensitivity and specificity of such testing can now be improved as a result of the recent discovery of the Cystic Fibrosis Transmembrane Conductance Regulatory (CFTR) gene. (cdc.gov)
  • The discovery of the Cystic Fibrosis Transmembrane Conductance Regulatory (CFTR) gene (5) renewed interest in this possibility, as the sensitivity and specificity of testing could be improved through DNA-based testing. (cdc.gov)
  • In addition, the knowledge of the genes conditioning resistance in different genotypes allows getting precise combination in new germplasm. (hindawi.com)
  • The incorporation of the known genes in new cultivars could contribute to broadening the resistance to the pathogen. (hindawi.com)
  • From the samples they've studied, the researchers estimate that between 59 and 94 percent of bollworms with any resistance had at least one non-recessive gene that was adapted for Bt resistance. (naturalnews.com)
  • RareSource offers rare disease gene variant annotations and links to rare disease gene literature. (nih.gov)
  • Collectively, we have obtained enough results to produce 8 scientific articles, describing, among other things, the identification of 3 new disease genes and the molecular causes of HPN and retinitis pigmentosa for a relatively large number of patients. (grstiftung.ch)
  • Click on a disease name to see all genes associated with that disease. (jax.org)
  • But if we are unlucky enough to inherit two copies of the faulty gene (HbS), we inherit the disease in all its viciousness. (thehindu.com)
  • About 10 years ago Erway et al (1993) demonstrated a recessive gene associated with early presbycusis in inbred mice: Ahl. (cdc.gov)
  • Based on reporter gene assays performed in mouse renal collecting duct cells (mIMCD-3), TFAP2B activated the Pkhd1 and Cys1 promoters and electromobility shift assay (EMSA) confirmed TFAP2B binding to the in silico identified sites. (bvsalud.org)
  • These results suggest that Tfap2b participates in a renal epithelial cell gene regulatory network that includes Pkhd1 and Cys1. (bvsalud.org)
  • a Genes included on this test are a subset of a larger methods-based validation from which the PPA values are derived. (arupconsult.com)
  • Testing for a known familial sequence variant by sequencing gene of interest. (arupconsult.com)
  • The primers Wh-ll and Wh-12 RC were chosen because they reside on opposite sides of the pearl gene sequence, and PCR using them would amplify the complete pearl sequence. (k-state.edu)
  • Linkage studies and mutation analysis have identified the OTOF gene as being responsible for this type of hearing loss in our families. (bmj.com)
  • The Wild-Type NF1 Gene: It's a Real Turnoff. (harvard.edu)
  • When Do Symptoms of Autosomal recessive spastic paraplegia type 49 Begin? (nih.gov)
  • 2001) has shown that the wild-type Ahl gene codes for an outer-hair cell specific cadherin. (cdc.gov)
  • There's even a specific gene for 'gap tooth' that's been discovered and is believed to be dominant. (parents.com)
  • With all the possible gene combinations, one pair of parents has the potential to produce 64 trillion different children. (parents.com)
  • However, epidemiologists found out that in some populations - especially in places where malaria was predominant, like Africa - the HbS gene is very common. (thehindu.com)
  • Common experimental animals (rats, guinea pigs, chinchillas, cats) are outbred?their genomes contain an admixture of many genes. (cdc.gov)
  • new study by the same group of researchers who discovered the RXFP2 gene two years ago. (thehindu.com)
  • A copy of the family member's test result documenting the familial gene variant is REQUIRED. (arupconsult.com)
  • GXD's primary emphasis is on endogenous gene expression during development. (jax.org)
  • This graph shows the total number of publications written about "Genes, Neurofibromatosis 1" by people in Harvard Catalyst Profiles by year, and whether "Genes, Neurofibromatosis 1" was a major or minor topic of these publication. (harvard.edu)
  • Below are the most recent publications written about "Genes, Neurofibromatosis 1" by people in Profiles. (harvard.edu)
  • Mutation of these genes is thought to cause NEUROFIBROMATOSIS 1, Watson syndrome, and LEOPARD syndrome. (harvard.edu)
  • Gitelman syndrome (GS) is an autosomal-recessive disorder distinguished by hypokalemia, hypomagnesemia, and hypocalciuria. (who.int)
  • Tumor suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. (harvard.edu)
  • Eye color is one example wherein dominant genes mask recessive genes. (differencebetween.net)
  • If one parent has brown eyes and the other blue, brown is the dominant color and blue is the recessive. (differencebetween.net)
  • We have recently succeeded in cloning the white cDNA from Tribolium -- the first time this gene has been cloned in an insect outside the Drosophilid Order, Diptera . (k-state.edu)
  • That is, pearl and white are homologous genes in Tribolium and Drosophila . (k-state.edu)
  • The fact that no recombination occurred during this experiment is strong evidence that pearl is closely linked to the white gene in Drosophila . (k-state.edu)
  • To make an enzyme that it needs, the chemical mechanisms inside an E. Coli cell make a copy of a gene from the DNA strand and use this template to manufacture the enzyme. (howstuffworks.com)
  • You can see from this discussion that the cell does not 'know' that one gibberelline gene is dominant and the other is recessive. (howstuffworks.com)
  • The cell is manufacturing enzymes from both copies of the gene. (howstuffworks.com)